UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

 

x

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

 

SECURITIES EXCHANGE ACT OF 1934

For the Fiscal Year Ended December 31, 2006

Commission File No. 1-9328

 

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

 

SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to                        

ECOLAB INC.

(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of
incorporation or organization)

 

41-0231510
(I.R.S. Employer
Identification No.)

370 Wabasha Street North, St. Paul, Minnesota
(Address of principal executive offices)

 

55102
(Zip Code)

 

Registrant’s telephone number, including area code: (651) 293-2233

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Name of each exchange on which registered

Common Stock, $1.00 par value

 

New York Stock Exchange, Inc.

Preferred Stock Purchase Rights

 

New York Stock Exchange, Inc.

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

x   YES      o   NO

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

o   YES      x   NO

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

x   YES      o   NO

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer” and “large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large Accelerated Filer   x

Accelerated Filer   o

Non-Accelerated Filer   o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

o   YES      x   NO

Aggregate market value of voting and non-voting common equity held by non-affiliates of registrant on June 30, 2006: $10,187,562,612 (see Item 12, under Part III hereof), based on a closing price of registrant’s Common Stock of $40.58 per share.

The number of shares of registrant’s Common Stock, par value $1.00 per share, outstanding as of January 31, 2007: 250,634,287 shares.

DOCUMENTS INCORPORATED BY REFERENCE

1.                Portions of the registrant’s Annual Report to Stockholders for the year ended December 31, 2006 (hereinafter referred to as “Annual Report”) are incorporated by reference into Parts I and II.

2.                Portions of the registrant’s Proxy Statement for the Annual Meeting of Stockholders to be held May 4, 2007 and to be filed within 120 days after the registrant’s fiscal year ended December 31, 2006 (hereinafter referred to as “Proxy Statement”) are incorporated by reference into Part III.

 




TABLE OF CONTENTS

PART I

Forward-Looking Statements

Item 1(a) General Development of Business

Item 1(b) Financial Information About Operating Segments

Item 1(c) Narrative Description of Business

Item 1(d) Financial Information About Geographic Areas

Item 1(e) Available Information

Executive Officers of the Company

Item 1A. Risk Factors

Item 1B. Unresolved Staff Comments

Item 2. Properties

Item 3. Legal Proceedings

Item 4. Submission of Matters to a Vote of Security Holders

 

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer purchases of Equity Securities

Item 6. Selected Financial Data

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operation

Item 7A. Quantitative and Qualitative Disclosures about Market Risk

Item 8. Financial Statements and Supplementary Data

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Item 9A. Controls and Procedures

Item 9B. Other Information

 

PART III

Item 10. Directors, Executive Officers of the Registrant and Corporate Governance

Item 11. Executive Compensation

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Item 13. Certain Relationships and Related Transactions

Item 14.  Principal Accounting Fees and Services

 

PART IV

Item 15. Exhibits and Financial Statement Schedules

 

SIGNATURES

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ON FINANCIAL STATEMENT SCHEDULE

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

SCHEDULE II —VALUATION AND QUALIFYING ACCOUNTS

 

EXHIBIT INDEX

 




PART I

Except where the context otherwise requires, references in this Form 10-K to either “Ecolab,” “Company,” “we” and “our” are to Ecolab Inc. and its subsidiaries, collectively.

Forward-Looking Statements

This Annual Report on Form 10-K, including “Management’s Discussion and Analysis of Financial Condition and Results of Operation” incorporated by reference into Item 7 of this Form 10-K,  contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements include expectations concerning business progress and expansion, business acquisitions, currency translation, cash flows, debt repayments, environmental and regulatory considerations, share repurchases, global economic conditions, pension expenses and potential contributions, income taxes and liquidity requirements.  Without limiting the foregoing, words or phrases such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “we believe,” “we expect,” “estimate,” “project” (including the negative or variations thereof) or similar terminology, generally identify forward-looking statements.  Forward-looking statements may also represent challenging goals for us.  We caution that undue reliance should not be placed on such forward-looking statements, which speak only as of the date made.  Some of the factors which could cause results to differ from those expressed in any forward-looking statement are set forth under Item 1A of this Form 10-K, entitled Risk Factors.

Item 1.  Business .

Item 1(a) General Development of Business .

Ecolab was incorporated as a Delaware corporation in 1924.  Our fiscal year is the calendar year ending December 31.

During 2006, we continued to make business acquisitions to broaden our product offerings and expand our geographic coverage, consistent with our “Circle the Customer — Circle the Globe” strategy.  These transactions included the following:

In June 2006, the Company acquired Shield Medicare Ltd., a developer, manufacturer and marketer of contamination control products used in pharmaceutical, medical device and hospital clean rooms.  Shield Medicare Ltd., located in the United Kingdom, has annual sales of approximately $19,000,000 and became part of our International operations beginning in the third quarter of 2006.

In September 2006, we acquired DuChem Industries, Inc.  DuChem manufactures and markets cleaning and sanitizing products with a focus on the protein (meat and poultry) segment of the food and beverage market.  Duchem is located in Newnan, Georgia and has annual sales of approximately $10,000,000 and became part of our United States Cleaning & Sanitizing operations in the third quarter of 2006.

In September 2006, we acquired Powles Hunt & Sons International Ltd.’s commercial laundry business from Quill International Group.  Powles Hunt is a leading supplier of professional laundry products in the United Kingdom with annual sales of approximately $5,000,000 and became part of our International operations beginning in the fourth quarter of 2006.

Additional details regarding certain of the above acquisition transactions are found in Note 5 located on pages 34 and 35 of the Annual Report, and incorporated into Item 8 of this Form 10-K.

Item 1(b) Financial Information About Operating Segments .

The financial information about reportable segments appearing under the heading “Operating Segments” in Note 16, located on pages 45 and 46 of the Annual Report, is incorporated herein by reference.

2




 

Item 1(c) Narrative Description of Business .

General :   Ecolab develops and markets premium products and services for the hospitality, foodservice, healthcare and industrial markets.  We provide cleaning and sanitizing products and programs, as well as pest elimination, maintenance and repair services primarily to hotels and restaurants, healthcare and educational facilities, quick-service (fast-food and other convenience store) units, grocery stores, commercial and institutional laundries, light industry, dairy plants and farms, food and beverage processors and the vehicle wash industry.  A strong commitment to customer support is a distinguishing characteristic of our business.  Additional information on our business philosophy is found below under the heading “Additional Information — Competition” of this Item 1(c).

The following description of our business is based upon our three reportable segments as reported in our consolidated financial statements.  However, we pursue a “Circle the Customer — Circle the Globe” strategy by providing products, systems and services which serve our customer base, and do so on a global basis to meet the needs of our customers’ various operations around the world.  Therefore, one customer may utilize the products or services of all three of the segments and there is interdependence among the operating segments.  Revenues of our International segment include sales outside the United States by our Kay and Pest Elimination businesses.

United States Cleaning & Sanitizing Segment

The “United States Cleaning & Sanitizing” segment is comprised of seven business units which provide cleaning and sanitizing products and programs to United States markets.

Institutional :  Our Institutional Division is our largest division and sells specialized cleaners and sanitizers for washing dishes, glassware, flatware, foodservice utensils and kitchen equipment (“warewashing”), for on-premise laundries (typically used by hotel and health care customers) and for general housekeeping functions, as well as food safety products and equipment, dishwasher racks and related kitchen sundries to the foodservice, lodging, educational and healthcare industries, and water filters to the foodservice industry.  The Institutional Division also provides pool and spa treatment programs for hospitality and other commercial customers.  The Institutional Division manufactures and markets various chemical dispensing device systems, which are made available to customers, to dispense our cleaners and sanitizers. In addition, the Institutional Division markets a lease program comprised of energy-efficient dishwashing machines, detergents, rinse additives and sanitizers, including full machine maintenance.

We believe we are the leading supplier of chemical warewashing products and programs to institutions in the United States.

The Institutional Division sells its products and programs primarily through company-employed field sales and service personnel.  However, to a significant degree, we also utilize independent, third-party foodservice distributors to market and sell our products to smaller accounts or accounts which purchase through food distributors.  We provide the same customer support to accounts supplied by food distributors as to direct customers.

Effective January 1, 2007, we integrated our former Professional Products division into the Institutional Division to deliver a broad range of cleaning and floor care products and programs to customers in hospitality, health care and commercial facilities.  The Institutional sales force along with a network of independent, third-party distributors serving the commercial janitorial industry, market Professional Products’ proprietary offerings (detergents, general purpose cleaners, carpet care, stone care, furniture polishes, disinfectants, floor care products, hand soaps and odor counteractants).

Kay :  Our Kay Division (which consists of certain wholly-owned subsidiaries of Ecolab Inc.) supplies chemical cleaning and sanitizing products primarily to national and regional quick-service restaurant chains and to the food retail (i.e., grocery store) industry.  Kay’s products include specialty and general purpose hard surface cleaners, degreasers, sanitizers, polishes, hand care products and

3




 

assorted cleaning tools.  Products are sold under the “Kay” brand or the customer’s private label. In addition, Kay supports its product sales with employee training programs and technical support designed to meet the special needs of its customers.  Kay’s customized cleaning and sanitation programs are designed to reduce labor costs and product usage while increasing sanitation levels, cleaning performance, equipment life and safety levels.

Kay employs a direct field sales force which primarily calls upon national and regional quick-service restaurant, franchisee, and food retail chain headquarters, although the sales are made to distributors who supply the chain or franchisee’s units.

We believe that our Kay Division is the leading supplier of chemical cleaning and sanitizing products to the traditional quick-service restaurant industry in the United States.  While Kay’s customer base has been growing, Kay’s business is largely dependent upon a limited number of major quick-service restaurant chains and franchisees.  Kay continues to seek growth and diversification opportunities.

Food & Beverage :  Our Food & Beverage Division addresses cleaning and sanitation at the beginning of the food chain to facilitate the production of products for human consumption.  The Division provides detergents, cleaners, sanitizers, lubricants and animal health products, as well as cleaning systems, electronic dispensers and chemical injectors for the application of chemical products, primarily to dairy plants, dairy farms, breweries, soft-drink bottling plants, and meat, poultry and other food processors.  The Food & Beverage Division is also a leading developer and marketer of antimicrobial products used in direct contact with meat, poultry, seafood and produce during processing in order to reduce microbial contamination on those surfaces.  The Division also designs, engineers and installs CIP (“clean-in-place”) process control systems and facility cleaning systems for its customer base.   Farm products are sold through dealers and independent, third-party distributors, while plant products are sold primarily by our field sales personnel.

We believe that we are one of the leading suppliers of cleaning and sanitizing products to the dairy plant, dairy farm, food, meat and poultry, and beverage/brewery processor industries in the United States.

Textile Care : Our Textile Care Division provides chemical laundry products and proprietary dispensing systems, as well as related programs, to large industrial and commercial laundries.  Typically these customers process a minimum of 1,000,000 pounds of linen each year and include free-standing laundry plants used by institutions such as hotels, restaurants and healthcare facilities as well as industrial and textile rental laundries.  Products and programs include laundry cleaning and specialty products and related dispensing equipment, which are marketed primarily through a Company-employed sales force and, to a lesser extent, through independent, third-party distributors. The Division’s programs are designed to meet our customer’s need for exceptional cleaning, while extending the useful life of linen and reducing the customer’s overall operating cost.

Healthcare :  Our Healthcare Division provides infection prevention and healthcare offerings to hospital, acute care and long-term care markets in the United States.  Healthcare’s proprietary infection prevention/healthcare products (skin care, disinfectants and instrument cleaners) are sold primarily under the “Ecolab” and “Huntington” brand names.

Vehicle Care :   Our Vehicle Care Division provides vehicle appearance products which include soaps, polishes, sealants, wheel and tire treatments and air fresheners.  Products are sold to vehicle rental, fleet and consumer car wash and detail operations.  Brand names utilized by the Vehicle Care Division include Blue Coral Ò , Black Magic Ò  and Rain-X Ò .

4




 

Water Care Services :  Water Care Services provides water and wastewater treatment products, services and systems for commercial/institutional customers (full service hotels, cruise ships, hospitals, healthcare, commercial real estate, government, and commercial laundries), food and beverage customers (dairies, meat, poultry, food processing and beverage) and other light industry. Water Care Services works closely with our Institutional, Textile Care and Food & Beverage Divisions to offer customized water care strategies to their accounts that have water care needs, primarily to treat water used in heating and cooling systems and manufacturing processes and to treat wastewater.

United States Other Services Segment

The “United States Other Services” segment is comprised of two business units:  Pest Elimination and GCS Service.  In general, these businesses provide service or equipment which can augment or extend our product offering to our business customers as a part of our “Circle the Customer” approach.

Pest Elimination :  Our Pest Elimination Division provides services for the detection, elimination and prevention of pests to restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick-service restaurant and grocery operations and other institutional and commercial customers.  These services are sold and performed by Company-employed sales and service personnel.  In addition, through our EcoSure Food Safety Management business, the Division provides customized on-site evaluations, training and quality assurance services to foodservice operations.

GCS Service :  GCS Service provides commercial cooking and refrigeration equipment repair and maintenance services for restaurant and other foodservice operations.  Repair services are offered for in-warranty repair, acting as the Manufacturer’s Authorized Service Agent, as well as after warranty repair.  In addition, GCS Service offers parts at a wholesale level to repair service companies and end users.

International Segment

We conduct business in approximately 70 countries outside of the United States through wholly-owned subsidiaries or, in the case of Israel, the United Arab Emirates and Venezuela, through joint ventures with local partners.  In other countries, selected products are sold by our export operations to distributors, agents or licensees, although the volume of those sales is not significant in terms of our overall revenues.  Our largest International operations are located in Europe, Asia Pacific, Latin America and Canada, with smaller operations in Africa and the Middle East.

In general, the businesses conducted internationally are similar to those conducted in the United States but are managed on a geographic basis.  The businesses which are similar to the United States’ Institutional and Food & Beverage businesses are the largest businesses in our International operations.  They are conducted in virtually all our International locations and, compared to the United States, constitute a larger portion of the overall business.  Kay also has sales in a number of International locations.  A significant portion of Kay’s international sales are to international units of United States-based quick-service restaurant chains. Consequently, a substantial portion of Kay’s international sales are made either to domestic or internationally-located third-party distributors who serve these chains.

Our Pest Elimination business continues to expand its geographic coverage.  Since 2001, we have entered markets in Brazil, Chile, the United Kingdom, Ireland, France and South Africa, primarily through acquisitions.

Our other businesses are conducted less extensively in our International locations.  However, in general, most of the principal businesses conducted in the United States are operated in Canada.

International businesses are subject to the usual risks of foreign operations, including possible changes in trade and foreign investment laws, tax laws, currency exchange rates and economic and

5




 

political conditions abroad.  The profitability of our International operations has historically been lower than the profitability of our businesses in the United States.  This has been due to the smaller scale of the International operations as well as the additional cost of operating in numerous and diverse foreign jurisdictions.

Additional Information

Competition :  Our business units have two significant classes of competitors.  First, each business unit competes with a small number of large companies selling directly or through distributors on a national or international scale.  Second, all of our business units have numerous smaller regional or local competitors which focus on more limited geographies, product lines and/or end-user segments.

Our objective is to achieve a significant presence in each of our business markets.  In general, competition is based on customer support, product performance and price.  We believe we compete principally by providing superior value, premium customer support and differentiated products.  Value is provided by state-of-the-art cleaning, sanitation and maintenance products and systems coupled with high customer support standards and continuing dedication to customer satisfaction.  This is made possible, in part, by our significant on-going investment in training and technology and by our standard practice of advising customers on means to lower operating costs and helping them comply with safety, environmental and sanitation regulations. In addition, we emphasize our ability to uniformly provide a variety of related premium cleaning and sanitation programs to our customers and to provide that level of customer support to multiple locations of chain customer organizations worldwide.  This approach is succinctly stated in our “Circle the Customer — Circle the Globe” strategy which is discussed above in this Item 1(c) under the heading “General.”

Sales and Service : Products, systems and services are primarily marketed in domestic and international markets by Company-trained sales and service personnel who also advise and assist our customers in the proper and efficient use of the products and systems in order to meet a full range of cleaning and sanitation needs.  Independent, third-party distributors are utilized in several markets, as described in the business unit descriptions found under the discussion of the three reportable segments above.

Number of Employees :  We have approximately 23,130 employees.

Customers and Classes of Products :  We believe that our business is not materially dependent upon a single customer although, as described above in this Item 1(c) under the description of the Kay business, Kay is largely dependent upon a limited number of national and international quick-service chains and franchisees.  Additionally, although we have a diverse customer base and no customer or distributor constitutes ten percent or more of our consolidated revenues, we do have customers and independent, third-party distributors, the loss of which could have a material negative effect on results of operations for the affected earnings periods; however, we consider it unlikely that such an event would have a material adverse impact on our financial position.  No material part of our business is subject to renegotiation or termination at the election of a governmental unit.  We sell two classes of products which each constitute 10 percent or more of our sales.  Sales of warewashing products in 2006, 2005 and 2004 approximated 21, 21 and 22 percent, respectively, of our consolidated net sales.  In addition, through our Institutional and Textile Care businesses, we sell laundry products and provide customer support to a broad range of laundry customers.  Sales of laundry products and services in 2006, 2005 and 2004 approximated 10, 11 and 10 percent, respectively, of our consolidated net sales.

Patents and Trademarks :  We own and license a number of patents, trademarks and other intellectual property, including through a license agreement with Henkel KGaA.  While we have an active program to protect our intellectual property by filing for patents or trademarks, and pursuing legal action, when appropriate, to prevent infringement, we do not believe that our overall business is materially dependent on any individual patent or trademark.

6




 

Seasonality :  Overall our business does not have a significant degree of seasonality.  However, we do experience variability in our quarterly operating results due to sales volume and business mix fluctuations in our operating segments.  Note 17, entitled “Quarterly Financial Data” located on page 47 of the Annual Report, is incorporated herein by reference.

Working Capital :  We have invested in the past, and will continue to invest in the future, in merchandising equipment consisting primarily of systems used by customers to dispense our cleaning and sanitizing products.  Otherwise, we have no unusual working capital requirements.

Manufacturing and Distribution :  We manufacture most of our products and related equipment in Company-owned manufacturing facilities.  Some products are also produced for us by third-party contract manufacturers, including Henkel KGaA.  Other products and equipment are purchased from third-party suppliers.  Additional information on product/equipment sourcing is found in the segment discussions above and additional information on our manufacturing facilities is located beginning at page 15 of this Form 10-K under the heading “Properties.”

Deliveries to customers are made from our manufacturing plants and a network of distribution centers and public warehouses.  We use common carriers, our own delivery vehicles, and distributors.  Additional information on our plant and distribution facilities is located beginning at page 15 of this Form 10-K under the heading “Properties.”

Raw Materials :  Raw materials purchased for use in manufacturing our products are inorganic chemicals, including phosphates, silicates, alkalis, salts and organic chemicals, including surfactants and solvents. These materials are generally purchased on an annual contract basis from a diverse group of chemical manufacturers.  When practical, global sourcing is used so that purchasing or production locations can be shifted to control product costs at globally competitive levels. Pesticides used by our Pest Elimination Division are purchased as finished products under contract or purchase order from the producers or their distributors.  We also purchase packaging materials for our manufactured products and components for our specialized cleaning equipment and systems.  Most raw materials, or substitutes for those materials, used by us, with the exception of a few specialized chemicals which we manufacture, are available from several suppliers.

Research and Development :  Our research and development program consists principally of devising and testing new products, processes, techniques and equipment, improving the efficiency of existing ones, improving service program content, and evaluating the environmental compatibility of products.  Key disciplines include analytical and formulation chemistry, microbiology, process and packaging engineering and product dispensing technology.  Substantially all of our principal products have been developed by our research, development and engineering personnel.  At times, technology has also been licensed from third parties to develop offerings.  Note 13, entitled “Research Expenditures” located on page 40 of the Annual Report, is incorporated herein by reference.

Environmental and Regulatory Considerations :  Our businesses are subject to various legislative enactments and regulations relating to the protection of the environment and public health.  While we cooperate with governmental authorities and take commercially practicable measures to meet regulatory requirements and avoid or limit environmental effects, some risks are inherent in our businesses.  Among the risks are costs associated with transporting and managing hazardous substances, waste disposal and plant site clean-up, fines and penalties if we are found to be in violation of law, as well as modifications, disruptions or discontinuation of certain operations or types of operations including product recalls.  Additionally, although we are not currently aware of any such circumstances, there can be no assurance that future legislation or enforcement policies will not have a material adverse effect on our consolidated results of operations, financial position or cash flows.  Environmental and regulatory matters most significant to us are discussed below.

7




 

Ingredient Legislation :  Various laws and regulations have been enacted by state, local and foreign jurisdictions pertaining to the sale of products which contain phosphorous, volatile organic compounds, or other ingredients that may impact human health or the environment. Under California Proposition 65, label disclosures are required for certain products containing chemicals listed by California.  To date, we generally have been able to comply with such legislative requirements by reformulation or labeling modifications.  Such legislation has not had a material negative effect on our consolidated results of operations, financial position or cash flows to date.

Pesticide Legislation :  Various international, federal and state environmental laws and regulations govern the manufacture and/or use of pesticides.  We manufacture and sell certain disinfecting and sanitizing products which kill or reduce microorganisms (bacteria, viruses, fungi) on hard environmental surfaces and on certain food products. Such products constitute “pesticides” or “antimicrobial pesticides” under the current definitions of the Federal Insecticide Fungicide and Rodenticide Act (“FIFRA”), as amended by the Food Quality Protection Act of 1996, the principal federal statute governing the manufacture, labeling, handling and use of pesticides.  We maintain approximately 400 product registrations with the U.S. Environmental Protection Agency (“EPA”).  Registration entails the necessity to meet certain efficacy, toxicity and labeling requirements and to pay on-going registration fees.  In addition, each state in which these products are sold requires registration and payment of a fee. In general, the states impose no substantive requirements different from those required by FIFRA.  However, California and certain other states have adopted additional regulatory programs, and California imposes a tax on total pesticide sales in that State.  While the cost of complying with rules as to pesticides has not had a material adverse effect on our consolidated results of operations, financial condition, or cash flows to date, the costs and delays in receiving necessary approvals for these products continue to increase.  Total fees paid to the EPA and the states to obtain or maintain pesticide registrations, and for the California tax, were approximately $3,400,000 in 2006 and $2,900,000 in 2005.  In Europe, the Biocidal Product Directive (98/8/EC) is establishing a program to evaluate and authorize marketing of biocidal active substances and products.  The Biocidal Product Directive requirements are transitioning into effect.  In September 2006, certain biocidal active substances not notified to the European Chemicals Bureau were required to be withdrawn from the market.  We are working with suppliers and industry groups to manage requirements associated with the Biocidal Products Directive.  Anticipated registration costs are not expected to significantly affect our consolidated results of operations, financial position or cash flows.

In addition, our Pest Elimination Division applies restricted-use pesticides which it generally purchases from third parties.  That Division must comply with certain standards pertaining to the use of such pesticides and to the licensing of employees who apply such pesticides.  Such regulations are enforced primarily by the states or local jurisdictions in conformity with federal regulations.  We have not experienced material difficulties in complying with these requirements.

FDA Antimicrobial Product Requirements :  Various laws and regulations have been enacted by federal, state, local and foreign jurisdictions regulating certain products manufactured and sold by us for controlling microbial growth on humans, animals, foods, and medical devices.  In the United States, these requirements generally are administered by the U.S. Food and Drug Administration (“FDA”).  However, the U.S. Department of Agriculture and EPA also may share in regulatory jurisdiction of antimicrobials applied to food.  The FDA also has been expanding requirements applicable to such products, including proposing regulations in a Tentative Final Monograph for Healthcare Antiseptic Drug Products dated June 17, 1994 that may impose additional requirements associated with antimicrobial hand care products and associated costs when finalized by the FDA.  To date, such

8




 

requirements have not had a material adverse effect on our consolidated results of operations, financial position or cash flows.

Europe :  The European Union is developing a new regulatory framework for the Registration, Evaluation and Authorization of Chemicals (REACH).  The European Parliament and Council adopted the REACH regulation in December 2006, and it will enter into force in June 2007.  REACH will establish a new European Chemicals Agency in Helsinki, Finland.  The Agency would be responsible for evaluating data to determine hazards and risks and to manage this program for authorizing chemicals for sale and distribution in Europe.  All “new” and “existing” chemicals produced or imported into the European Union in quantities above one ton per year must be registered in a central database.  For chemicals deemed to be of most concern, industry must gain specific authorization for particular uses which have been demonstrated to be safe.  Other uses would be prohibited.  To manage this new program, we are simplifying our product line and working with chemical suppliers to comply with registration requirements.  The eventual impact of REACH will also be felt by our competitors.  Potential costs to us are not yet fully quantifiable.

Other Environmental Legislation :  Our manufacturing plants are subject to federal, state, local or foreign jurisdiction laws and regulations relating to discharge of hazardous substances into the environment and to the transportation, handling and disposal of such substances.  The primary federal statutes that apply to our activities are the Clean Air Act, the Clean Water Act and the Resource Conservation and Recovery Act (“RCRA”).  We are also subject to the Superfund Amendments and Reauthorization Act of 1986, which imposes certain reporting requirements as to emissions of hazardous substances into the air, land and water.  We make capital investments and expenditures to comply with environmental laws and regulations, to ensure employee safety and to carry out its announced environmental stewardship principles.  To date, such expenditures have not had a significant adverse effect on our consolidated results of operations, financial position or cash flows.  Our capital expenditures for environmental health and safety projects world-wide were approximately $6,410,000 in 2006 and $4,230,000 in 2005.  Approximately $9,370,000 has been budgeted globally for projects in 2007.

Environmental Remediation and Proceedings :  Along with numerous other potentially responsible parties (“PRPs”), we are currently involved with waste disposal site clean-up activities imposed by the federal Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”) or state equivalents at 22 sites in the United States.  Additionally, we have similar liability at eight sites outside the United States.  In general, under CERCLA, we and each other PRP which actually contributes hazardous substances to a Superfund site are jointly and severally liable for the costs associated with cleaning up the site.  Customarily, the PRPs will work with the EPA to agree and implement a plan for site remediation.  Pursuant to an Environmental Agreement dated December 7, 2000 with Henkel KGaA, Henkel agreed to indemnify us for certain environmental liabilities associated with the parties’ former joint venture in Europe.  Reimbursement from Henkel has been requested for 647,924 euro (or approximately $855,000) spent for such environmental liabilities prior to December 31, 2006.

Based on an analysis of our experience with such environmental proceedings, our estimated share of all hazardous materials deposited on the sites referred to in the preceding paragraph, and our estimate of the contribution to be made by other PRPs which we believe have the financial ability to pay their shares, we have accrued our best estimate of our probable future costs relating to such known sites.  Unasserted claims are not reflected in the accrual.  In establishing accruals, potential insurance reimbursements are not included.  The accrual is not discounted.  It is not feasible to predict when the amounts accrued will be paid due to the uncertainties inherent in the environmental remediation and associated regulatory processes.

9




 

Our worldwide net expenditures for contamination remediation were approximately $950,000 in 2006 and $1,240,000 in 2005.  Including the ChemLawn matters described below, our worldwide accruals at December 31, 2006 for probable future remediation expenditures totaled approximately $4,900,000.  We review our exposure for contamination remediation costs periodically and our accruals are adjusted as considered appropriate. While the final resolution of these issues could result in costs below or above current accruals and, therefore, have an impact on our consolidated financial results in a future reporting period, we believe the ultimate resolution of these matters will not have a material effect on our consolidated results of operations, financial condition or liquidity.  In addition, we have retained responsibility for certain sites where our former ChemLawn business is a PRP.  Currently there are five such locations and, at each, ChemLawn is a de minimis party.  Anticipated costs currently accrued for these matters were included in our loss from our discontinued ChemLawn operations in 1991.  The accrual remaining reflects our best estimate of probable future costs.

Item 1(d) Financial Information About Geographic Areas .

The financial information about geographic areas appearing under the heading “Operating Segments” in Note 16, located on pages 45 and 46 of the Annual Report, is incorporated herein by reference.

Item 1(e) Available Information .

Our Internet address is www.ecolab.com.  Copies of our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to these reports, are available free of charge on our website at www.ecolab.com/investor as soon as reasonably practicable after such material is filed with, or furnished to, the Securities and Exchange Commission.

In addition, the following governance materials are available on our website at www.ecolab.com/investor/governance and the same information is available in print to any requesting persons, free of charge, by writing to the Corporate Secretary at our headquarters address, or by submitting an e-mail request to investor.info@ecolab.com:  (i)  charters of the Audit, Compensation, Finance and Governance Committees of our Board of Directors; (ii) our Board’s Corporate Governance Principles; and (iii) our Code of Conduct and Code of Ethics for Senior Officers and Finance Associates.

Executive Officers of the Company

The persons listed in the following table are our current executive officers.  Officers are elected annually.  There is no family relation­ship among any of the directors or executive officers, and no executive officer has been involved during the past five years in any legal proceedings described in applicable Securities and Exchange Commission regulations.

10




 

Name

 

 

 

Age

 

Office

 

Positions Held Since
Jan. 1, 2002

 

Douglas M. Baker, Jr.

 

48

 

Chairman of the Board, President and Chief Executive Officer

 

May 2006 - Present

 

 

 

 

 

President and Chief Executive Officer

 

Jul. 2004 - Apr. 2006

 

 

 

 

 

President and Chief Operating Officer

 

Aug. 2002 - Jun. 2004

 

 

 

 

 

President — Institutional Sector

 

Mar. 2002 - Jul. 2002

 

 

 

 

 

Senior Vice President — Institutional Sector

 

Jan. 2002 - Feb. 2002

 

Lawrence T. Bell

 

59

 

Senior Vice President, General Counsel and Secretary

 

Jul. 2002 - Present

 

 

 

 

 

Senior Vice President — Law and General Counsel

 

Jan. 2002 - Jun. 2002

 

Steven L. Fritze

 

52

 

Executive Vice President and Chief Financial Officer

 

Feb. 2004 - Present

 

 

 

 

 

Senior Vice President and Chief Financial Officer

 

Mar. 2002 - Jan. 2004

 

 

 

 

 

Senior Vice President — Finance and Controller

 

Jan. 2002 - Feb. 2002

 

Robert K. Gifford

 

49

 

Senior Vice President — Global Supply Chain

 

Oct. 2005 - Present

 

 

 

 

 

Vice President — Supply Chain Management

 

Sep. 2004 - Sep. 2005(1)

 

Thomas W. Handley

 

52

 

Executive Vice President-Specialty Sector

 

Jan. 2004 - Present

 

 

 

 

 

Senior Vice President — Strategic Planning

 

Aug. 2003 - Dec. 2003(2)

 

Michael A. Hickey

 

45

 

Senior Vice President — Global Business Development

 

Jan. 2006 - Present

 

 

 

 

 

Senior Vice President — Global / Corporate Accounts

 

Nov. 2005 - Dec. 2005

 

 

 

 

 

Vice President — Global/Corporate Accounts, Institutional Division

 

Jan. 2002 - Oct. 2005

 

Diana D. Lewis

 

60

 

Senior Vice President — Human Resources

 

Jan. 2002 - Present

 

 

11




 

Phillip J. Mason

 

56

 

Executive Vice President — Asia Pacific and Latin America

 

Dec. 2004 - Present

 

 

 

 

 

Senior Vice President — Strategic Business Development

 

May 2004 - Nov. 2004(3)

 

James A. Miller

 

50

 

Executive Vice President — Institutional Sector North America

 

Jan. 2004 - Present

 

 

 

 

 

Vice President and General Manager — Institutional

 

Sept. 2002 - Dec. 2003

 

 

 

 

 

Institutional Vice President-Marketing North America

 

Jan. 2002 - Aug. 2002

 

Susan K. Nestegard

 

46

 

Senior Vice President-Research, Development and Engineering and Chief Technical Officer

 

Dec. 2004 - Present

 

 

 

 

 

Vice President-Research, Development and Engineering and Chief Technical Officer

 

Mar. 2003 - Nov. 2004(4)

 

Daniel J. Schmechel

 

47

 

Senior Vice President and Controller

 

Dec. 2005 - Present

 

 

 

 

 

Vice President and Controller

 

Apr. 2002 - Nov. 2005

 

 

 

 

 

Vice President and Treasurer

 

Jan. 2002 - Mar. 2002

 

C. William Snedeker

 

61

 

Executive Vice President — Global Services Sector

 

Mar. 2006 - Present

 

 

 

 

 

Senior Vice President — Global Pest Elimination

 

May 2003 - Feb. 2006

 

 

 

 

 

Vice President and General Manager — Pest Elimination

 

Jan. 2002 - Apr. 2003

 

Robert P. Tabb

 

55

 

Vice President and Chief Information Officer

 

Sep. 2003 - Present(5)

 


1.                Prior to joining Ecolab in September 2004, Mr. Gifford served as Vice President, World Logistics and Program Manager of Hewlett Packard Corporation for three years.  Prior to Hewlett Packard, Mr. Gifford was employed by Compaq and Tandem.

2.                Prior to joining Ecolab in August 2003, Mr. Handley was employed by the Procter & Gamble Company for 22 years in various management, marketing and executive positions including assignments in Japan and Mexico.  Mr. Handley’s last position at P&G was Vice President - Feminine Care Strategic Planning.

3.                Mr. Mason re-joined Ecolab in May 2004, where he formerly served 23 years in various management and executive positions, most recently as Vice President — Asia Pacific.  Prior to re-joining Ecolab, Mr. Mason was employed by HAVI Group, LP, serving as President, HPR Partners from 1997-2004.

4.                Prior to joining Ecolab in March 2003, Ms. Nestegard was employed by 3M Company for 20 years, most recently as Business Director of Optical Components.  Ms. Nestegard’s experience includes product and process development and technical management as Director Engineering Systems Technology Center and as Technical Director of the Electronic Products Division of 3M in Austin, Texas.

5.                Prior to joining Ecolab in September 2003, Mr. Tabb held various executive positions in the systems technology industry, most recently with Focus IT Group, a consulting firm.  From 1997 — 2000 Mr. Tabb was employed by CNF Transportation, Inc. as Vice President and Chief Information Officer.  From 2000 — 2001 Mr. Tabb served as Vice President, Global Information Technology at Nike, Inc.

12




 

Item 1A. Risk Factors .

The following are important factors which could affect our financial performance and could cause our actual results for future periods to differ materially from our anticipated results or other expectations, including those expressed in any forward-looking statements made in this Form 10-K.  See the section entitled Forward-Looking Statements located on page 2 of this Form 10-K.

We may also refer to this disclosure to identify factors that may cause results to differ from those expressed in other forward-looking statements made in oral presentations, including telephone conference and/or webcasts open to the public.

Except as may be required under applicable law, we undertake no duty to update our Forward-Looking Statements.

Our results depend upon the continued vitality of the markets we serve:  Economic downturns, and in particular downturns in the foodservice, hospitality, travel, health care and food processing industries, can adversely impact our end-users who are sensitive to changes in travel and dining activities.  During such downturns, these end-users typically reduce their volume of purchases of cleaning, hygiene and appearance products, which would likely in turn have an adverse impact on our consolidated results of operations, financial condition, or cash flows.

Our growth depends upon our ability to successfully compete with respect to value, product offerings and customer support:   Our competitive market is made up of numerous national, regional and local competitors.  Our ability to compete depends in part upon our ability to maintain a superior technological capability and to continue to identify, develop and commercialize innovative, high value-added products for niche applications.  There can be no assurance that we will be able to accomplish this or that technological developments by our competitors will not place certain of our products at a competitive disadvantage in the future.  In addition, certain of the new products that we have under development will be offered in markets in which we do not currently compete, and there can be no assurance that we will be able to compete successfully in those new markets.  If we fail to timely introduce new technologies, we may lose market share and our consolidated results of operations, financial condition, or cash flows could be adversely affected.

We enter into multi-year contracts with customers that can impact our results.   We enter into multi-year contracts with some of our customers which include terms affecting our pricing flexibility.  There can be no assurance that these restraints will not have an adverse impact on our margins and operating income.

Consolidation of our customer and vendors can affect our results:  Customers and vendors in the foodservice, hospitality and lodging industry have been consolidating in recent years and that trend may continue.  This consolidation could have an adverse impact on our ability to retain customers and on our margins and operating income.

Our results can be adversely affected by fluctuations in the cost of raw materials:   The prices of raw materials used in our business can fluctuate significantly from time to time, and have increased in recent years.  Changes in oil or raw material prices, unavailability of adequate and reasonably priced raw materials or substitutes for those raw materials, or the inability to obtain or renew supply agreements on favorable terms can adversely affect our consolidated results of operations, financial position or cash flows.

13




 

If we are unsuccessful in integrating acquisitions, our business could be adversely affected : As part of our long-term strategy, we seek to acquire complementary businesses.  There can be no assurance that we will find attractive acquisition candidates or succeed at effectively managing the integration of acquired businesses into existing businesses.  If the expected synergies from such transactions do not materialize or we fail to successfully integrate new businesses into our existing businesses, our consolidated results of operations, financial position or cash flows could be adversely affected.

Our business depends on our ability to comply with governmental regulations:   Our business is subject to numerous regulations relating to the environment and to the manufacture, storage, distribution, sale and use of our products.  Compliance with these regulations, as well as changes in tax, fiscal, governmental and other regulatory policies expose us to potential financial liability and increase our operating costs.  Regulation of our products and operations continues to increase with more stringent standards, causing increased costs of operations and potential for liability if a violation occurs.  The potential cost to us relating to environmental and product registration laws and regulations is uncertain due to factors such as the unknown magnitude and type of possible contamination and clean-up costs, the complexity and evolving nature of laws and regulations, and the timing and expense of compliance.  In addition, changes in accounting standards, including the adoption effective January 1, 2007 of FASB Interpretation No. 48 “Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement No. 109,” could increase the volatility of our quarterly tax rate.

Our results are impacted by general worldwide economic factors:   Economic factors such as the worldwide economy, interest rates and currency movements including, in particular, our exposure to foreign currency risk have affected our business in the past and may have a material adverse impact on our consolidated results of operations, financial condition, or cash flows in the future.

Extraordinary events may significantly impact our business:   The occurrence of (a) litigation or claims, (b) the loss or insolvency of a major customer or distributor, (c) war (including acts of terrorism or hostilities which impact our markets), (d) natural or manmade disasters, or (e) severe weather conditions or public health epidemics affecting the foodservice, hospitality and travel industries may have a significant, adverse impact on our business.

Defense of litigation, particularly certain types of actions such as antitrust, patent infringement and class action lawsuits, can be costly and time consuming even if ultimately successful, and if not successful could have a material adverse impact on our consolidated results of operations, financial position or cash flows.

While we have a diverse customer base and no customer or distributor constitutes ten percent or more of our consolidated revenues, we do have customers and independent, third-party distributors, the loss of which could have a material negative effect on our consolidated results of operations for the affected earnings periods; however, we consider it unlikely that such an event would have a material adverse impact on our financial position.

War (including acts of terrorism or hostilities), natural or manmade disasters or severe weather conditions or public health epidemics affecting the foodservice, hospitality and travel industries cause a downturn in the business of restaurants, motels and hotels and other of our customers, which in turn can have a material adverse impact on our business, financial condition, results of operations and cash flows.

14




 

We depend on key personnel to lead our business:   Our continued success will largely depend on our ability to attract and retain a high caliber of talent and on the efforts and abilities of our executive officers and certain other key employees.  Our operations could be adversely affected if for any reason such officers or key employees did not remain with us.

Item 1B. Unresolved Staff Comments .

We have no unresolved comments from the staff of the Securities and Exchange Commission.

Item 2.  Properties .

Our manufacturing philosophy is to manufacture products wherever an economic, process or quality assurance advantage exists or where proprietary manufacturing techniques dictate internal production processes.  Currently, most products sold by us are manufactured at our facilities.

Our manufacturing facilities produce chemical products or equipment for all of our businesses, although the businesses constituting the United States Other Services segment purchase the majority of their products and equipment from outside suppliers.  Our chemical production process consists primarily of blending and packaging powders and liquids and casting solids.  Our equipment manufacturing operations consist primarily of producing chemical product dispensers and injectors and other mechanical equipment and dishwasher racks and related sundries.

The following chart profiles our main manufacturing facilities with ongoing production activities.  In general, manufacturing facilities located in the United States serve the “United States Cleaning & Sanitizing” segment and facilities located outside of the United States serve the “International” segment.  However, certain of the United States facilities do manufacture products for export and which are used by the International segment.  The facilities having export involvement are marked with an asterisk(*).

ECOLAB OPERATIONS PLANT PROFILES

Location

 

 

 

Size (Sq. Ft.)

 

Types of Products

 

Majority
Owned or
Leased

 

UNITED STATES

 

 

 

 

 

 

 

Joliet, IL *

 

610,000

 

Solids, Liquids, Powders

 

Owned

 

South Beloit, IL *

 

313,000

 

Equipment

 

Owned

 

Garland, TX *

 

239,000

 

Solids, Liquids

 

Owned

 

Martinsburg, WV

 

228,000

 

Liquids

 

Owned

 

Hebron, OH

 

196,000

 

Liquids

 

Owned

 

Greensboro, NC

 

193,000

 

Liquids, Powders

 

Owned

 

San Jose, CA

 

175,000

 

Liquids

 

Owned

 

McDonough, GA*

 

141,000

 

Solids, Liquids

 

Owned

 

Eagan, MN *

 

133,000

 

Solids, Liquids, Emulsions, Powders

 

Owned

 

Huntington, IN *

 

127,000

 

Liquids

 

Owned

 

City of Industry, CA

 

125,000

 

Liquids

 

Owned

 

Elk Grove Village, IL *

 

115,000

 

Equipment

 

Leased

 

Fort Worth, TX

 

101,000

 

Equipment

 

Leased

 

Carrollton, TX

 

70,000

 

Liquids

 

Owned

 

St. Louis, MO

 

37,000

 

Equipment

 

Leased

 

City of Industry, CA

 

30,000

 

Equipment

 

Leased

 

15




 

Location

 

 

 

Size (Sq. Ft.)

 

Types of Products

 

Majority
Owned or
Leased

 

INTERNATIONAL

 

 

 

 

 

 

 

Chalons, FRANCE

 

280,000

 

Liquids, Powders

 

Owned

 

Nieuwegein, NETHERLANDS

 

168,000

 

Powders

 

Owned

 

Tessenderlo, BELGIUM

 

153,000

 

Solids, Liquids

 

Owned

 

Melbourne, AUSTRALIA

 

145,300

 

Liquids, Powders

 

Owned

 

Rozzano, ITALY

 

126,000

 

Liquids

 

Owned

 

Mississauga, CANADA

 

120,400

 

Liquids

 

Leased

 

Johannesburg, SOUTH AFRICA

 

100,000

 

Liquids, Powders

 

Owned

 

Hamilton, NEW ZEALAND

 

96,000

 

Solids, Liquids, Powders

 

Owned

 

Mullingar, IRELAND

 

74,300

 

Liquids

 

Leased

 

Valby, DENMARK

 

70,000

 

Liquids

 

Owned

 

Sao Paulo, BRAZIL

 

62,325

 

Solids, Liquids

 

Leased

 

Shika, JAPAN

 

60,000

 

Liquids

 

Owned

 

Santiago, CHILE

 

60,000

 

Liquids, Powders

 

Leased

 

Revesby, AUSTRALIA

 

59,200

 

Liquids, Powders

 

Owned

 

Cheadle (Hulme), UNITED KINGDOM

 

52,575

 

Liquids

 

Leased

 

Guangzhou, CHINA

 

50,230

 

Liquids, Powders

 

Leased

 

Noda, JAPAN

 

49,000

 

Solids, Liquids, Powders

 

Owned

 

Siegsdorf, GERMANY

 

42,000

 

Equipment

 

Owned

 

Mexico City, MEXICO

 

40,000

 

Liquids, Powders

 

Owned

 

Maribor, SLOVENIA

 

39,000

 

Liquids, Powders

 

Owned

 

Leeds, UNITED KINGDOM

 

35,000

 

Liquids

 

Owned

 

Pilar, ARGENTINA

 

30,000

 

Liquids, Powders

 

Owned

 

Shanghai, CHINA

 

27,000

 

Solids, Liquids, Powders

 

Owned

 

Perth, AUSTRALIA

 

26,900

 

Liquids, Powders

 

Owned

 

Dorado, PUERTO RICO

 

25,000

 

Liquids, Powders

 

Leased

 

Singapore, SINGAPORE

 

25,000

 

Liquids, Powders

 

Owned

 

Dar es Salaam, TANZANIA

 

22,900

 

Liquids, Powders

 

Leased

 

Seoul, SOUTH KOREA

 

22,160

 

Liquids, Powders

 

Owned

 

Racibor, POLAND

 

20,000

 

Liquids

 

Leased

 

Mandras, GREECE

 

18,000

 

Liquids

 

Owned

 

San Jose, COSTA RICA

 

11,000

 

Liquids, Powders

 

Owned

 

Cikarang, INDONESIA

 

10,000

 

Solids, Liquids, Powders

 

Owned

 

Bangkok, THAILAND

 

10,000

 

Liquids, Powders

 

Owned

 

Manilla, PHILIPPINES

 

7,600

 

Liquids, Powders

 

Owned

 

 

16




 

We believe our manufacturing facilities are in good condition and are adequate to meet our existing production needs, except that a new manufacturing facility in Wales, U.K. is being constructed to support continued growth in Europe.

Most of our manufacturing plants also serve as distribution centers.  In addition, we operate distribution centers around the world, all of which are leased, and utilize various public warehouses to facilitate the distribution of our products and services.  In the United States, our sales and service associates are located in approximately 90 leased offices.  Additional sales offices are located internationally.

Our corporate headquarters is comprised of three adjacent multi-storied buildings located in downtown St. Paul, Minnesota.  The main 19-story building was constructed to our specifications and is leased through 2008.  Thereafter, it is subject to multiple renewals at our option.  The second building is leased through 2011 with additional options available.  The third building is owned.  The corporate headquarters includes an employee training center.  In April 2004, we purchased a 90 acre campus in Eagan, Minnesota to provide for future growth.  The acquired facility houses the research and development and data center requirements as well as several of our administrative functions.  Renovations of the buildings on this property, comprising approximately 500,000 square feet, have been completed and more than 800 associates now work at this site.  Our former research center in Mendota Heights, Minnesota and the data center in St. Paul were sold in 2005.

Item 3.  Legal Proceedings .

The Company and certain of our subsidiaries are defendants in various lawsuits and claims arising out of the normal course of business.  Accruals have been established reflecting our best estimate of probable future costs relating to such matters.

As previously reported, the New York State Department of Environmental Conservation issued a Notice of Violation in 2006 alleging that two products had been sold by us with phosphorous levels exceeding New York State requirements for certain household cleansing products.  We have provided information to the State resolving allegations relating to one of the products that is not in violation of the relevant statute, have suspended sales of the other product, and are in discussions with the State attempting to resolve the matter.

As previously reported, in June 2006 Ecolab received notice from the Connecticut Department of Environmental Protection alleging violations of state regulatory requirements for the business of commercial pesticide applications.  This matter relates mainly to supervisory issues relative to application procedures.  In December 2006 Ecolab signed an Administrative Order on Consent (AOC) that resolved the state’s pest elimination enforcement action.  Under the terms of the AOC, Ecolab will pay a $145,750 penalty and fund three supplemental environmental improvement projects worth a total of $437,250.

Other matters arising under laws relating to protection of the environment are discussed at Item 1(c) above, under the heading “Environmental and Regulatory Considerations.”

Item 4.  Submission of Matters to a Vote of Security Holders .

No matters were submitted to a vote of our security holders during the fourth quarter of 2006.

17




 

PART II

Item 5.  Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities .

Market Information :  Our Common Stock is listed on the New York Stock Exchange under the symbol “ECL.”  The Common Stock is also traded on an unlisted basis on certain other United States exchanges.  The high and low sales prices of our Common Stock on the consolidated transaction reporting system during 2006 and 2005 were as follows:

 

 

 

2006

 

2005

 

Quarter

 

 

 

High

 

Low

 

High

 

Low

 

First

 

$

40.50

 

$

33.64

 

$

35.08

 

$

31.20

 

Second

 

$

41.20

 

$

37.00

 

$

34.23

 

$

30.68

 

Third

 

$

45.44

 

$

39.57

 

$

34.14

 

$

30.75

 

Fourth

 

$

46.40

 

$

42.17

 

$

37.15

 

$

30.93

 

 

The closing Common Stock price on January 31, 2007 was $43.90.

Holders :  On January 31, 2007, we had 5,222 holders of Common Stock of record.

Dividends :  We have paid Common Stock dividends for 70 consecutive years.  Quarterly cash dividends of $0.0875 per share were declared in February, May and August 2005.  Cash dividends of $0.10 per share were declared in December 2005, and February, May and August 2006.  A dividend of $0.115 per share was declared in December 2006.

Issuer Purchases of Equity Securities :

Period

 

 

 

(a)
Total number
of shares
purchased(1)

 

(b)
Average price
paid per share(2)

 

(c)
Number of shares
purchased as part of
publicly announced
plans or programs(3)

 

(d)
Maximum number of
shares that may yet be
purchased under the
plans or programs

 

October 1-31, 2006

 

256,733

 

$

43.8163

 

199,900

 

13,312,500

 

November 1-30, 2006

 

215,309

 

$

45.1004

 

200,000

 

13,112,500

 

December 1-31, 2006

 

204,885

 

$

44.6910

 

186,500

 

12,926,000

 

Total

 

676,927

 

$

44.4895

 

586,400

 

12,926,000

 


(1)              In addition to programs under publicly announced plans, column (a) includes 90,527 shares reacquired from employees and/or directors as swaps for the cost of stock options, shares surrendered to satisfy minimum statutory tax obligations, under our stock incentive plans, or forfeitures of unvested shares of restricted stock.

(2)              The average price paid per share includes brokerage commissions associated with publicly announced plan purchases plus the value of such other reacquired shares.

(3)              As announced on December 9, 2004, our Board of Directors authorized the repurchase of up to 10,000,000 additional shares of Common Stock, including shares to be repurchased under Rule 10b5-1.  As announced on October 26, 2006, our Board of Directors authorized the repurchase of up to 10,000,000 additional shares of Common Stock, including shares to be repurchased under Rule 10b5-1.  We intend to repurchase all shares under this authorization, for which no expiration date has been established, in open market or privately negotiated transactions, subject to market conditions.

18




 

Item 6.  Selected Financial Data .

The comparative data for the years ended December 31, 2006, 2005, 2004, 2003 and 2002 inclusive, which are set forth under the heading entitled “Summary Operating and Financial Data” located on pages 50 and 51 of the Annual Report, are incor­porated herein by reference.

Item 7.  Management’s Discussion and Analysis of Financial Condition and Results of Operation .

The material appearing under the heading entitled “Financial Discussion,” located on pages 17 through 26 of the Annual Report, is incorporated herein by reference.

Item 7A.  Quantitative and Qualitative Disclosures about Market Risk .

The material appearing under the heading entitled “Market Risk,” located on page 26 of the Annual Report, is incorporated herein by reference.

Item 8.  Financial Statements and Supplementary Data .

The financial statements and material which are an integral part of the financial statements listed under Item 15.I(1). below and located on pages 27 through 51 of the Annual Report, are incorporated herein by reference.

Item 9.  Changes in and Disagreements With Accountants on Accounting and Financial Disclosure .

None.

Item 9A. Controls and Procedures .

Disclosure Controls and Procedures As of December 31, 2006, we carried out an evaluation, under the supervision and with the participation of our management, including the Chairman of the Board, President and Chief Executive Officer and the Executive Vice President and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 as amended). Based upon that evaluation, our Chairman of the Board, President and Chief Executive Officer and the Executive Vice President and Chief Financial Officer concluded that our disclosure controls and procedures are effective.

Internal Control Over Financial Reporting : Our management is responsible for establishing and maintaining adequate internal control over financial reporting.  Under the supervision and with the participation of our management, including our Chairman of the Board,  President and Chief Executive Officer and Executive Vice President and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission.  Based on our evaluation under this framework, our management concluded that our internal control over financial reporting was effective as of December 31, 2006.

Our management’s assessment of the effectiveness of our internal control over financial reporting as of December 31, 2006 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm.  PricewaterhouseCoopers LLP has issued an attestation report on our controls over financial reporting.  Their report, and our management reports, can be found in our Annual Report, the relevant portion of which has been filed as Exhibit (13) to this Form 10-K and is incorporated into Item 8 of this Form 10-K.

19




 

During the period October 1 - December 31, 2006, there were no changes in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Item 9B.  Other Information .

The following disclosures would otherwise be filed on Form 8-K under the heading “Item 5.02(e) — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.”

In the paragraphs below describing certain of our executive compensation plans and programs, the “Named Executive Officers or NEOs” refer to our Principal Executive Officer and Principal Financial Officer during 2006 and the next three most-highly compensated executive officers who were serving in those capacities at December 31, 2006, and the “Committee” refers to the Compensation Committee of the Board of Directors.

General The components of the overall compensation program for the Company’s executive officers include base salary, long-term incentives in the form of annual stock option awards, cash-based annual bonus incentives, participation in deferred compensation and retirement plans, and certain perquisites. Information regarding the compensation awarded to the NEOs in respect of and during the year ended December 31, 2006 will be provided in the definitive proxy statement for the Company’s 2007 annual meeting of stockholders, which is expected to be filed with the Securities and Exchange Commission on or around March 30, 2007.

Base Salary For the 2007 fiscal year, base salaries for the NEOs, other than the CEO, are scheduled to increase on an annualized basis by an average of 7.1%.  The salary of the CEO has been established at $900,000, representing an increase of $100,000 over 2006.  The base salaries established for the 2007 fiscal year for the NEOs are included as a part of the Named Executive Officer Summary of Base Salary, Bonus Award Opportunities, and Executive Benefits and Perquisites filed as Exhibit (10)U to this Form 10-K and incorporated by reference herein.

Establishment of 2007 Non-Equity Incentive Plan Compensation Criteria The Company maintains annual cash incentive programs for executives referred to as the Management Incentive Plan or MIP and Management Performance Incentive Plan or MPIP.  The Company’s stockholders approved the current version of the MPIP in 2004, an annual incentive plan under which awards should qualify as performance based under Internal Revenue Code Section 162(m).  On February 22, 2007, as required under the terms of the MPIP, the Committee selected the CEO and CFO and one other NEO to participate in the MPIP for 2007, established the 2007 performance goal based upon the performance criteria of diluted earnings per share (“EPS”), set an EPS performance target of a designated earnings per share, and designated a cash award of 300% of the base salary of each such officer for 2007 to the extent the goal is achieved.  The award is subject to and interpreted in accordance with the terms and conditions of the MPIP and no amount will be paid under the MPIP unless and until the Committee has determined the extent to which the performance goal has been met and the corresponding amount of the award earned by the participant.  The MPIP permits the Committee to exercise downward discretion so as to pay an amount which is less than the amount of the award earned by the participant.  In applying this downward discretion, the Committee considers underlying operable metrics communicated to the participant, which are described as a part of the Named Executive Officer Summary of Base Salary, Bonus Award Opportunities, and Executive Benefits and Perquisites filed as Exhibit (10)U to this Form 10-K and incorporated by reference herein.  Two other NEOs will participate in the MIP in 2007 and the operating metrics with respect to such NEOs’ participation are similarly included as a part of Exhibit (10)U.

Adoption of Form of Restricted Stock Award Agreement :  On February 22, 2007, the Committee approved the form of Agreement for restricted stock awards granted under our 2005 Stock Incentive Plan (“2005 Plan”).  Each restricted stock award will vest at such times and in such installments as may be determined by the Committee and, until such award vests, will be subject to restrictions on transferability and the possibility of forfeiture.  An unvested restricted stock award will become fully

20




vested upon the termination of employment due to death or disability of the holder of such award or if we have a change-in-control (as such term is defined in the 2005 Plan).  Such an award will be terminated and forfeited upon such holder’s termination of employment for any other reason.  A holder will have all voting, liquidation and other rights with respect to the shares covered by a restricted stock award.  A holder will have no right to receive dividends or distributions with respect to unvested shares, however, the Committee may distribute special dividends or distributions paid on such unvested shares or direct that such special dividends or distributions be held subject to the award restrictions.

The foregoing summary of the restricted stock award agreement is qualified in its entirety by reference to the full text of such agreement, a copy of which is attached as Exhibit (10)W(iii) to this Form 10-K and incorporated by reference herein.

PART III

Item 10.  Directors, Executive Officers of the Registrant and Corporate Governance .

Information about our directors is incorporated by reference from the discussion under the heading “Proposal to Elect Directors” located in the Proxy Statement.  Information about compliance with Section 16(a) of the Securities Exchange Act of 1934, as amended, is incorporated by reference from the discussion under the heading “Section 16(a) Beneficial Ownership Reporting Compliance” located in the Proxy Statement.  Information about our Audit Committee, including the members of the Committee, and our Audit Committee financial experts, is incorporated by reference from the discussion under the heading “Corporate Governance,” and sub-headings “Board Committees” and “Audit Committee,” located in the Proxy Statement.  Information about our Code of Conduct is incorporated by reference from the discussion under the heading “Corporate Governance Materials and Code of Conduct” located in the Proxy Statement.  Information regarding our executive officers is presented under the heading “Executive Officers of the Company” in Part I on pages 10 through 12 of this Form 10-K, and is incorporated herein by reference.

Item 11.  Executive Compensation .

Information appearing under the headings entitled “Executive Compensation” and “Director Compensation” located in the Proxy Statement is incorporated herein by reference.  However, pursuant to Instructions to Item 407(e)(5) of Securities and Exchange Commission Regulation S-K, the material appearing under the sub-heading “Compensation Committee Report” shall not be deemed to be “filed” with the Commission, other than as provided in this Item 11.

Item 12.  Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters .

Information appearing under the heading entitled “Security Ownership” located in the Proxy Statement is incorporated herein by reference.  The holdings of Henkel KGaA and Henkel Corporation are subject to certain limitations with respect to our voting securities as more fully described in our Proxy Statement under the heading “Stockholder Agreement,” and is incorporated herein by reference.

A total of 494,715 shares of Common Stock held by our directors and executive officers, some of whom may be deemed to be “affiliates” of the Company, have been excluded from the computation of market value of our Common Stock on the cover page of this Form 10-K.  This total represents that portion of the shares reported as beneficially owned by our directors and executive officers as of June 30, 2006, which are actually issued and outstanding.

21




 

Equity Compensation Plan Information The following table presents, as of December 31, 2006, compensation plans (including individual compensation arrangements) under which our equity securities are authorized for issuance.

Plan Category

 

 

 

(a)
Number of
securities to be
issued upon
exercise
of outstanding
options, warrants
and rights

 

(b)
Weighted
average
exercise price
of outstanding
options, warrants
and rights

 

(c)
Number of
securities
remaining
available for
future issuance
under equity
compensation
plans (excluding
securities reflected
in column (a))

 

Equity compensation plans approved by security holders

 

21,778,635

(1)(2)

$

29.74

(2)

11,689,435

(3)

Equity compensation plans not approved by security holders

 

-0-

 

 

-0-

 

Total

 

21,778,635

(1)(2)

$

29.74

(2)

11,689,435

(3)


(1)              Includes 125,492 Common Stock equivalents under our 2001 Non-Employee Director Stock Option and Deferred Compensation Plan.  These Common Stock equivalents represent deferred compensation earned by non-employee directors and are excluded from the calculation of weighted average exercise price of outstanding options, warrants and rights in column (b) of this table.

(2)              Includes 14,343 shares of our Common Stock subject to stock options with a weighted-average exercise price of $26.97, which we assumed in connection with our acquisition of Alcide Corporation effective July 30, 2004.  These assumed options are deemed exempt from shareholder approval under Rule 303A.08 of the New York Stock Exchange in accordance with our notice to the NYSE dated August 18, 2004.  The respective Alcide plans were amended to prohibit future grants.

(3)              Includes 1,100,000 shares restored to reserves as part of a refueling feature of our 2002 Stock Incentive Plan.  The refueling feature permits the restoration of shares repurchased on the open market using proceeds from options exercised under the Plan.

Item 13.  Certain Relationships and Related Transactions .

Information appearing under the heading entitled “Director Independence Standards and Determinations” and “Related Person Transactions” located in the Proxy Statement as well as the biographical material pertaining to Messrs. Stefan Hamelmann, Kasper Rorsted and Hans Van Bylen, located in the Proxy Statement under the heading “Proposal to Elect Directors” are incorporated herein by reference.

Item 14.  Principal Accountant Fees and Services .

Information appearing under the heading entitled “Audit Fees” located in the Proxy Statement is incorporated herein by reference.

22




PART IV

Item 15.  Exhibits and Financial Statement Schedules .

I(1).                            The following financial statements of the Company, included in the Annual Report, are incorporated into Item 8 hereof.

(i)                                      Consolidated Statement of Income for the years ended December 31, 2006, 2005 and 2004, Annual Report page 27.

(ii)                                   Consolidated Balance Sheet at December 31, 2006 and 2005, Annual Report page 28.

(iii)                                Consolidated Statement of Cash Flows for the years ended December 31, 2006, 2005 and 2004, Annual Report page 29.

(iv)                               Consolidated Statement of Comprehensive Income and Shareholders’ Equity for the years ended December 31, 2006, 2005 and 2004, Annual Report page 30.

(v)                                  Notes to Consolidated Financial Statements, Annual Report pages 31 through 47.

(vi)                               Report of Independent Registered Public Accounting Firm, Annual Report page 49.

I(2).                            The following financial statement schedule to the Company’s financial statements listed in Item 15.I(1). for the years ended December 31, 2006, 2005 and 2004 located on page 33 hereof, and the Report of Independent Registered Public Accounting Firm on Financial Statement Schedule at page 32 hereof, are filed as part of this Report.

(i)                                      Schedule II — Valuation and Qualifying Accounts for the years ended December 31, 2006, 2005 and 2004.

All other schedules, for which provision is made in the applicable regulations of the Securities and Exchange Commission, are not required under the related instructions or are inapplicable and therefore have been omitted.  All significant majority-owned subsidiaries are included in the filed consolidated financial statements.

II.                                      The following documents are filed as exhibits to this Report.  We will, upon request and payment of a fee not exceeding the rate at which copies are available from the Securities and Exchange Commission, furnish copies of any of the following exhibits to stockholders.

(3)A.                      Restated Certificate of Incorporation of Ecolab Inc., dated as of February 27, 2006, effective as of March 13, 2006 — Incorporated by reference to Exhibit (3)A of our Form 10-K Annual Report for the year ended December 31, 2005.

B.                                      Certificate of Designation, Preferences and Rights of Series A Junior Participating Preferred Stock of Ecolab Inc., dated as of February 27, 2006, effective as of March 13, 2006 — Incorporated by reference to Exhibit (3)C of our Form 10-K Annual Report for the year ended December 31, 2005.

C.                                      By-Laws, as amended through February 18, 1999 - Incorporated by reference to Exhibit (3)B of our Form 10-K Annual Report for the year ended December 31, 1998.

(4)A.                      Common Stock - see Exhibits (3)A and (3)C.

B.                                      Form of Common Stock Certificate effective February 28, 2007.

C.                                      Rights Agreement, dated as of February 24, 2006, between Ecolab Inc. and Computershare Investor Services, LLC, as Rights Agent, which includes the following exhibits thereto: (i) Exhibit A — Form of Certificate of Designation,

23




 

Preferences and Rights of Series A Junior Participating Preferred Stock and (ii) Exhibit B — Form of Rights Certificate — Incorporated by reference to Exhibit (4)C of our Form 10-K Annual Report for the year ended December 31, 2005.

D.                                     Second Amended and Restated Stockholder’s Agreement between Henkel KGaA and Ecolab Inc., dated November 30, 2001 - Incorporated by reference to Exhibit (4) of our Form 8-K dated November 30, 2001.

E.                                       Amended and Restated Indenture, dated as of January 9, 2001, between Ecolab Inc. and Bank One, NA (formerly known as The First National Bank of Chicago) as Trustee - Incorporated by reference to Exhibit (4)(A) of our Current Report on Form 8-K dated January 23, 2001.

F.                                       Officer’s Certificate establishing terms and conditions of 6.875% Notes due February 1, 2011 - Incorporated by reference to Exhibit 4(B) of our Form 8-K dated January 23, 2001.

G.                                      Form of 6.875% Note due February 2, 2011 - Incorporated by reference to Exhibit 4(c) of our Form 8-K dated January 23, 2001.

Copies of other constituent instruments defining the rights of holders of our long-term debt are not filed herewith, pursuant to Section (b)(4)(iii) of Item 601 of Regulation S-K, because the aggregate amount of securities authorized under each of such instruments is less than 10% of our total assets on a consolidated basis.  We will, upon request by the Securities and Exchange Commission, furnish to the Commission a copy of each such instrument.

(10)A.                Multicurrency Credit Agreement, dated as of September 29, 1993, as amended and restated as of June 1, 2006, among Ecolab Inc., the financial institutions party thereto as Banks from time to time, the financial institutions party thereto as Issuing Banks from time to time, Citibank, N.A., as administrative agent for the Banks and Issuing Banks thereunder, Citibank International PLC, as agent for the Banks in connection with certain of the Eurocurrency Advances, and JPMorgan Chase Bank, N.A., as syndication agent — Incorporated by reference to Exhibit (10) of our Form 8-K dated June 1, 2006.

B.                                      Documents comprising global Commercial Paper Programs

(i)                                      U.S. $200,000,000 Euro-Commercial Paper Programme

(a)                                   Amended and Restated Dealer Agreement dated 2 December 2005 between Ecolab Inc. (as Guarantor), Ecolab B.V. and Ecolab Holding GmbH (as Issuers),  Ecolab Inc., Credit Suisse First Boston (Europe) Limited (as Arranger), and Citibank International plc and Credit Suisse First Boston (Europe) Limited (as Dealers). — Incorporated by reference to Exhibit (10)B(i)(a) of our Form 10-K Annual Report for the year ended December 31, 2005.

(b)                                  Amended and Restated Note Agency Agreement dated as of 2 December 2005 between Ecolab Inc., Ecolab B.V. and Ecolab Holding GmbH (as Issuers) and Citibank, N.A. as Issue and Paying Agent. — Incorporated by reference to Exhibit (10)B(i)(b) of our Form 10-K Annual Report for the year ended December 31, 2005.

(c)                                   Deed of Covenant made on 2 December 2005 by Ecolab Inc., Ecolab B.V. and Ecolab Holding GmbH. — Incorporated by reference to Exhibit (10)B(i)(c) of our Form 10-K Annual Report for the year ended December 31, 2005.

(d)                                  Deed of Guarantee made on 2 December 2005. — Incorporated by reference to Exhibit (10)B(i)(d) of our Form 10-K Annual Report for the year ended December 31, 2005.

(ii)                                   U.S. $450,000,000 U.S. Commercial Paper Program

(a)                                   Form of Commercial Paper Dealer Agreement for 4 (2) Program.  Agreements have been executed with Salomon Smith Barney, Inc. and Banc One Capital Markets, Inc - Incorporated by reference to Exhibit (10)A(ii)(a) of our Form 10-Q for the quarter ended June 30, 2003.

24




 

(b)                                  Issuing and Paying Agency Agreement dated as of July 10, 2000 between Ecolab Inc. and Bank One, National Association as Issuing and Paying Agent - Incorporated by reference to Exhibit (10)A(ii)(b) of our Form 10-Q for the quarter ended June 30, 2003.

C.                                      (i)            Ecolab Inc. 1997 Stock Incentive Plan, as Amended and Restated as of August 18, 2000 -

Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended September 30, 2000.

(ii)                                   Non-Statutory Stock Option Agreement as in effect for grants through May 12, 2000 — Incorporated by reference to Exhibit (10)B(i) of our Form 10-Q for the quarter ended June 30, 2004.

(iii)                                Non-Statutory Stock Option Agreement as in effect for grants beginning May 13, 2000 through May 10, 2002 — Incorporated by reference to Exhibit (10)B(ii) of our Form 10-Q for the quarter ended June 30, 2004.

D.                                     (i)            1995 Non-Employee Director Stock Option Plan.

(ii)                                   Amendment No. 1 to 1995 Non-Employee Director Stock Option Plan effective February 25, 2000 - Incorporated by reference to Exhibit (10)E(ii) of our Form 10-K Annual Report for the year ended December 31, 2000.

(iii)                                Amendment No. 2 to 1995 Non-Employee Director Stock Option Plan effective May 11, 2001 - Incorporated by reference to Exhibit (10)G(iii) of our Form 10-K Annual Report for the year ended December 31, 2003.

E.                                       (i)            Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan as amended

effective May 1, 2004 — Incorporated by reference to Exhibit (10)H(ii) of our Form 10-K Annual Report for the year ended December 31, 2003.

(ii)                                   Amendment No. 1 adopted December 15, 2004 to Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan, as amended and restated effective May 1, 2004, with respect to the American Jobs Creation Act of 2004 — Incorporated by reference to Exhibit (10)F(ii) of our Form 10-K Annual Report for the year ended December 31, 2004.

(iii)                                Master Agreement Relating to Options (as in effect through May 7, 2004) — Incorporated by reference to Exhibit (10)D(i) of our Form 10-Q for the quarter ended June 30, 2004.

(iv)                               Master Agreement Relating to Periodic Options, as amended effective as of May 1, 2004 — Incorporated by reference to Exhibit (10)D(ii) of our Form  10-Q for the quarter ended June 30, 2004.

F.                                       Note Purchase Agreement, dated as of July 26, 2006 by and among Ecolab Inc. and the Purchasers party thereto — Incorporated by reference to Exhibit (10) of our Form 8-K dated July 26, 2006.

G.                                      Form of Director Indemnification Agreement.  Substantially identical agreements are in effect as to each of our directors — Incorporated by reference to Exhibit (10)I of our Form 10-K Annual Report for the year ended December 31, 2003.

H.                                     (i)            Ecolab Executive Death Benefits Plan, as amended and restated effective March 1, 1994.  See also Exhibit

(10)N hereof.

(ii)                                   Amendment No. 1 to Ecolab Executive Death Benefits Plan — Incorporated by reference to Exhibit (10)H(ii) of our Form 10-K Annual Report for the year ended December 31, 1998.

(iii)                                Second Declaration of Amendment to Ecolab Executive Death Benefits Plan, effective March 1, 1998 - Incorporated by reference to Exhibit (10)H(iii) of our Form 10-K Annual Report for the year ended December 31, 1998.

25




 

(iv)                               Amendment No. 3 to the Ecolab Executive Death Benefits Plan, effective August 12, 2005 — Incorporated by reference to Exhibit (10)B of our Form 8-K dated December 13, 2005.

I.                                          Ecolab Executive Long-Term Disability Plan, as amended and restated effective January 1, 1994.  See also Exhibit (10)N hereof — Incorporated by reference to Exhibit (10)I of our Form 10-K Annual Report for the year ended December 31, 2004.

J.                                         Ecolab Executive Financial Counseling Plan — Incorporated by reference to Exhibit (10)J of our Form 10-K Annual Report for the year ended December 31, 2004.

K.                                     (i)            Ecolab Supplemental Executive Retirement Plan, as amended and restated effective January 1, 2003 —

Incorporated by reference to Exhibit (10)M of our Form 10-K Annual Report for the year ended December 31, 2003.

(ii)                                   Amendment No. 1 and Instrument of Benefit Freeze adopted December 16, 2004 to the Ecolab Supplemental Executive Retirement Plan (As Amended and Restated effective January 1, 2003) With Respect to the American Jobs Creation Act of 2004 — Incorporated by reference to Exhibit (10)K(ii) of our Form 10-K Annual Report for the year ended December 31, 2004.

L.                                       (i)            Ecolab Mirror Savings Plan, as amended and restated effective as of March 1, 2002 - Incorporated by

reference to Exhibit (10)N of our Form 10-K Annual Report for the year ended December 31, 2002.

(ii)                                   Amendment No. 1 adopted December 16, 2004 to the Ecolab Mirror Savings Plan (As Amended and Restated Effective as of March 1, 2002) With Respect to the American Jobs Creation Act of 2004 — Incorporated by reference to Exhibit (10)L(ii) of our Form 10-K Annual Report for the year ended December 31, 2004.

(iii)                                Amendment No. 2 to the Ecolab Mirror Savings Plan, effective January 1, 2005 — Incorporated by reference to Exhibit (10)A of our Form 8-K dated December 13, 2005.

M.                                  (i)            Ecolab Mirror Pension Plan, as amended and restated effective as of January 1, 2003 - Incorporated by

reference to Exhibit (10)B of our Form 10-Q for the quarter ended June 30, 2003.  See also Exhibit (10)N hereof.

(ii)                                   Amendment No. 1 and Instrument of Benefit Freeze adopted December 16, 2004 to the Ecolab Mirror Pension Plan (As Amended and Restated effective January 1, 2003) With Respect to the American Jobs Creation Act of 2004 — Incorporated by reference to Exhibit (10)M(ii) of our Form 10-K Annual Report for the year ended December 31, 2004.

N.                                     (i)            Ecolab Inc. Administrative Document for Non-Qualified Benefit Plans, as amended and restated effective

as of January 1, 2003 — Incorporated by reference to Exhibit (10)P of our Form 10-K Annual Report for the year ended December 31, 2003.

(ii)                                   Amendment No. 1 adopted December 16, 2004 to the Ecolab Inc. Administrative Document for Non-Qualified Benefit Plans (As Amended and Restated effective January 1, 2003) With Respect to the American Jobs Creation Act of 2004 — Incorporated by reference to Exhibit (10)N(ii) of our Form 10-K Annual Report for the year ended December 31, 2004.

O.                                     (i)            Ecolab Inc. Management Performance Incentive Plan, as amended and restated on February 28, 2004 —

Incorporated by reference to Exhibit (10)A of our Form 10-Q for the quarter ended March 31, 2004.

(ii)                                   Amendment No. 1 adopted February 26, 2005 to the Ecolab Inc. Management Performance Incentive Plan — Incorporated by reference to Exhibit (10)O(ii) of our Form 10-K Annual Report for the year ended December 31, 2004.

26




 

P.                                       Ecolab Inc. Change in Control Severance Compensation Policy, effective February 22, 2002 - Incorporated by reference to Exhibit (10)R of our Form 10-K Annual Report for the year ended December 31, 2001.

Q.                                     (i)            Master Agreement, dated as of December 7, 2000, between Ecolab Inc. and Henkel KGaA - Incorporated

by reference to Exhibit 18 of HC Investments, Inc.’s and Henkel KGaA’s Amendment No. 5 to Schedule 13D dated December 14, 2000.

(ii)                                   Amendment No. 1 to the Master Agreement, dated December 7, 2000, between Ecolab Inc. and Henkel KGaA - Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended September 30, 2001.

(iii)                                Intellectual Property Agreement dated November 30, 2001, between Ecolab and Henkel KGaA - Incorporated by reference to Exhibit (10) of our Form 8-K dated November 30, 2001.

R.                                      (i)            Ecolab Inc. 2002 Stock Incentive Plan - Incorporated by reference to Exhibit (10) of our Form 10-Q for the

quarter ended June 30, 2002.

(ii)                                   Non-statutory Stock Option Agreement as in effect for grants beginning May 11, 2002 through August 12, 2003 — Incorporated by reference to Exhibit (10)A(i) of our Form 10-Q for the quarter ended June 30, 2004.

(iii)                                Non-statutory Stock Option Agreement as in effect for grants beginning August 13, 2003 — Incorporated by reference to Exhibit (10)A(ii) of our Form 10-Q for the quarter ended June 30, 2004.

S.                                       (i)            Transition Agreement effective February 28, 2004 by and between Ecolab Inc. and Allan L. Schuman

including related arrangements — Incorporated by reference to Exhibit (10)B(i) of our Form 10-Q for the quarter ended March 31, 2004.

(ii)                                   Amendment No. 1 to Transition Agreement by and between Ecolab Inc.
and Allan L. Schuman — Incorporated by reference to Exhibit (10) of our Form 8-K dated January 1, 2006.

(iii)                                Non-statutory Stock Option Agreement — Incorporated by reference to Exhibit (10)B(ii) of our Form 10-Q for the quarter ended March 31, 2004.

(iv)                               Mutual Release by Allan L. Schuman and Ecolab Inc. — Incorporated by reference to Exhibit (10)B(iii) of our Form 10-Q for the quarter ended March 31, 2004.

(v)                                  Employment Agreement (Management) dated December 19, 1994 — Incorporated by reference to Exhibit (10)B(iv) of our Form 10-Q for the quarter ended March 31, 2004.

T.                                      Letter Agreement dated November 7, 2006 between Ecolab S.r.l. and Luciano Iannuzzi.

U.                                     2007 Named Executive Officer Summary of Base Salary, Bonus Award Opportunities, and Executive Benefits and Perquisites.

V.                                      Non-Employee Director Compensation and Benefits Summary — Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended March 31, 2006.

W.                                 (i)            Ecolab Inc. 2005 Stock Incentive Plan — Incorporated by reference to Exhibit (10)A of our Form 8-K

dated May 6, 2005.

(ii)                                   Sample form of Non-Statutory Stock Option Agreement under the Ecolab Inc. 2005 Stock Incentive Plan — Incorporated by reference to Exhibit (10)B of our Form 8-K dated May 6, 2005.

(iii)                                Sample form of Restricted Stock Award Agreement under the Ecolab Inc. 2005 Stock Incentive Plan.

 

27




 

(13)                             Those portions of our Annual Report to Stockholders for the year ended December 31, 2006 which are incorporated by reference into Parts I and II hereof.

(21)                             List of Subsidiaries as of January 31, 2007.

(23)                             Consent of Independent Registered Public Accounting Firm at page 32 hereof is filed as a part hereof.

(24)                             Powers of Attorney.

(31)                             Rule 13a-14(a) Certifications.

(32)                             Section 1350 Certifications.

28




 

EXECUTIVE COMPENSATION PLANS AND ARRANGEMENTS

Included in the preceding list of exhibits are the following management contracts or compensatory plans or arrangements:

Exhibit No.

 

Description

 

 

 

(10)C.

 

Ecolab Inc. 1997 Stock Incentive Plan.

 

(10)D.

 

1995 Non-Employee Director Stock Option Plan.

 

(10)E.

 

Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan.

 

(10)G.

 

Form of Director Indemnification Agreement.

 

(10)H.

 

Ecolab Executive Death Benefits Plan.

 

(10)I.

 

Ecolab Executive Long-Term Disability Plan.

 

(10)J.

 

Ecolab Executive Financial Counseling Plan.

 

(10)K.

 

Ecolab Supplemental Executive Retirement Plan.

 

(10)L.

 

Ecolab Mirror Savings Plan.

 

(10)M.

 

Ecolab Mirror Pension Plan.

 

(10)N.

 

Ecolab Inc. Administrative Document for Non-Qualified Benefit Plans.

 

(10)O.

 

Ecolab Inc. Management Performance Incentive Plan.

 

(10)P.

 

Ecolab Inc. Change in Control Severance Compensation Policy.

 

(10)R.

 

Ecolab Inc. 2002 Stock Incentive Plan.

 

(10)S.

 

Transition Agreement and related arrangements of Allan L. Schuman.

 

(10)T.

 

Letter Agreement between Ecolab S.r.l. and Luciano Iannuzzi.

 

(10)U.

 

2007 Named Executive Officer Summary of Base Salary, Bonus Award Opportunities, and Executive Benefits and Perquisites.

 

(10)V.

 

Non-Employee Director Compensation and Benefits Summary.

 

(10)W.

 

Ecolab Inc. 2005 Stock Incentive Plan.

 

 

29




 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, Ecolab Inc. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 28 th  day of February, 2007.

ECOLAB INC.

 

(Registrant)

 

 

 

 

 

 

By:

/s/Douglas M. Baker, Jr.

 

 

Douglas M. Baker, Jr.

 

 

Chairman of the Board, President

 

 

and Chief Executive Officer

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of Ecolab Inc. and in the capacities indicated, on the 28 th  day of February 2007.

 

/s/Douglas M. Baker, Jr.

 

Chairman of the Board, President

Douglas M. Baker, Jr.

 

and Chief Executive Officer

 

 

(Principal Executive Officer and Director)

 

 

 

/s/Steven L. Fritze

 

Executive Vice President and

Steven L. Fritze

 

Chief Financial Officer

 

 

(Principal Financial Officer)

 

 

 

/s/Daniel J. Schmechel

 

Senior Vice President and Controller

Daniel J. Schmechel

 

 (Principal Accounting Officer)

 

 

 

/s/Lawrence T. Bell

 

Directors

Lawrence T. Bell

 

 

 

 

 

as attorney-in-fact for:

 

 

Les S. Biller, Richard U. De Schutter, Stefan
Hamelmann, Jerry A. Grundhofer, Joel W.
Johnson, Jerry W. Levin, Robert L. Lumpkins,
Beth M. Pritchard, Kasper Rorsted and John J. Zillmer

 

 

 

 

 

Director not signing: Hans Van Bylen

 

 

 

30




 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

ON FINANCIAL STATEMENT SCHEDULE

To the Shareholders and Directors of Ecolab Inc.:

Our audits of the consolidated financial statements, of management’s assessment of the effectiveness of internal control over financial reporting and of the effectiveness of internal control over financial reporting referred to in our report, dated February 23, 2007, which contains an explanatory paragraph indicating that Ecolab Inc. changed the manner in which it accounts for defined benefit and other post retirement plans effective December 31, 2006, appearing in the 2006 Annual Report to Shareholders of Ecolab Inc. (which report and consolidated financial statements are incorporated by reference in this Annual Report on Form 10-K) also included an audit of the financial statement schedule listed in Item 15.I(2).(i) of this Form 10-K. In our opinion, this financial statement schedule presents fairly, in all material respects, the information set forth therein when read in conjunction with the related consolidated financial statements.

 

/s/ PricewaterhouseCoopers LLP

 

 

PricewaterhouseCoopers LLP

 

Minneapolis, Minnesota
February 23, 2007

31




 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (Registration Nos. 2-60010; 2-74944; 33-1664; 33-41828; 2-90702; 33-18202; 33-55986; 33-56101; 333-95043; 333-109890; 33-26241; 33-34000; 33-56151; 333-18627; 333-109891; 33-39228; 33-56125; 333-70835; 33-60266; 333-95041; 33-65364; 333-18617; 333-40239; 333-95037; 333-50969; 333-58360; 333-97927; 333-115567; 333-115568; 333-129427; 333-129428; 333-115568; and 333-132139) of Ecolab Inc. of our report dated February 23, 2007 relating to the consolidated financial statements, management’s assessment of the effectiveness of internal control over financial reporting and the effectiveness of internal control over financial reporting, which appears in the Annual Report to Shareholders, which is incorporated in this Annual Report on Form 10-K. We also consent to the inclusion in this Annual Report on Form 10-K of our report dated February 23, 2007 relating to the financial statement schedule, which appears in this Form 10-K.

 

/s/ PricewaterhouseCoopers LLP

 

 

PricewaterhouseCoopers LLP

 

Minneapolis, Minnesota
February 28, 2007

32




 

SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS

ECOLAB INC.
(In Thousands)

COL. A

 

COL. B

 

COL. C

 

COL. D

 

COL. E

 

 

 

 

 

Additions

 

 

 

 

 

 

 

Balance at

 

Charged to

 

Charged

 

 

 

Balance

 

 

 

Beginning

 

Costs and

 

to Other

 

 

 

at End

 

Description

 

of Period

 

Expenses

 

Accounts (A)

 

Deductions (B)

 

of Period (C)

 

Allowance for Doubtful Accounts:

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2006

 

$

38,851

 

$

12,947

 

$

3,304

 

$

(17,483

)

$

37,619

 

Year Ended December 31, 2005

 

$

44,199

 

$

11,589

 

$

(2,194

)

$

(14,743

)

$

38,851

 

Year Ended December 31, 2004

 

$

44,011

 

$

14,278

 

$

2,414

 

$

(16,504

)

$

44,199

 

 


(A)          Includes the effects of changes in currency translation and business acquisitions.

(B)            Uncollectible accounts charged off, net of recovery of accounts previously written off.

(C)            Includes an allowance of approximately $6,500,000 million as of December 31, 2006 for the expected return of products shipped, credits related to pricing or quantities shipped.  All of the returns and credit activity is recorded directly to accounts receivable or sales.

 

33




 

EXHIBIT INDEX

The following documents are filed as exhibits to this Report.

Exhibit No.

 

Document

 

Method of Filing

(3)

 

A.

 

 

 

Restated Certificate of Incorporation of Ecolab Inc., dated as of February 27, 2006, effective as of March 13, 2006.

 

Incorporated by reference to Exhibit (3)A of our Form 10-K Annual Report for the year ended December 31, 2005.

 

 

B.

 

 

 

Certificate of Designation, Preferences and Rights of Series A Junior Participating Preferred Stock of Ecolab Inc., dated as of February 27, 2006, effective as of March 13, 2006.

 

Incorporated by reference to Exhibit (3)C of our Form 10-K Annual Report for the year ended December 31, 2005.

 

 

C.

 

 

 

By-Laws, as amended through February 18, 1999.

 

Incorporated by reference to Exhibit (3)B of our Form 10-K Annual Report for the year ended December 31, 1998.

(4)

 

A.

 

 

 

Common Stock.

 

See Exhibits (3)A and (3)C.

 

 

B.

 

 

 

Form of Common Stock Certificate effective February 28, 2007.

 

Filed herewith electronically.

 

 

C.

 

 

 

Rights Agreement, dated as of February 24, 2006, between Ecolab Inc. and Computershare Investor Services, LLC, as Rights Agent, which includes the following exhibits thereto: (i) Exhibit A — Form of Certificate of Designation, Preferences and Rights of Series A Junior Participating Preferred Stock and (ii) Exhibit B — Form of Rights Certificate.

 

Incorporated by reference to Exhibit (4)C of our Form 10-K Annual Report for the year ended December 31, 2005.

 

 

D.

 

 

 

Second Amended and Restated Stockholder’s Agreement between Henkel KGaA and Ecolab Inc., dated November 30, 2001.

 

Incorporated by reference to Exhibit (4) of our Form 8-K dated November 30, 2001.

 

 

E.

 

 

 

Amended and Restated Indenture dated as of January 9, 2001 between Ecolab Inc. and Bank One, N.A. (formerly known as The First National Bank of Chicago) as Trustee.

 

Incorporated by reference to Exhibit (4)(A) of our Current Report on Form 8-K dated January 23, 2001.

 

 

F.

 

 

 

Officer’s Certificate establishing terms and conditions of 6.875% Notes due February 1, 2011.

 

Incorporated by reference to Exhibit 4(B) of our Form 8-K dated January 23, 2001.

 

 

G.

 

 

 

Form of 6.875% Note due February 2, 2011.

 

Incorporated by reference to Exhibit 4(c) of our Form 8-K dated January 23, 2001.

 




 

Exhibit No.

 

Document

 

Method of Filing

(10)

 

A.

 

 

 

Multicurrency Credit Agreement, dated as of September 29, 1993, as amended and restated as of June 1, 2006, among Ecolab Inc., the financial institutions party thereto as Banks from time to time, the financial institutions party thereto as Issuing Banks from time to time, Citibank, N.A., as administrative agent for the Banks and Issuing Banks thereunder, Citibank International PLC, as agent for the Banks in connection with certain of the Eurocurrency Advances, and JPMorgan Chase Bank, N.A., as syndication agent.

 

Incorporated by reference to Exhibit (10) of our Form 8-K dated June 1, 2006.

 

 

B.

 

 

 

Documents comprising global Commercial Paper Programs.

 

 

 

 

 

 

 

 

(i)

U.S. $200,000,000 Euro-Commercial Paper Programme.

 

 

 

 

 

 

 

 

 

(a)

Amended and Restated Dealer Agreement dated 2 December 2005 between Ecolab Inc. (as Guarantor), Ecolab B.V. and Ecolab Holding GmbH (as Issuers), Ecolab Inc., Credit Suisse First Boston (Europe) Limited (as Arranger), and Citibank International plc and Credit Suisse First Boston (Europe) Limited (as Dealers).

 

Incorporated by reference to Exhibit (10)B(i)(a) of our Form 10-K Annual Report for the year ended December 31, 2005.

 

 

 

 

 

 

 

(b)

Amended and Restated Note Agency Agreement dated as of 2 December 2005 between Ecolab Inc., Ecolab B.V. and Ecolab Holding GmbH (as Issuers) and Citibank, N.A. as Issue and Paying Agent.

 

Incorporated by reference to Exhibit (10)B(i)(b) of our Form 10-K Annual Report for the year ended December 31, 2005.

 

 

 

 

 

 

 

(c)

Deed of Covenant made on 2 December 2005 by Ecolab Inc., Ecolab B.V. and Ecolab Holding GmbH.

 

Incorporated by reference to Exhibit (10)B(i)(c) of our Form 10-K Annual Report for the year ended December 31, 2005.

 

 

 

 

 

 

 

(d)

Deed of Guarantee made on 2 December 2005.

 

Incorporated by reference to Exhibit (10)B(i)(d) of our Form 10-K Annual Report for the year ended December 31, 2005.

 

 

 

 

 

 

(ii)

U.S. $450,000,000 U.S. Commercial Paper Program.

 

 

 

 

 

 

 

 

 

(a)

Form of Commercial Paper Dealer Agreement for 4 (2) Program. Agreements have been executed with Salomon Smith Barney, Inc. and Banc One Capital Markets, Inc.

 

Incorporated by reference to Exhibit (10)A(ii)(a) of our Form 10-Q for the quarter ended June 30, 2003.

 




 

Exhibit No.

 

Document

 

Method of Filing

 

 

 

 

 

 

 

(b)

Issuing and Paying Agency Agreement dated as of July 10, 2000 between Ecolab Inc. and Bank One, National Association as Issuing and Paying Agent.

 

Incorporated by reference to Exhibit (10)A(ii)(b) of our Form 10-Q for the quarter ended June 30, 2003.

 

 

C.

 

(i)

 

Ecolab Inc. 1997 Stock Incentive Plan, as Amended and Restated as of August 18, 2000.

 

Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended September 30, 2000.

 

 

 

 

(ii)

 

Non-Statutory Stock Option Agreement as in effect for grants through May 12, 2000.

 

Incorporated by reference to Exhibit (10)B(i) of our Form 10-Q for the quarter ended June 30, 2004.

 

 

 

 

(iii)

 

Non-Statutory Stock Option Agreement as in effect for grants beginning May 13, 2000 through May 10, 2002.

 

Incorporated by reference to Exhibit (10)B(ii) of our Form 10-Q for the quarter ended June 30, 2004.

 

 

D.

 

(i)

 

1995 Non-Employee Director Stock Option Plan.

 

Filed herewith electronically.

 

 

 

 

(ii)

 

Amendment No. 1 to 1995 Non-Employee Director Stock Option Plan effective February 25, 2000.

 

Incorporated by reference to Exhibit (10)E(ii) of our Form 10-K Annual Report for the year ended December 31, 2000.

 

 

 

 

(iii)

 

Amendment No. 2 to 1995 Non-Employee Director Stock Option Plan effective May 11, 2001.

 

Incorporated by reference to Exhibit (10)G(iii) of our Form 10-K Annual Report for the year ended December 31, 2003.

 

 

E.

 

(i)

 

Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan as amended effective May 1, 2004.

 

Incorporated by reference to Exhibit (10)H(ii) of our Form 10-K Annual Report for the year ended December 31, 2003.

 

 

 

 

(ii)

 

Amendment No. 1 adopted December 15, 2004 to Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan, as amended and restated effective May 1, 2004, with respect to the American Jobs Creation Act of 2004.

 

Incorporated by reference to Exhibit (10)F(ii) of our Form 10-K Annual Report for the year ended December 31, 2004.

 

 

 

 

(iii)

 

Master Agreement Relating to Options (as in effect through May 7, 2004).

 

Incorporated by reference to Exhibit (10)D(i) of our Form 10-Q for the quarter ended June 30, 2004.

 

 

 

 

(iv)

 

Master Agreement Relating to Periodic Options, as amended effective as of May 1, 2004.

 

Incorporated by reference to Exhibit (10)D(ii) of our Form 10-Q for the quarter ended June 30, 2004.

 




 

Exhibit No.

 

Document

 

Method of Filing

 

 

F.

 

 

 

Note Purchase Agreement, dated as of July 26, 2006 by and among Ecolab Inc. and the Purchasers party thereto.

 

Incorporated by reference to Exhibit (10) of our Form 8-K dated July 26, 2006.

 

 

G.

 

 

 

Form of Director Indemnification Agreement. Substantially identical agreements are in effect as to each of our directors

 

Incorporated by reference to Exhibit (10)I of our Form 10-K Annual Report for the year ended December 31, 2003.

 

 

H.

 

(i)

 

Ecolab Executive Death Benefits Plan, as amended and restated effective March 1, 1994. See also Exhibit (10)N hereof.

 

Filed herewith electronically.

 

 

 

 

(ii)

 

Amendment No. 1 to Ecolab Executive Death Benefits Plan.

 

Incorporated by reference to Exhibit (10)H(ii) of our Form 10-K Annual Report for the year ended December 31, 1998.

 

 

 

 

(iii)

 

Second Declaration of Amendment to Ecolab Executive Death Benefits Plan, effective March 1, 1998.

 

Incorporated by reference to Exhibit (10)H(iii) of our Form 10-K Annual Report for the year ended December 31, 1998.

 

 

 

 

(iv)

 

Amendment No. 3 to the Ecolab Executive Death Benefits Plan, effective August 12, 2005.

 

Incorporated by reference to Exhibit (10)B of our Form 8-K dated December 13, 2005.

 

 

I.

 

 

 

Ecolab Executive Long-Term Disability Plan, as amended and restated effective January 1, 1994. See also Exhibit (10)N hereof.

 

Incorporated by reference to Exhibit (10)I of our Form 10-K Annual Report for the year ended December 31, 2004.

 

 

J.

 

 

 

Ecolab Executive Financial Counseling Plan.

 

Incorporated by reference to Exhibit (10)J of our Form 10-K Annual Report for the year ended December 31, 2004.

 

 

K.

 

(i)

 

Ecolab Supplemental Executive Retirement Plan, as amended and restated effective January 1, 2003.

 

Incorporated by reference to Exhibit (10)M of our Form 10-K Annual Report for the year ended December 31, 2003.

 

 

 

 

(ii)

 

Amendment No. 1 and Instrument of Benefit Freeze adopted December 16, 2004 to the Ecolab Supplemental Executive Retirement Plan (As Amended and Restated effective January 1, 2003) With Respect to the American Jobs Creation Act of 2004.

 

Incorporated by reference to Exhibit (10)K(ii) of our Form 10-K Annual Report for the year ended December 31, 2004.

 

 

L.

 

(i)

 

Ecolab Mirror Savings Plan, as amended and restated effective as of March 1, 2002.

 

Incorporated by reference to Exhibit (10)N of our Form 10-K Annual Report for the year ended December 31, 2002.

 




 

Exhibit No.

 

Document

 

Method of Filing

 

 

 

 

(ii)

 

Amendment No. 1 adopted December 16, 2004 to the Ecolab Mirror Savings Plan (As Amended and Restated Effective as of March 1, 2002) With Respect to the American Jobs Creation Act of 2004.

 

Incorporated by reference to Exhibit (10)L(ii) of our Form 10-K Annual Report for the year ended December 31, 2004.

 

 

 

 

(iii)

 

Amendment No. 2 to the Ecolab Mirror Savings Plan, effective January 1, 2005.

 

Incorporated by reference to Exhibit (10)A of our Form 8-K dated December 13, 2005.

 

 

M.

 

(i)

 

Ecolab Mirror Pension Plan, as amended and restated effective as of January 1, 2003.

 

Incorporated by reference to Exhibit (10)B of our Form 10-Q for the quarter ended June 30, 2003. See also Exhibit (10)N hereof.

 

 

 

 

(ii)

 

Amendment No. 1 and Instrument of Benefit Freeze adopted December 16, 2004 to the Ecolab Mirror Pension Plan (As Amended and Restated effective January 1, 2003) With Respect to the American Jobs Creation Act of 2004.

 

Incorporated by reference to Exhibit (10)M(ii) of our Form 10-K Annual Report for the year ended December 31, 2004.

 

 

N.

 

(i)

 

Ecolab Inc. Administrative Document for Non-Qualified Benefit Plans, as amended and restated effective as of January 1, 2003.

 

Incorporated by reference to Exhibit (10)P of our Form 10-K Annual Report for the year ended December 31, 2003.

 

 

 

 

(ii)

 

Amendment No. 1 adopted December 16, 2004 to the Ecolab Inc. Administrative Document for Non-Qualified Benefit Plans (As Amended and Restated effective January 1, 2003) With Respect to the American Jobs Creation Act of 2004.

 

Incorporated by reference to Exhibit (10)N(ii) of our Form 10-K Annual Report for the year ended December 31, 2004.

 

 

O.

 

(i)

 

Ecolab Inc. Management Performance Incentive Plan, as amended and restated on February 28, 2004.

 

Incorporated by reference to Exhibit (10)A of our Form 10-Q for the quarter ended March 31, 2004.

 

 

 

 

(ii)

 

Amendment No. 1 adopted February 26, 2005 to the Ecolab Inc. Management Performance Incentive Plan.

 

Incorporated by reference to Exhibit (10)O(ii) of our Form 10-K Annual Report for the year ended December 31, 2004.

 

 

P.

 

 

 

Ecolab Inc. Change in Control Severance Compensation Policy, effective February 22, 2002.

 

Incorporated by reference to Exhibit (10)R of our Form 10-K Annual Report for the year ended December 31, 2001.

 




 

Exhibit No.

 

Document

 

Method of Filing

 

 

Q.

 

(i)

 

Master Agreement, dated as of December 7, 2000, between Ecolab Inc. and Henkel KGaA.

 

Incorporated by reference to Exhibit 18 of HC Investments, Inc.’s and Henkel KGaA’s Amendment No. 5 to Schedule 13D dated December 14, 2000.

 

 

 

 

(ii)

 

Amendment No. 1 to the Master Agreement, dated December 7, 2000, between Ecolab Inc. and Henkel KGaA.

 

Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended September 30, 2001.

 

 

 

 

(iii)

 

Intellectual Property Agreement dated November 30, 2001, between Ecolab and Henkel KGaA.

 

Incorporated by reference to Exhibit (10) of our Form 8-K dated November 30, 2001.

 

 

R.

 

(i)

 

Ecolab Inc. 2002 Stock Incentive Plan.

 

Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended June 30, 2002.

 

 

 

 

(ii)

 

Non-statutory Stock Option Agreement as in effect for grants beginning May 11, 2002 through August 12, 2003.

 

Incorporated by reference to Exhibit (10)A(i) of our Form 10-Q for the quarter ended June 30, 2004.

 

 

 

 

(iii)

 

Non-statutory Stock Option Agreement as in effect for grants beginning August 13, 2003.

 

Incorporated by reference to Exhibit (10)A(ii) of our Form 10-Q for the quarter ended June 30, 2004.

 

 

S.

 

(i)

 

Transition Agreement effective February 28, 2004 by and between Ecolab Inc. and Allan L. Schuman including related arrangements.

 

Incorporated by reference to Exhibit (10)B(i) of our Form 10-Q for the quarter ended March 31, 2004.

 

 

 

 

(ii)

 

Amendment No. 1 to Transition Agreement by and between Ecolab Inc. and Allan L. Schuman.

 

Incorporated by reference to Exhibit (10) of our Form 8-K dated January 1, 2006.

 

 

 

 

(iii)

 

Non-statutory Stock Option Agreement.

 

Incorporated by reference to Exhibit (10)B(ii) of our Form 10-Q for the quarter ended March 31, 2004.

 

 

 

 

(iv)

 

Mutual Release by Allan L. Schuman and Ecolab Inc.

 

Incorporated by reference to Exhibit (10)B(iii) of our Form 10-Q for the quarter ended March 31, 2004.

 




 

Exhibit No.

 

Document

 

Method of Filing

 

 

 

 

(v)

 

Employment Agreement (Management) dated December 19, 1994.

 

Incorporated by reference to Exhibit (10)B(iv) of our Form 10-Q for the quarter ended March 31, 2004.

 

 

T.

 

 

 

Letter Agreement dated November 7, 2006 between Ecolab S.r.l. and Luciano Iannuzzi.

 

Filed herewith electronically.

 

 

U.

 

 

 

2007 Named Executive Officer Summary of Base Salary, Bonus Award Opportunities, and Executive Benefits and Perquisites.

 

Filed herewith electronically.

 

 

V.

 

 

 

Non-Employee Director Compensation and Benefits Summary.

 

Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended March 31, 2006.

 

 

W.

 

(i)

 

Ecolab Inc. 2005 Stock Incentive Plan.

 

Incorporated by reference to Exhibit (10)A of our Form 8-K dated May 6, 2005.

 

 

 

 

(ii)

 

Sample form of Non-Statutory Stock Option Agreement under the Ecolab Inc. 2005 Stock Incentive Plan.

 

Incorporated by reference to Exhibit (10)B of our Form 8-K dated May 6, 2005.

 

 

 

 

(iii)

 

Sample form of Restricted Stock Award Agreement under the Ecolab Inc. 2005 Stock Incentive Plan

 

Filed herewith electronically.

(13)

 

 

 

 

 

Those portions of our Annual Report to Stockholders for the year ended December 31, 2006 which are incorporated by reference into Parts I and II hereof.

 

Filed herewith electronically.

(21)

 

 

 

 

 

List of Subsidiaries as of January 31, 2007.

 

Filed herewith electronically.

(23)

 

 

 

 

 

Consent of Independent Registered Public Accounting Firm at page 32 hereof is filed as a part hereof.

 

See page 32 hereof.

(24)

 

 

 

 

 

Powers of Attorney.

 

Filed herewith electronically.

(31)

 

 

 

 

 

Rule 13a-14(a) Certifications.

 

Filed herewith electronically.

(32)

 

 

 

 

 

Section 1350 Certifications.

 

Filed herewith electronically.

 



Exhibit (4)B

 

COMMON STOCK

 

COMMON STOCK

 

 

 

 

 

 

 

PAR VALUE $1.00

 

THIS CERTIFICATE IS TRANSFERABLE IN
NEW YORK, NY OR CHICAGO, IL

 

Certificate
Number

 

 

Shares

 

 

 

 

 

 

 

ECOLAB INC.
INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE

 

 

 

THIS CERTIFIES THAT

CUSIP 278865 10 0

 

 

 

 

is the owner of

 

 

 

 

 

FULLY-PAID AND NON-ASSESSABLE SHARES OF THE COMMON STOCK OF

 

 

 

 

Ecolab Inc. transferable on the books of the Corporation by the holder hereof in person or by duly authorized attorney upon surrender of this certificate properly endorsed. This certificate is not valid unless countersigned by the Transfer Agent and registered by the Registrar.

 

 

 

Witness the facsimile seal of the Corporation and the facsimile signatures of its duly authorized officers.

 

 

 

 

 

 

 

 

 

 

 

 

 

DATED

 

 

/s/ D.M. Baker

COUNTERSIGNED AND REGISTERED:

 

Chairman of the Board

COMPUTERSHARE INVESTOR

 

 

SERVICES, LLC.

 

 

(CHICAGO)

 

 

TRANSFER AGENT AND REGISTRAR,

 

 

 

 

/s/ L. T. Bell

By:

 

 

Secretary

AUTHORIZED SIGNATURE

SECURITY INSTRUCTIONS ON REVERSE

 




ECOLAB INC.

The Corporation will furnish, without charge, to each stockholder who so requests, a printed statement of the powers, designations, preferences and relative, participating, optional or other special rights of each class of stock or series thereof which the corporation is authorized to issue and the qualifications, limitations or restrictions of such preferences and/or rights. requests may be directed to the secretary of ecolab inc. at its principal office, or the transfer agent named on the face of this certificate.

This certificate also evidences and entitles the holder hereof to certain Rights as set forth in the Rights Agreement between Ecolab Inc. (the “Company”) and Computershare Investor Services, LLC (the “Rights Agent”), dated as of February 24, 2006, as amended from time to time (the “Rights Agreement”), the terms of which are hereby incorporated herein by reference and a copy of which is on file at the principal offices of the Company. Under certain circumstances, as set forth in the Rights Agreement, such Rights will be evidenced by separate certificates and will no longer be evidenced by this certificate. The Company will mail to the holder of this certificate a copy of the Rights Agreement, as in effect on the date of mailing, without charge promptly after receipt of a written request therefor. Under certain circumstances set forth in the Rights Agreement, Rights issued to, or held by, any Person who is, was or becomes an Acquiring Person or an Adverse Person or any Affiliate or Associate thereof (as such terms are defined in the Rights Agreement), whether currently held by or on behalf of such Person or by any subsequent holder, may become null and void.

The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations:

TEN COM -as tenants in common

 

UNIF GIFT MIN ACT-

 

Custodian

 

 

 

 

 

(Cust)

 

(Minor)

 

TEN ENT -as tenants by the entireties

 

 

 

under Uniform Gifts to Minors Act

 

 

 

 

 

 

 

 

 

JT TEN - as joint tenants with right of survivorship

 

UNIF TRF MIN ACT -

 

Custodian (until age   )

 

and not as tenants in common

 

 

 

(Cust)

 

(Minor)

 

 

 

 

 

under Uniform Transfers to Minors Act

 

 

 

 

 

(State)

 

Additional abbreviations may also be used though not in the above list.

 

 

 

 

 

For value received,                                    hereby sell, assign and transfer unto

PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE

(PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING POSTAL ZIP CODE, OF ASSIGNEE)

Shares

of the capital stock represented by the within Certificate, and do hereby irrevocably constitute and appoint

Attorney

to transfer the said stock on the books of the within-named Corporation with full power of substitution in the premises.

 

Dated:

 

20

 

 

 

Signature:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Signature:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NOTICE:

 

THE SIGNATURE TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE FACE OF THE CERTIFICATE, IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT, OR ANY CHANGE WHATEVER.

 

Signature(s) Guaranteed:

 

 

 

 

 

 

BY:

 

 

 

THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE
GUARANTOR INSTITUTION (Banks, Stockbrokers, Savings and Loan
Associations and Credit Unions) WITH MEMBERSHIP IN AN APPROVED
SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO
S.E.C. RULE 17Ad-15.

SECURITY INSTRUCTIONS

THIS IS WATERMARKED PAPER, DO NOT ACCEPT WITHOUT NOTING WATERMARK. HOLD TO LIGHT TO VERIFY WATERMARK.



Exhibit (10)D(i)

ECOLAB INC.

1995 NON-EMPLOYEE DIRECTOR STOCK OPTION PLAN

1.                                        Purpose .  The purpose of this 1995 Non-Employee Director Stock Option Plan (the “Plan”) is to advance the interests of Ecolab Inc.  (the “Company”) and its stockholders by enabling the Company to attract and retain the services of experienced and knowledgeable non-employee directors and to provide an incentive for such directors to increase their proprietary interest in the Company’s long-term success and progress.

2.                                        Administration .  The Plan shall be administered by a committee consisting solely of three or more members of the Board of Directors (the “Committee”).  Grants of stock options under the Plan (“Options”) and the amount and nature of the Options to be granted shall be automatic, as described in paragraph 5(b)(i) of the Plan.  All questions of interpretation of the Plan or of any Options issued under it shall be determined by the Committee and such determination shall be final and binding upon all persons having an interest in the Plan.  Any or all powers and discretion vested in the Committee under this Plan may be exercised by any subcommittee of three or more persons so authorized by the Committee.

3.                                        Participation in the Plan .  Directors of the Company who are not employees of the Company or any subsidiary of the Company (“Eligible Directors”) shall be eligible to participate in the Plan.

4.                                        Stock Subject to the Plan .

(a)                                   Number of Shares.   The maximum number of shares of Common Stock that shall be reserved for issuance under the Plan shall be two hundred thousand (200,000) shares of the Company’s common stock, $1.00 par value (the “Common Stock”), subject to adjustment upon changes in capitalization of the Company as provided in subparagraph (b) below.  The maximum number of shares authorized may be increased from time to time by approval of the Board of Directors and the stockholders of the Company.  Shares of Common Stock that may be issued upon exercise of Options granted under the Plan shall be applied to reduce the maximum number of shares of Common Stock remaining available for use under the Plan.  The shares to be issued pursuant to the Plan may be, at the election of the Company, either treasury shares or shares authorized but unissued.  Any shares of Common Stock that are subject to an Option granted under the Plan (or any portion thereof) that lapses, expires or for any reason is terminated unexercised shall automatically again become available for use under the Plan.

(b)                                  Adjustments to Shares and Options .  In the event of any reorganization, merger, consolidation, recapitalization, liquidation, reclassification, stock dividend, stock split, combination of shares, rights offering, divestiture or extraordinary dividend (including a spin-off) or any other change in the corporate structure or shares of the




Company, the Committee (or, if the Company is not the surviving Company in any such transaction, the board of directors of the surviving corporation)  will make appropriate adjustment (which determination will be conclusive) as to the number and kind of securities available for issuance under the Plan (including, without limitation, the number of securities as to which Options are to be granted and as to which Options become exercisable pursuant to paragraphs 5(b)(i) and 5(b)(iii) below after the effective date of such change) and, in order to prevent dilution or enlargement of the rights of Optionees, the number, kind and exercise price of securities subject to outstanding Options.

5.                                        Terms of Options .

(a)                                   Non-Statutory Stock Options .  All Options granted under the Plan shall be non-statutory stock options not entitled to special tax treatment under Section 422 of the Internal Revenue Code of 1986, as amended to date and as may be amended from time to time (the “Code”).

(b)                                  Terms, Conditions and Form of Options .  Each Option granted under the Plan shall be evidenced by a written agreement in such form as the Committee shall from time to time approve, which agreements shall comply with and be subject to the following terms and conditions:

(i)                                      Grant of Options .  An Option to purchase shares of Common Stock shall be granted automatically on the date the Plan is adopted by the stockholders of the Company to each Eligible Director as of such date (including directors who are elected or re-elected on such date), in the following amounts:  Class I Directors, one thousand two hundred (1,200) shares; Class II Directors, two thousand four hundred (2,400) shares; Class III Directors, six thousand (6,000) shares. An Option to purchase six thousand (6,000) shares of Common Stock shall thereafter be granted automatically to each Eligible Director upon the election (or re-election) of such director to the Board of Directors for a full term by the stockholders of the Company at an annual meeting of stockholders, beginning with the annual meeting of stockholders to be held in 1996.  An Eligible Director chosen pursuant to the provisions of Article IV of the Company’s Restated Certificate of Incorporation to fill a newly created directorship or a vacancy in the Board of Directors shall be automatically granted, as of the date of the next subsequent annual meeting of stockholders (unless the director is chose on the date of an annual meeting of stockholders, in which case as of such date) an Option to purchase a number of shares of Common Stock equal to the product of (i) two thousand (2,000), and (ii) the number of years remaining in such director’s term of office as of the date of automatic option grant.  No eligible Director shall be granted more than one Option at any annual meeting of stockholders.  The written agreement evidencing each Option granted under the Plan shall be

2




dated as of the applicable date of grant (the “Date of Grant”).  An Eligible Director accepting such a grant of an Option (an “Optionee”) shall execute and return a copy of such option agreement to the Secretary of the Company.  Whenever there is a reference in the Plan to the years remaining in the term of office of a director, the word “year” shall refer to the interval between the annual meeting of stockholders in one year and such meeting in the next subsequent year.

(ii)                                   Option Exercise Price .  The per share price to be paid by the Optionee at the time an Option is exercised shall be 100% of the Fair Market Value of one share of Common Stock on the Date of Grant.  For purposes of the Plan, “Fair Market Value” shall mean, as of any date (or, if no shares were traded or quoted on such date, as of the next preceding date on which there was such a trade or quote), the mean between the reported high and low sale prices of the Common stock as reported on the New York Stock Exchange Composite Tape.

(iii)                                Exercisability of Options .  Except for an Option which becomes exercisable pursuant to paragraph 5(b)(iv)(A) below, an Option may not be exercised before the next subsequent annual meeting of stockholders after its Date of Grant.  The Option of an Optionee whose remaining term as a director is three years as of the Date of Grant may be exercised on a cumulative basis to the extent of two thousand (2,000) of the total shares covered by the Option beginning on the date of the next subsequent annual meeting of stockholders after the Date of Grant, an additional two thousand (2,000) of the total shares beginning on the date of the second subsequent annual meeting of stockholders after the Date of Grant and the remaining two thousand (2,000) shares on the date of the third subsequent annual meeting of stockholders after the Date of Grant.  The Option of an Optionee whose remaining term as a director is two years as of the Date of Grant may be exercised on a cumulative basis to the extent of two thousand (2,000) of the total shares covered by the Option beginning on the date of the next subsequent annual meeting of stockholders after the date of Grant and the remaining two thousand (2,000) shares on the date of the second subsequent annual meeting of stockholders after the Date of Grant.  The Option of an Optionee whose remaining term as a director is one year as of the Date of Grant may be exercised in full on the date of the next subsequent annual meeting. Notwithstanding the foregoing, an Option granted on the date the Plan is adopted by the stockholders of the Company to (A) a Class I Director may be exercised in full on the date of the next subsequent annual meeting of stockholders after the Date of Grant and (B) a Class II Director may be exercised on a cumulative basis to the extent of one thousand two hundred (1,200) of the total shares covered by the Option beginning on the date of the next subsequent annual meeting of stockholders after the Date of Grant and the remaining one thousand two hundred (1,200)

3




shares on the date of the second subsequent annual meeting of stockholders after the Date of Grant.

(iv)                               Duration of Options .  Each Option shall terminate ten years after its Date of Grant.  Each Option shall terminate and may no longer be exercised if and when the Optionee ceases to serve as a director of the Company, except (A) if the Optionee ceases to serve as a director of the Company by reason of death or the occurrence of an event which constitutes permanent and total disability (within the meaning of Section 22(e)(3) of the Code), then the Option shall become immediately exercisable in full and shall remain exercisable until the earlier of the expiration of five years or the remaining term of the Option, and (B) if the Optionee ceases to serve as a director of the Company for any other reason, then the Option shall remain exercisable to the extent that the Option was exercisable on the date the Optionee ceased to serve as a director of the Company until the earlier of the expiration of five years after the date the Optionee ceased to serve as a director of the Company or the remaining term of the Option.

(v)                                  Manner of Option Exercise .  An Option may be exercised by an Optionee in whole or in part from time to time, subject to the conditions contained in the Plan and in the agreement evidencing such Option, by giving written notice of exercise to the Company at its principal executive office (Attn: Secretary), such notice shall specify the particular Option that is being exercised and the number of shares with respect to which the Option is being exercised and shall be accompanied by payment of the total purchase price of the shares to be purchased under the Option.  The Company shall not be required to sell or issue any shares under any outstanding Option if, in the sole opinion of the Committee, the issuance of such shares would constitute a violation by the Optionee or the Company of any applicable law or regulation of any governmental authority, including without limitation federal and state securities laws.

(vi)                               Payment of Exercise Price .  The total purchase price of the shares to be purchased may be paid entirely in cash (including check, bank draft or money order) or by tendering shares of the Company’s Common Stock already owned by the Optionee (“Previously Acquired Shares”), or by an combination thereof; provided, however, that any such Previously Acquired Shares tendered by an Optionee must be “mature” shares, as such term may be defined from time-to-time by the Financial Accounting Standards Board or any successor body.

(vii)                            Restrictions on Transfer .  Except pursuant to testamentary will or the laws of descent and distribution or as otherwise expressly permitted by the Plan, no right or interest of any Optionee in an Option prior to the exercise

4




or vesting of such Option will be assignable or transferable, or subjected to any lien, during the lifetime of the Optionee, either voluntarily or involuntarily, directly or indirectly, by operation of law or otherwise.  An Optionee will, however, be entitled to designate a beneficiary to receive an Option upon such Optionee’s death, and in the event of an Optionee’s death, payment of any amounts due under the Plan will be made to, and exercise of any Options (to the extent permitted pursuant to paragraph 5(b)(iii)(A) above may be made by, the Optionee's legal representatives, heirs and legatees.

(viii)                         Successive Options .  Successive Options may be granted to the same Optionee, whether or not the Options previously granted to such Optionee remain unexercised.  An Optionee may exercise an Option if then exercisable, notwithstanding that Options previously granted to such Optionee remain unexercised.

(ix)                                 Withholding .  The Company may require an Optionee to promptly pay the Company the amount of any federal, state or local withholding or other employment-related tax attributable to the Optionee's exercise of an Option before acting on the Optionee's notice of exercise of the Option.  An Optionee may satisfy any such withholding or employment-related tax obligation by electing to tender Previously Acquired Shares or withhold shares of Common Stock that are to be issued upon exercise of an Option, or by a combination of such methods.

6.                                        Limitation of Rights .

(a)                                   No Right to Continue as a Director .  Neither the plan, nor the granting of an Option nor any other action taken pursuant to the Plan, shall constitute or be evidence of any agreement or understanding, express or implied that the Company will retain a director for any period of time, or at any particular rate of compensation.

(b)           Rights as Stockholder.   No Optionee shall have any rights as a stockholder with respect to any shares of Common Stock covered by an Option granted pursuant to the Plan until the Optionee shall have become the holder of record of such shares, and no adjustments shall be made for dividends or other distributions or other rights as to which there is a record date preceding the date the Optionee becomes the holder of record of such shares.

7.                                        Plan Amendment, Modification and Termination .  The Board of Directors may suspend or terminate the Plan or any portion thereof at any time, and may amend the Plan from time to time in such respects as the Board of Directors may deem advisable in order that Options under the Plan will conform to any change in applicable laws or regulations or in any other respect the Board of Directors may deem to be in the best interest of the Company; provided, however, that no amendments to the Plan will be effective without approval of the

5




stockholders of the Company if stockholder approval of the amendment is then required pursuant to Rule 16b-3 under the Exchange Act, the Code or the rules of the New York Stock Exchange.  No termination, suspension or amendment of the Plan may adversely affect any outstanding Option without the consent of the affected Optionee; provided, however, that this sentence will not impair the right of the Committee to take whatever action it deems appropriate under paragraph 4(b) above.

8.                                        Effective Date and Duration of the Plan .  The Plan shall be effective on the date of adoption by the stockholders of the Company.  The Plan shall terminate at midnight on June 30, 2000, and may be terminated prior thereto by action of the Board of Directors, and no Option shall be granted after such termination.  Options outstanding upon termination of the Plan may continue to be exercised in accordance with their terms.

9.                                        Governing Laws .  The Plan and all rights and obligations under the Plan shall be construed in accordance with and governed by the laws of the State of Minnesota.

6



Exhibit (10)H(i)

ECOLAB

EXECUTIVE DEATH BENEFITS PLAN

(As Amended and Restated Effective March 1, 1994)

Pursuant to Section 8.1 of the Ecolab Executive Death Benefits Plan (1991 Restatement) (the “Plan”), and the resolutions of the Board of Directors of Ecolab Inc. (the “Company”) dated February 26, 1994, the Company hereby amends and restates the Plan in its entirety to read as follows, effective March 1, 1994.

ARTICLE I

PREFACE

SECTION 1.1 .                        Effective Date .  The effective date of this amendment and restatement of the Plan is March 1, 1994.  The benefit, if any, payable with respect to a former Executive who Retired or died prior to the Effective Date (and who is not rehired by a member of the Controlled Group thereafter) shall be determined by, and paid in accordance with, the terms and provisions of the Plan as in effect prior to the Effective Date.

SECTION 1.2 .                        Purpose of the Plan .  The purpose of this Plan is to provide further means whereby the Company may afford financial security for certain management and highly compensated employees who perform management and professional functions for the Company and certain related entities, by providing their beneficiaries with a level of protection from the financial losses that may be suffered on account of the death of such an employee.

SECTION 1.3 .                        Administrative Document .  This Plan includes the Ecolab Inc. Administrative Document for Non-Qualified Benefit Plans (the “Administrative Document”), which is incorporated herein by reference.

ARTICLE II

DEFINITIONS

Words and phrases used in this Plan with initial capital letters which are defined in the Administrative Document are used herein as so defined, unless specifically defined herein or the context clearly indicates otherwise.  The following words and phrases when used in this Plan with initial capital letters shall have the following respective meanings, unless the context clearly indicates otherwise:

SECTION 2.1 .                        Death Beneficiary .”  An Executive’s Death Beneficiary shall be the person or persons (natural or otherwise) designated by the Executive as his primary or




contingent Death Beneficiary under this Plan.  Such a designation may be made, revoked or changed at any time (without the consent of any previously designated Death Beneficiary) only by a written instrument in a form prescribed by the Administrator, signed by the Executive and delivered to the Administrator during the Executive’s lifetime.

SECTION 2.2 .                        Disability ” or “ Disabled .”  An Executive shall be deemed to have a “Disability” or be “Disabled” if the Executive’s active employment with an Employer ceases due to a disability that entitles the Executive to benefits under any long-term disability plan sponsored by the Company.  An Executive’s Disability shall continue until the earliest to occur of (1) the date on which the Executive’s employment with the Controlled Group as an Executive terminates, (2) the date the Executive recovers from the Disability, or (3) the date of termination of payments under the Company’s long-term disability plan for any reason.

SECTION 2.3 .                        Executive ” shall mean an Employee who is selected by the Administrator to participate in this Plan and who is in a pay grade of 24 or above.

SECTION 2.4 .                        Executive Death Benefits ” shall mean the benefits described in Article III.

SECTION 2.5 .                        Final Average Compensation ” shall mean the average of an Executive’s Annual Compensation for the five (5) consecutive Plan Years of employment with the Employers preceding the Executive’s Retirement (including the Plan Year of Retirement) which yields the highest average compensation.  If the Executive has been employed by the Employers for a period of less than five (5) Plan Years preceding his Retirement, Final Average Compensation shall be calculated using the Executive’s total period of employment with the Employers.

SECTION 2.6 .                        Plan ” shall mean the Ecolab Executive Death Benefits Plan, as described herein and as it may be amended from time to time.

SECTION 2.7 .                        Retirement ” or “ Retired .”  The Retirement of an Executive shall occur upon his termination of employment with the Controlled Group for any reason other than death or Disability on or after (1) his attainment of age 55 and the completion of at least 10 Years of Eligibility Service, or (2) his attainment of age 65.  For purposes of determining Retirement under this Plan, the employment of a Disabled Executive shall be deemed to have terminated “for reasons other than Disability” at such time as he ceases to meet the definition of Disability, provided he does not resume active employment with the Controlled Group.

2




SECTION 2.8 .                        Year of Eligibility Service .”

(1)                                   An Executive shall be credited with one Year of Eligibility Service for each year of “Continuous Service” (or such other defined term which is used to determine vesting service) as defined by and credited to the Executive under the Pension Plan.

(2)                                   A Disabled Executive shall continue to accrue Years of Eligibility Service during the period of his Disability for purposes of determining his eligibility for Retirement hereunder.

ARTICLE III

EXECUTIVE DEATH BENEFITS

SECTION 3.1 .                        Coverage .  An Employee shall become covered under the Plan as of the first date on or after the Effective Date on which he is an Executive.

SECTION 3.2 .                        Executive Death Benefit for Actively Employed Executives .

(1)                                   Eligibility .  An Executive’s entitlement to the Executive Death Benefit coverage described in this Section 3.2 shall cease on the earliest to occur of (a) thirty-one (31) days after the date the Executive’s employment as an Executive ceases for any reason other than death or Disability, (b) the date the Executive Retires, or (c) with respect to a Disabled Executive, the date the Executive is no longer Disabled, provided he does not resume active employment as an Executive.

(2)                                   Amount of Executive Death Benefit .

(a)                                   The Death Beneficiary of a deceased Executive who is covered by the provisions of this Section 3.2 shall be entitled to receive a lump sum Executive Death Benefit in an amount equal to the lesser of (i) three million dollars ($3,000,000) or (ii) three hundred percent (300%) of the Executive’s Annual Compensation (A) for the last full Plan Year that ended prior to the Executive’s death in which the Executive actively performed services as an Employee, or (B) if the Executive did not actively perform services as an Employee in any full prior Plan Year, for the last Plan Year in which the Executive actively performed services as an Employee, in which case his Annual Compensation shall be annualized based on the number of days employed by the Controlled Group out of a Plan Year of 365 days.

(b)                                  The Executive Death Benefit described in paragraph (a) shall be reduced (but not below zero) by any amount payable under any life insurance or other death benefit covering the Executive which is provided by, or payable by or on behalf of a member of the Controlled Group.

3




(c)                                   If the Executive Death Benefit described in paragraph (a), after any reduction described in (b), is subject to United States federal income tax when paid to the Executive’s Death Beneficiary, the amount of such Executive Death Benefit shall be “grossed-up” for federal income taxes, using a thirty-four percent (34%) tax rate, so that the total Executive Death Benefit under this Section 3.2 shall be equal to the amount calculated under paragraph (a), after any reduction described in (b), divided by sixty-six percent (66%).

SECTION 3.3 .                        Executive Death Benefit for Retired Executives .

(1)                                   Eligibility .  The Death Beneficiary of an Executive who dies while he is Retired shall be entitled to receive the Executive Death Benefit described in this Section 3.3.

(2)                                   Amount of Executive Death Benefit .

(a)                                   The Death Beneficiary of a deceased Executive who is covered by the provisions of this Section 3.3 shall be entitled to receive a lump sum Executive Death Benefit in an amount equal to the lesser of (i) seven hundred and fifty thousand dollars ($750,000) or (ii) two hundred percent (200%) of the Executive’s Final Average Compensation.

(b)                                  The Executive Death Benefit described in paragraph (a) of this Subsection shall be reduced (but not below zero) by any amount payable under any life insurance or other death benefit covering the Executive which is provided by, or payable by or on behalf of a member of the Controlled Group.

SECTION 3.4 .                        Disabled Executives .  An Executive who is Disabled shall be entitled to the Executive Death Benefit described in Section 3.2, until coverage terminates in accordance with the provisions of Section 3.2(1).  In the event an Executive dies while he is Disabled, no Executive Death Benefit shall be payable under the provisions of Section 3.3.

SECTION 3.5 .                        Protective Provisions .  Notwithstanding the preceding Sections of the Article, if an Executive commits suicide during the two-year period beginning on the date of his commencement of participation in the Plan or makes any material misstatement of information or nondisclosure of medical history, then, in the Administrator’s sole and absolute discretion, no Executive Death Benefits shall be payable hereunder or such Executive Death Benefits may be paid in a reduced amount (as determined by the Administrator).

4




ARTICLE IV

PAYMENT OF EXECUTIVE DEATH BENEFITS

SECTION 4.1 .                        Commencement of Executive Death Benefits .  Executive Death Benefits hereunder shall be paid to the Executive’s Death Beneficiary after the amount of the Executive Death Benefit and the identity of the Death Beneficiary have been identified and, in any event, within ninety (90) days after the date of the Executive’s death.  Notwithstanding the foregoing, if payment during such 90-day period is prevented due to reasons outside of the Administrator’s control, payment of the Executive Death Benefits shall be made as soon as practicable following the date of the Executive’s death.

ARTICLE V

AMENDMENT AND TERMINATION

SECTION 5.1 .                        Effect of Amendment and Termination .  No amendment or termination shall operate to deprive any Executive or, in the event of the Executive’s death, any Death Beneficiary of any Executive Death Benefit otherwise payable with respect to an Executive who has Retired or died prior to the date such amendment or termination is adopted.

IN WITNESS WHEREOF, Ecolab Inc. has executed this Executive Death Benefits Plan and has caused its corporate seal to be affixed this 29 th  day of August, 1994.

 

ECOLAB INC.

 

 

 

 

 

 

 

By:

/s/Michael E. Shannon

 

 

Michael E. Shannon

 

 

Vice Chairman, Chief Financial

 

 

and Administrative Officer

 

(Seal)

/s/Kenneth A. Iverson

 

Kenneth A. Iverson

 

Secretary

 

 

5



EXHIBIT (10)T

November 7, 2006

Luciano Iannuzzi

Executive VP — EMEA

Ecolab GmbH & Co. OHG

Reisholzer Werftstrasse 38-42

D-40589 Düsseldorf

GERMANY

Dear Luciano:

Further to our understandings, we hereby confirm our agreement to terminate the existing employment relationship with Ecolab S.r.l. (“the Company”) under the following terms and conditions:

1.                Your current assignment as EVP EMEA will continue until November 30, 2006.  Thereafter, you will revert to your Italian contract until May 31, 2007, or any prior date if you voluntarily decide to resign earlier with reciprocal waiver to any notice.  Hereinafter “Termination Date” shall mean May 31, 2007 or such a prior date in case of earlier voluntary resignation.  Through January 1, 2007, you will assist the Company with transition and, thereafter, assist the Company CEO with special projects.

2.                Your employment shall continue until the Termination Date on your current terms and conditions, except that effective January 1, 2007, you will be relocated to Milan, Italy.  Costs of relocation will be paid by the Company, as per the agreement dated February 25, 2002, and you will remain entitled to the benefits of this agreement which are based upon your assignment in Germany and relocation to Italy.

3.                At any time after January 1, 2007, the Company may offer you another position within the group (in the EMEA region), to begin on or before June 1, 2007.  If for any reason whatsoever you do not accept such a position or such a position is not offered within the Termination Date, the employment relationship shall be considered automatically terminated by mutual consent effective from the




Termination Date with reciprocal waiver to the notice period or the correspondent indemnity in-lieu-of notice and without possibility of interruption of suspension due to illness, accident or other events.  If instead you accept the offer of the Company, all following terms and conditions will cease to apply and shall be replaced by the new terms and conditions in the offer governing the continuation of employment.

4.                You will be provided with tax advice (through the tax consultants of Deloitte), at the Company’s expense, regarding your foreign assignment in Germany and the relocation and your tax return for the fiscal year 2006.  We will also continue to be responsible for the tax equalization (i.e., for any tax paid in excess by you in Germany with respect to Italy in years during the assignment).  All of this consistent with the TAXES term of your February 25, 2002 agreement.

5.                You will resign as director of the Ecolab GmbH & Co. OHG and any other company of the group effective from the Termination Date.

6.                Your compensation and benefits until the Termination Date will continue at their present level.

7.                In addition to your salary up to the Termination Date, the severance indemnity (TFR), the pro-rata amounts of additional monthly wages, the indemnity in-lieu-of holidays (if accrued), the 2006 bonus and the pro-rata 2007 bonus (based upon a 100% bonus plan payout for 2007), we will pay you an indemnity “ una tantum ” of €504,000 as an incentive to execute this agreement and to leave the Company (in Italian “ incentivazione all’esodo ”).

8.                By virtue of your continuing employment, you will vest in stock options in December 2006 consistent with the terms of the Company’s 2002 and 2005 Stock Incentive Plans.

9.                The bonus 2006 shall be paid consistent with the terms of the plan within March 2007; the payment of the severance indemnity (TFR), of the other pro-rata amounts of additional monthly wages including the indemnity in-lieu-of holidays (if accrued) shall be made within the last day of the month following the Termination Date, whereas the payment of the “ una tantum ” indemnity provided in article 7 shall be made within June 2007, provided that in the meantime the parties have executed a conciliation agreement, consistent with the terms of this private agreement, before the appropriate committee of the Ministry of Labor Office or before the Unions.

2




10.          It is understood and agreed that the indemnity “una tantum” , also in consideration of its amount, is hereby accepted by you as full, final and general satisfaction of all of your possible claims connected with or arising from the employment relationship and its termination by consent, even if not expressly asserted and/or waived, including, inter alia, those concerning past salaries, alleged downgrading, biological damages or other damages, indemnities or compensation connected or related to the employment relationship (including the assignment) and with your service as director with Ecolab GmbH & Co. OHG and any other company of the group.

11.          At or before the Employment Termination Date you are requested to return to the Company any Company property still in your possession.

12.          It is understood and agreed that, even after the Termination Date, you will not reveal to any third parties any confidential information relating to the employment or termination from the Company, its operations, or any confidential matters entrusted to you as an employee of the Company.

13.          For a period of two years after the Termination Date, you shall not engage, directly or indirectly, as a proprietor, director, officer, employee, or in any other capacity or manner whatsoever, in competition with Ecolab throughout Europe, Africa and the Middle East.  You, therefore, agree:

(a)     If your new employer could be construed as a Conflicting Organization, you will inform your new employer, prior to accepting employment, of the existence of this non-compete convenant and provide such employer with a copy.

(b)    You will not render services, directly or indirectly, to any Conflicting Organization, except that you may accept employment with a Conflicting Organization whose business is diversified and which, as to that part of its business in which you will be employed, is not a Conflicting Organization, provided that the Company, prior to your beginning such employment, receives separate written assurances satisfactory to the Company from such Conflicting Organization and from you stating that you will not render services, directly or indirectly in connection with any Conflicting Product or Service for the two (2) year non-compete period.

3




(c)    You will not hire or induce directly or indirectly any employee or agent of the Company to terminate such employee’s or agent’s relationship with the Company.

(d)    You will not service, sell, solicit the sale of, or accept orders for any Conflicting Product or Service to any customer of the Company.

For the purposes of this Agreement, a “Conflicting Product or Service” means any product or process of, or service by, any person or organization other than the Company, in existence or under development, which is the same as or similar to or improves upon or competes with a product or process of, or service rendered by, the Company.  A “Conflicting Organization” means any person or organization (including one owned in whole or in part by you) which is engaged in or is about to become engaged in the research on, or the development, production, marketing or sale of, or consulting pertaining to, a Conflicting Product or Service.

14.          As consideration for the non-compete undertaking, you shall be paid, starting at the end of the working relationship, a compensation of €120,000 gross in 12 bi-monthly installments of €10,000 each, the first of which to be paid within July 31, 2007.

You agree that any breach of the above obligation would immediately and throughout the duration of the non-compete provision cause irreparable damages to us and therefore you agree that our Company will, under those circumstances, be entitled to obtain (i) a Court’s order for specific performance, as well as adequate injunctive relief (“provvedimento cautelare”); or (ii) the termination of the non-compete obligation.  In the first case, you will be bound to pay a penalty amounting to €120,000; in the second case, in addition to the penalty as above indicated, you will be bound to return to our Company the whole amount received until that time in connection with your non-compete obligation, with interest, paid by our Company.  In both cases our Company will be entitled to ask for all other damages, if actually incurred.

4




Please return a copy of this letter, signed for acceptance.

Thanking you for your cooperation, we remain

Yours faithfully,

ECOLAB S.r.l.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

/s/Doug Baker

 

 

 

/s/Luciano Iannuzzi

 

 

Doug Baker

 

 

 

Luciano Iannuzzi

 

 

 

5



EXHIBIT (10)U

2007 NAMED EXECUTIVE OFFICER

SUMMARY OF BASE SALARY, BONUS AWARD OPPORTUNITIES,

AND EXECUTIVE BENEFITS AND PERQUISITES

Base Salary

The table below sets forth the base salaries established for the 2007 fiscal year for the Company’s Principal Executive Officer and Principal Financial Officer and the next three most-highly compensated executive officers who were serving in those capacities at December 31, 2006 (the “NEOs”).

Name and Principal Position

 

Amount

 

Douglas M. Baker, Jr.

Chairman of the Board, President and

Chief Executive Officer

 

$

900,000

 

 

 

 

 

Steven L. Fritze

Executive Vice President and Chief

Financial Officer

 

$

450,000

 

 

 

 

 

James A. Miller

Executive Vice President — Institutional

Sector

 

$

400,000

 

 

 

 

 

Lawrence T. Bell

Senior Vice President, General Counsel

and Secretary

 

$

355,000

 

 

 

 

 

C. William Snedeker

Executive Vice President — Global

Services Sector

 

$

330,000

 

 

Bonus Award Opportunities

 

The Company maintains annual cash incentive programs for executives referred to as the Management Incentive Plan or MIP and Management Performance Incentive Plan or MPIP.  The Company’s stockholders approved the current version of the MPIP in 2004, an annual incentive plan under which awards should qualify as performance based under Internal Revenue Code Section 162(m).  On February 22, 2007, as required under the terms of the MPIP, the Compensation Committee of the Board (“Committee”) selected Messrs. Baker, Fritze and Miller to participate in the MPIP for 2007, established the 2007 performance goal based upon the performance criteria of diluted earnings per share (“EPS”), set an EPS performance target of a designated earnings per share, and designated a cash award of 300% of the base salary of each such officer for 2007 to the extent the goal is achieved.  The award is subject to and interpreted in accordance with the terms and conditions of the MPIP and no amount will be paid under the MPIP unless and until the Committee has determined the extent to which the performance goal has been met and the corresponding amount of the award earned by the participant.  The MPIP permits the Committee to exercise downward discretion so as to pay an amount which is less than the amount of the award earned by the participant.  In applying this downward discretion, the Committee considers




underlying operable metrics communicated to the participant, which are noted in the table below.  Messrs. Bell and Snedeker will participate in the MIP in 2007 and the operating metrics with respect to their participation are similarly noted in the table below.

 

 

Target
Award
Opportunity

 

Potential Award Payouts at Different Levels 
of Performance
(% of Target Award)

 

Performance Measure Mix

 

 

 

(% of base

 

 

 

 

 

 

 

 

 

Business

 

 

 

Name

 

salary)

 

Threshold

 

Target

 

Max

 

EPS

 

Unit

 

Individual

 

Douglas M. Baker

 

110

%

40

%

100

%

200

%

100

%

0

%

0

%

Steven L. Fritze

 

60

%

40

%

100

%

200

%

70

%

0

%

30

%

James A. Miller

 

60

%

40

%

100

%

200

%

30

%

70

%

0

%

Lawrence T. Bell

 

55

%

40

%

100

%

200

%

70

%

0

%

30

%

C. William Snedeker

 

55

%

40

%

100

%

200

%

30

%

70

%

0

%

Executive Benefits and Perquisites

The following table sets forth the executive benefits and perquisites made available by the Company to the NEOs for the 2007 fiscal year.

 

Executive Benefit

 

Description

Physical Examination

 

·   Annual reimbursement

Mirror Savings and Pension Plan

 

·   Nonqualified ERISA excess benefit plans intended to restore benefits limited by law under the tax-qualified savings and pension plans

·   Executives may also elect to defer up to 25% of base salary and annual bonus, subject to the same investment alternatives and returns as under the tax-qualified savings plan

Supplemental Executive Retirement Plan

 

·   Maximum annual benefit of 60% of highest five consecutive years of base salary and annual bonus (offset by other qualified and nonqualified pension benefits)

·   Provides past service credit

Post-Retirement Death Benefit

 

·   Two times final average pay

Executive Life, Accidental Death and Dismemberment and Business Travel Accident Insurance

 

·   Each are three times annual compensation for the preceding year

Long-Term Disability Insurance

 

·   60% of compensation, less the amount of the qualified benefit

Company Automobile

 

·   Full reimbursement to principal executive officer

·   $39,800 purchase price or $790 monthly lease rate for other named executive officers

Financial Counseling

 

·   Five percent of base salary for principal executive officer

·   Three percent of base salary for other named executive officers

Club Memberships

 

·   Limited to principal executive officer

Private Aircraft Usage

 

·   Limited to principal executive officer (Not used in 2006)

 




 

Spousal Travel

 

·   Only when related to a business purpose

Relocation Expense

 

·   Includes home sale assistance, transportation of household goods, temporary living costs, travel to new location, home finding costs, closing costs on home purchase and expense allowance.

 



Exhibit (10)W(iii)

RESTRICTED STOCK AWARD AGREEMENT

THIS AGREE MENT is entered into and effective as of this           day of            , 20    , (the “Date of Grant”), by and between Ecolab Inc. (the “Company”) and                  (the “Grantee”).

A.            The Company has adopted the Ecolab Inc. 2005 Stock Incentive Plan, (the “Plan”), authorizing the Board of Directors of the Company, or a committee as provided for in the Plan (the Board or such a committee to be referred to as the “Committee”), to grant restricted stock awards to certain employees of the Company and its Subsidiaries.

B.            The Company desires to give the Grantee a proprietary interest in the Company and an added incentive to advance the interests of the Company by granting to the Grantee a restricted award of shares of common stock of the Company pursuant to the Plan.

Accordingly, the parties agree as follows:

ARTICLE 1.           GRANT OF AWARD .

The Company hereby grants to the Grantee a restricted stock award (the “Award”) consisting of                    (        ) shares (the “Award Shares”) of the Company’s common stock, par value $1.00 per share (the “Common Stock”), according to the terms and subject to the restrictions and conditions hereinafter set forth and as set forth in the Plan.  Reference to the Award Shares in this Agreement will be deemed to include the Non-Quarterly Dividend Proceeds (as defined in Section 3.2 of this Agreement) with respect to such Award Shares that are retained and held by the Committee as provided in Section 3.2 of this Agreement.

ARTICLE 2.           GRANT RESTRICTION .

2.1           Restriction and Forfeiture .  The Grantee’s right to retain the Award Shares will be subject to the Grantee remaining in the continuous employ or service of the Company or any Subsidiary for a period of            (       ) years (the “Restriction Period”) following the Date of Grant; provided, however, that such employment period restrictions (the “Restrictions”) will lapse and terminate prior to end of the Restriction Period with respect to        % of the Award Shares (excluding any fractional portion less than one share) on the               anniversary of the Date of Grant and with respect to the remaining Award Shares on the              anniversary of the Date of Grant.

2.2           Termination of Employment or Other Service .

(a)           In the event that the Grantee’s employment or other service with the Company and all Subsidiaries is terminated by reason of the Grantee’s death or Disability, all Restrictions applicable to the Award Shares will immediately lapse and terminate.

(b)           In the event that the Grantee’s employment or other service with the Company and all Subsidiaries is terminated by reason of the Grantee’s Retirement or for any reason other than death or Disability, all rights of the Grantee under the Plan and this Agreement will immediately




terminate without notice of any kind, and this Award will be terminated and all Award Shares with respect to which Restrictions have not lapsed will be forfeited and returned to the Company.

2.3           Change in Control .  In the event of a Change in Control, all Restrictions applicable to Award Shares will immediately lapse and terminate.

2.4           Effects of Actions Constituting Cause .  Notwithstanding anything in this Agreement to the contrary, in the event that the Grantee is determined by the Committee, acting in its sole discretion, to have committed any action which would constitute Cause, irrespective of whether such action or the Committee’s determination occurs before or after termination of the Grantee’s employment with the Company or any Subsidiary, all rights of the Grantee under the Plan and this Agreement shall terminate and be forfeited without notice of any kind.  The Company may defer the vesting of the Award Shares for up to forty-five (45) days in order for the Committee to make any determination as to the existence of Cause.

ARTICLE 3.           ISSUANCE OF AWARD SHARES .

3.1           Privileges of a Stockholder; Transferability .  As soon as practicable after this Agreement is executed and delivered, the Award Shares will be transferred on the books of the Company into the name of, or into an account for the benefit of, the Grantee.  Except as provided in Section 3.2 of this Agreement, the Grantee will have all voting, dividend, liquidation and other rights with respect to the Award Shares in accordance with their terms upon becoming the holder of record of such shares; provided, however, that prior to the lapse or other termination of the Restrictions applicable to Award Shares, such shares will not be assignable or transferable by the Grantee, either voluntarily or involuntarily, and may not be subjected to any lien, directly or indirectly, by operation of law or otherwise.  Any attempt to transfer, assign or encumber the Award Shares other than in accordance with this Agreement and the Plan will be null and void and will void the Award, and all Award Shares for which the Restrictions have not lapsed will be forfeited and immediately returned to the Company.

3.2           Dividends and Other Distributions .  The Grantee will have no right to receive dividends or distributions with respect to Award Shares, including stock dividends or dividends in kind, the proceeds of any stock split or the proceeds resulting from any changes or exchanges described in Article 4 of this Agreement (all of which will collectively be referred to as “Non-Quarterly Dividend Proceeds”).  The Committee may, in its sole discretion, distribute such Non-Quarterly Dividend Proceeds to the Grantee or it may direct the retention and holding of such proceeds subject to the Restrictions and the other terms and conditions of this Agreement.  In addition, the Committee may, in its sole discretion, cause such Non-Quarterly Dividend Proceeds to be paid to the Company pursuant to Article 7 of this Agreement in order to satisfy any federal, state or local withholding or other employment-related tax requirements attributable to such dividends or to the Grantee’s receipt of the Award or the lapse or termination of the Restrictions applicable to Award Shares.

ARTICLE 4.           ADJUSTMENTS .

In the event of any reorganization, merger, consolidation, recapitalization, liquidation, reclassification, stock dividend, stock split, combination of shares, rights offering or divestiture (including a spin-off) or any other change in the corporate structure or shares of the Company, the Committee (or, if the Company is not the surviving corporation in any such transaction, the board of directors of the surviving corporation), in order to prevent dilution or enlargement of the rights of the

2




Grantee, will make appropriate adjustment (which determination will be conclusive) as to the number and kind of securities subject to this Award.

ARTICLE 5.           RIGHTS AS A STOCKHOLDER .

The Grantee will have no rights as a stockholder with respect to any of the Award Shares until the Grantee becomes the holder of record of such Award Shares, and no adjustments will be made for dividends or other distributions or other rights as to which there is a record date preceding the date the Grantee becomes the holder of record of such Award Shares.

ARTICLE 6.           EMPLOYMENT OR SERVICE .

Nothing in this Agreement will be construed to (a) limit in any way the right of the Company to terminate the employment or service of the Grantee at any time, or (b) be evidence of any agreement or understanding, express or implied, that the Company will retain the Grantee in any particular position at any particular rate of compensation or for any particular period of time.

ARTICLE 7.           WITHHOLDING TAXES .

7.1           General Rules .  The Company is entitled to (a) withhold and deduct from future wages of the Grantee, or cause to be paid to the Company out of Non-Quarterly Dividend Proceeds, all legally required amounts necessary to satisfy any federal, state or local withholding tax requirements attributable to the receipt of the Award, the receipt of dividends or distributions on Award Shares, or the lapse or termination of the Restrictions applicable to Award Shares, (b) withhold cash paid or payable or Award Shares issued or issuable to the Grantee, or (c) require the Grantee to promptly remit the amount of such withholding to the Company.  In the event that the Company is unable to withhold such amounts, for whatever reason, the Grantee must promptly pay to the Company an amount equal to the amount the Company would otherwise be required to withhold under federal, state or local law.

7.2           Special Rules .  The Committee may, in its sole discretion and upon terms and conditions established by the Committee, permit or require the Grantee to satisfy, in whole or in part, any withholding or tax obligation as described in Section 7.1 above by electing to tender, or by attestation as to ownership of, Previously Acquired Shares that have been held for the period of time necessary to avoid a charge to the Company’s earnings for financial reporting purposes and that are otherwise acceptable to the Committee.  For purposes of satisfying the Grantee’s withholding or employment-related tax obligation, Previously Acquired Shares tendered or covered by an attestation will be valued at their Fair Market Value.

ARTICLE 8.           SUBJECT TO PLAN .

8.1           Terms of Plan Prevail .  The Award and the Award Shares granted pursuant to this Agreement have been granted under, and are subject to the terms of, the Plan.  The terms of the Plan are incorporated by reference in this Agreement in their entirety, and the Grantee, by execution of this Agreement, acknowledges having received a copy of the Plan.  The provisions of this Agreement will be interpreted as to be consistent with the Plan, and any ambiguities in this Agreement will be interpreted by reference to the Plan.  In the event that any provision in this Agreement is inconsistent with the terms of the Plan, the terms of the Plan will prevail.

3




8.2           Definitions .  Unless otherwise defined in this Agreement, the terms capitalized in this Agreement have the same meanings as given to such terms in the Plan.

ARTICLE 9.           MISCELLANEOUS .

9.1           Binding Effect .  This Agreement will be binding upon the heirs, executors, administrators and successors of the parties hereto.

9.2           Governing Law .  This Agreement and all rights and obligations under this Agreement will be construed in accordance with the Plan and governed by the laws of the State of Minnesota without regard to conflicts of law provisions.  Any legal proceeding related to this Agreement will be brought in an appropriate Minnesota court, and the parties to this Agreement consent to the exclusive jurisdiction of the court for this purpose.

9.3           Entire Agreement .  This Agreement and the Plan set forth the entire agreement and understanding of the parties hereto with respect to the grant and exercise of this Award and the administration of the Plan and supersede all prior agreements, arrangements, plans and understandings relating to the grant and vesting of this Award and the administration of the Plan.

9.4           Amendment and Waiver .  Other than as provided in the Plan, this Agreement may be amended, waived, modified or canceled only by a written instrument executed by the parties hereto or, in the case of a waiver, by the party waiving compliance.

9.5           Captions .  The Article, Section and paragraph captions in this Agreement are for convenience of reference only, do not constitute part of this Agreement and are not to be deemed to limit or otherwise affect any of the provisions of this Agreement.

9.6           Counterparts .  For convenience of the parties hereto, this Agreement may be executed in any number of counterparts, each such counterpart to be deemed an original instrument, and all such counterparts together to constitute the same agreement.

The parties hereto have executed this Agreement effective the day and year first above written.

 

 

 

By execution hereof, the Grantee acknowledges having received a copy of the Plan.

 

 

 

 

 

 

ECOLAB INC.

 

 

GRANTEE

 

 

 

 

 

By:

 

 

By:

 

 

 

 

 

(Signature)

Its

 

 

 

 

 

 

 

 

(Print Name)

 

 

 

 

 

 

 

 

 

(Address)

 

 

 

 

 

 

 

 

 

(City, State, Zip)

 

 

 

 

 

 

 

 

 

SSN

 

 

4



Exhibit 13

Financial Discussion

 

EXECUTIVE SUMMARY

 

This Financial Discussion should be read in conjunction with the information on Forward-Looking Statements and Risk Factors found at the end of the Financial Discussion.

 

2006 was an outstanding year for Ecolab. We achieved a strong financial performance including record net sales of $4.9 billion and improved operating income margins which drove 16 percent diluted earnings per share growth. We realized major competitive gains, made significant investments in our people and business, and further improved our long-term growth potential.

 

We exceeded all three of our long-term financial objectives:

 

 

2006 RESULTS

 

LONG-TERM OBJECTIVE

EPS Growth

 

16.3%

 

15%

ROBE

 

22.4%

 

20%

Balance Sheet

 

A

 

Investment Grade

 

OPERATING HIGHLIGHTS

 

·   We made important competitive gains in our market during 2006, creating enhanced global opportunities to pursue our Circle the Customer — Circle the Globe growth strategy as we believe Ecolab alone can offer consistent service around the globe.

 

·   We enjoyed double-digit sales and profit growth in the United States and improved sales and profit growth from our International operations.

 

·   In 2006 we continued our tradition of new product innovation building on our core product platforms. We introduced a product in our antimicrobial platform that reduces microbial contamination in ready-to-eat meat and poultry products, making them safer and contributing to a longer shelf life. To help reduce the risk of foodborne illness, we introduced the first EPA-registered antimicrobial product that reduces pathogens in fruit and vegetable process water at food processing plants. We also continued our efforts to customize solutions to meet specific customer needs through new programs.

 

·   We continued to make business acquisitions in order to broaden our product and service offerings in line with our Circle the Customer — Circle the Globe strategy. Details of these acquisitions are shown below.

 

·   We grew our industry-leading sales and service force by more than 500 people, to more than 13,400 strong, and made key investments in tools, training and technology to improve their sales productivity and effectiveness.

 

·   We made significant investments in our business systems that will drive competitive advantage in the future.

 

·   We continue to work to simplify and streamline our business processes, bolstering our ability to deliver growth more efficiently in the future.

 

FINANCIAL PERFORMANCE

 

·   Consolidated net sales reached a record of $4.9 billion for 2006, an increase of 8 percent over net sales of $4.5 billion in 2005.

 

·   Our operating income for 2006 increased 13 percent to a record $612 million.

 

·   Diluted net income per share increased 16 percent to $1.43 per share for 2006, compared to $1.23 per share in 2005.

 

·   Cash flow from operating activities reached a record $628 million in 2006 and allowed us to fund investments in our business operations, make business acquisitions, reacquire $283 million of our common stock and make a voluntary contribution of $45 million to our U.S. pension plan.

 

·   We increased our quarterly dividend rate for the fifteenth consecutive year. The dividend was increased 15 percent in December 2006 to an indicated annual rate of $0.46 per common share.

 

 

·   Our return on beginning shareholder’s equity (net income divided by beginning shareholder’s equity) rose to 22.4 percent in 2006, the fifteenth consecutive year in which we achieved our long-term financial objective of a 20 percent return on beginning shareholder’s equity.

 

·   Our balance sheet remained strong, maintaining our debt rating within the “A” categories of the major rating agencies during 2006. We also strengthened and solidified our capital structure, successfully refinancing a maturing debt instrument and lowering our future financing cost.

 

·   We adopted the provisions of Statement of Financial Accounting Standard No. 158, “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans” (“SFAS 158”) effective as of our 2006 year end. The impact of adopting SFAS 158 is reflected as a reduction in net assets on our balance sheet of $168 million, with no impact to the statements of income and cash flows. See Note 15 for more information on this adoption.

 

ACQUISITIONS

 

·   In June, we acquired Shield Medicare Ltd., based in the UK. With annual sales of $19 million, Shield is a leading provider of contamination control products for pharmaceutical, medical device and hospital clean rooms.

 

·   In September, we acquired DuChem Industries, Inc., a U.S. manufacturer and marketer of cleaning and sanitizing products for the food and beverage market. DuChem’s core focus is the protein (meat & poultry) market segment, and has annual sales of $10 million.

 

·   In September, we acquired Powles Hunt & Sons International Ltd’s UK commercial laundry business. With annual sales of $5 million, this acquisition will add scale to our textile care business in the UK.

 

2007 EXPECTATIONS

·   We look for continued momentum from our existing business, investments in our key growth drivers and from competitive gains achieved in 2006 to drive growth and market share opportunities in 2007.

17




·   We will continue to leverage our Circle the Customer — Circle the Globe growth strategy through cross-selling and enhanced marketing of our many product and service solutions under the Ecolab brand.

 

·   We will continue to invest in new product, system and service development in order to deliver improved value to our customers and thereby earn more of their business.

 

·   We plan to seek strategic business acquisitions which complement our growth strategy.

 

·   We will continue to work on streamlining our business processes in order to reduce costs and improve sustainability.

 

·   We intend to make significant investments in our business systems to drive growth in the future.

 

·   We will continue to work to deliver superior results to our customers, returns to shareholders and opportunity to our valued associates.

 

CRITICAL ACCOUNTING ESTIMATES

 

Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). We have adopted various accounting policies to prepare the consolidated financial statements in accordance with U.S. GAAP. Our most significant accounting policies are disclosed in Note 2 of the notes to the consolidated financial statements.

 

Preparation of our consolidated financial statements, in conformity with U.S. GAAP, requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates are considered to be critical if they meet both of the following criteria: (1) the estimate requires assumptions to be made about matters that are highly uncertain at the time the accounting estimate is made, and (2) different estimates that the company reasonably could have used for the accounting estimate in the current period, or changes in the accounting estimate that are reasonably likely to occur from period to period, have a material impact on the presentation of the company’s results of operations.

 

Besides estimates that meet the “critical” estimate criteria, we make many other accounting estimates in preparing our financial statements and related disclosures. All estimates, whether or not deemed critical, affect reported amounts of assets, liabilities, revenues and expenses as well as disclosures of contingent assets and liabilities. Estimates are based on experience and other information available prior to the issuance of the financial statements. Materially different results can occur as circumstances change and additional information becomes known, even from estimates not deemed critical. Our critical accounting estimates include the following:

 

REVENUE RECOGNITION

 

We recognize revenue on product sales at the time title to the product and risk of loss transfers to the customer. We recognize revenue on services as they are performed. Our sales policies do not provide for general rights of return and do not contain customer acceptance clauses. We record estimated reductions to revenue for customer programs and incentive offerings including pricing arrangements, promotions and other volume-based incentives at the time the sale is recorded. Depending on market conditions, we may increase customer incentive offerings, which could reduce gross profit margins at the time the incentive is offered.

 

VALUATION ALLOWANCES AND ACCRUED LIABILITIES

 

We estimate sales returns and allowances by analyzing historical returns and credits, and apply these trend rates to the most recent 12 months’ future credits. We estimate the allowance for doubtful accounts by analyzing accounts receivable balances by age, applying historical write-off trend rates to the most recent 12 months’ sales, less actual write-offs to date. In addition, our estimates also include separately providing for 100 percent of specific customer balances when it is deemed probable that the balance is uncollectible. Actual results could differ from these estimates under different assumptions.

 

Estimates used to record liabilities related to pending litigation and environmental claims are based on our best estimate of probable future costs. Estimated future legal costs are expensed as incurred. We record the amounts that represent the points in the range of estimates that we believe are most probable or the minimum amounts when no amount within the range is a better estimate than any other amount. Potential insurance reimbursements are not anticipated in our accruals for environmental liabilities. While the final resolution of litigation and environmental contingencies could result in amounts different than current accruals, and therefore have an impact on our consolidated financial results in a future reporting period, we believe the ultimate outcome will not have a significant effect on our consolidated results of operations, financial position or cash flows.

 

ACTUARIALLY DETERMINED LIABILITIES

 

The measurement of our pension and postretirement benefit obligations are dependent on a variety of assumptions determined by management and used by our actuaries. These assumptions affect the amount and timing of future contributions and expenses.

 

The assumptions used in developing the required estimates include, among others, discount rate, projected salary and health financial care cost increases and expected return or earnings on assets. Beginning in 2005, the discount rate assumption for the U.S. Plans is calculated using a bond yield curve constructed from a large population of high-quality, non-callable, corporate bond issues with maturity dates of six months to thirty years. Bond issues in the population are rated no less than Aa by Moody’s Investor Services or AA by Standard & Poors. The discount rate is calculated by matching of the plan liability cash flows to the yield curve. Prior to 2005, the discount rate assumption was based on the investment yields available at year-end on corporate long-term bonds rated AA. Projected salary and health care cost increases are based on our long-term actual experience, the near-term outlook and assumed inflation. The expected return on plan assets reflects asset allocations, investment strategies and the views of investment advisors. The effects of actual results differing from our assumptions, as well as changes in assumptions, are reflected in the unrecognized actuarial loss and amortized over future periods and, therefore, generally affect our recognized expense in future periods. Our unrecognized actuarial loss on our U.S. qualified and nonqualified pension plans decreased to $189 million (before tax) due primarily to a better than expected return on plan assets and an increase in the discount rate at the end of 2006. As of December 31, 2006, this unrecognized loss is included on our balance sheet as a component of Accumulated Other Comprehensive Income due to the adoption of SFAS 158. Significant differences in actual experience or significant changes in assumptions may materially affect pension and other post-retirement obligations.

18




In determining our U.S. pension and postretirement obligations for 2006, our discount rate increased to 5.79 percent from 5.57 percent at year-end 2005. Our projected salary increase was unchanged at 4.32 percent and our expected return on plan assets used for determining 2006 expense remained unchanged at 8.75 percent.

 

The effect on 2007 expense of a decrease in the discount rate or expected return on assets assumption as of December 31, 2006 is shown below assuming no changes in benefit levels and no amortization of gains or losses for our major plans:

 

 

 

Effect on U.S. Pension Plan

 

 

 

 

 

Increase in

 

Higher

 

millions

 

Assumption

 

Recorded

 

2007

 

Assumption

 

Change

 

Obligation

 

Expense

 

 

 

 

 

 

 

 

 

Discount rate

 

-0.25 pts

 

$

30.8

 

$

4.2

 

Expected return on assets

 

-0.25 pts

 

N/A

 

$

1.9

 

 

 

 

Effect on U.S. Postretirement

 

 

 

Health Care Benefits Plan

 

 

 

 

 

Increase in

 

Higher

 

millions

 

Assumption

 

Recorded

 

2007

 

Assumption

 

Change

 

obligation

 

Expense

 

 

 

 

 

 

 

 

 

Discount rate

 

-0.25 pts

 

$

4.8

 

$

0.7

 

Expected return on assets

 

-0.25 pts

 

N/A

 

$

0.1

 

 

See Note 15 for further discussion concerning our accounting policies, estimates, funded status, planned contributions and overall financial positions of our pension and post-retirement plan obligations.

 

We are self-insured in North America for most workers compensation, general liability and automotive liability losses, subject to per occurrence and aggregate annual liability limitations. We are insured for losses in excess of these limitations. We have recorded both a liability and an offsetting receivable for amounts in excess of these limitations. We are also self-insured for health care claims for eligible participating employees, subject to certain deductibles and limitations. We determine our liabilities for claims incurred but not reported on an actuarial basis. A change in these assumptions would cause reported results to differ.

 

SHARE-BASED COMPENSATION

 

Effective October 1, 2005 we adopted Statement of Financial Accounting Standards No. 123 (Revised 2004), “Share-Based Payment” (“SFAS 123R”) under the modified retrospective application method. All prior period financial statements were restated to recognize share-based compensation historically reported in the notes to the consolidated financial statements. As required by SFAS 123R, we measure compensation expense for share-based awards at fair value at the date of grant and recognize compensation expense over the service period for awards expected to vest. Upon adoption of SFAS 123R in the fourth quarter of 2005 we began using a lattice-based binomial model for valuing new stock option grants. We believe this model considers appropriate probabilities of option exercise and post-vesting termination which are more consistent with actual and projected experience, and therefore support more accurate valuation of a stock option. We also started using a forfeiture estimate for all share-based awards in the amount of compensation expense being recognized. This change from our historical practice of recognizing forfeitures as they occur did not result in the recognition of any cumulative adjustment to income.

 

Determining the fair value of share-based awards at the grant date requires judgment, including estimating expected volatility, exercise and post-vesting termination behavior, expected dividends and risk-free rates of return. Additionally, the expense that is recorded is dependent on the amount of share-based awards that is expected to be forfeited. If actual forfeiture results differ significantly from these estimates, share-based compensation expense and our results of operations could be impacted. For additional information on our stock incentive and option plans, including significant assumptions used in determining fair value, see Note 10.

 

INCOME TAXES

 

Judgment is required to determine the annual effective income tax rate, deferred tax assets and liabilities and any valuation allowances recorded against net deferred tax assets. Our effective income tax rate is based on annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which we operate. We establish liabilities or reserves when we believe that certain positions are likely to be challenged by authorities and we may not succeed, despite our belief that our tax return positions are fully supportable. We adjust these reserves in light of changing facts and circumstances. Our annual effective income tax rate includes the impact of reserve provisions and changes to reserves that we consider appropriate. During interim periods, this annual rate is then applied to our year-to-date operating results. In the event that there is a significant one-time item recognized in our interim operating results, the tax attributable to that item would be separately calculated and recorded in the same period as the one-time item.

 

Tax regulations require items to be included in our tax returns at different times than the items are reflected in our financial statements. As a result, the effective income tax rate reflected in our financial statements differs from that reported in our tax returns. Some of these differences are permanent, such as expenses that are not deductible on our tax return, and some are temporary differences, such as depreciation expense. Temporary differences create deferred tax assets and liabilities. Deferred tax assets generally represent items that can be used as a tax deduction or credit in our tax return in future years for which we have already recorded the tax benefit in our income statement. We establish valuation allowances for our deferred tax assets when the amount of expected future taxable income is not likely to support the utilization of the deduction or credit. Deferred tax liabilities generally represent items for which we have already taken a deduction in our tax return, but have not yet recognized that tax benefit in our financial statements. Undistributed earnings of foreign subsidiaries are considered to have been reinvested indefinitely or available for distribution with foreign tax credits available to offset the amount of applicable income tax and foreign withholding taxes that might be payable on earnings. It is impractical to determine the amount of incremental taxes that might arise if all undistributed earnings were distributed.

 

A number of years may elapse before a particular tax matter, for which we have established a reserve, is audited and finally resolved. The number of tax years with open tax audits varies depending on the tax jurisdiction. In the United States, during 2004, the Internal Revenue Service completed their field work examination of our tax returns for 1999 through 2001. We expect the final resolution for these returns by 2008. We also expect the Internal Revenue Service to complete their field work examination of our tax returns for 2002 through 2004 in 2007.

19




While it is often difficult to predict the final outcome or the timing of resolution of any tax matter, we believe that our reserves reflect the probable outcome of known tax contingencies. Unfavorable settlement of any particular issue could result in additional tax expense and would require the use of cash. Favorable resolution could result in reduced income tax expense reported in the financial statements in the future. Our tax reserves are presented in the balance sheet within other non-current liabilities.

 

LONG-LIVED AND INTANGIBLE ASSETS

 

We periodically review our long-lived and intangible assets for impairment and assess whether significant events or changes in business circumstances indicate that the carrying value of the assets may not be recoverable. This could occur when the carrying amount of an asset exceeds the anticipated future undiscounted cash flows expected to result from the use of the asset and its eventual disposition. The amount of the impairment loss to be recorded, if any, is calculated as the excess of the asset’s carrying value over its estimated fair value. We also periodically reassess the estimated remaining useful lives of our long-lived assets. Changes to estimated useful lives would impact the amount of depreciation and amortization expense recorded in earnings. We have experienced no significant changes in the carrying value or estimated remaining useful lives of our long-lived assets.

 

We review our goodwill for impairment on an annual basis for all reporting units. If circumstances change significantly within a reporting unit, we would test for impairment prior to the annual test.

 

Goodwill and certain intangible assets are assessed for impairment using fair value measurement techniques. Specifically, goodwill impairment is determined using a two-step process. Both the first step of determining the fair value of a reporting unit and the second step of determining the fair value of individual assets and liabilities of a reporting unit (including unrecognized intangible assets) are judgmental in nature and often involve the use of significant estimates and assumptions. Estimates of fair value are primarily determined using discounted cash flows, market comparisons and recent transactions. These valuation methodologies use significant estimates and assumptions, which include projected future cash flows (including timing), discount rate reflecting the risk inherent in future cash flows, perpetual growth rate, and determination of appropriate market comparables. No impairments were recorded in 2006, 2005 or 2004 as a result of the tests performed. Of the total goodwill included in our consolidated balance sheet, 19 percent is recorded in our United States Cleaning & Sanitizing reportable segment, 5 percent in our United States Other Services segment and 76 percent in our International segment.

 

FUNCTIONAL CURRENCIES

 

In preparing the consolidated financial statements, we are required to translate the financial statements of our foreign subsidiaries from the currency in which they keep their accounting records, generally the local currency, into United States dollars. Assets and liabilities of these operations are translated at the exchange rates in effect at each fiscal year end. The translation adjustments related to assets and liabilities that arise from the use of differing exchange rates from period to period are included in accumulated other comprehensive income in shareholders’ equity. Income statement accounts are translated at average rates of exchange prevailing during the year. We evaluate our International operations based on fixed rates of exchange; however, the different exchange rates from period to period impact the amount of reported income from our consolidated operations.

 

RESULTS OF OPERATIONS

CONSOLIDATED

 

millions, except per share

 

2006

 

2005

 

2004

 

 

 

 

 

 

 

 

 

Net sales

 

$

4,896

 

$

4,535

 

$

4,185

 

Operating income

 

612

 

542

 

490

 

Net income

 

369

 

319

 

283

 

Diluted net income per common share

 

1.43

 

1.23

 

1.09

 

 

Our consolidated net sales for 2006 increased 8 percent over 2005. The components include 6 percent volume growth and 2 percent favorable effect from price changes. Acquisitions and divestitures and changes in currency translation did not have a significant impact on the consolidated sales growth rate.

 

 

2006

 

2005

 

2004

 

 

 

 

 

 

 

 

 

Gross profit as a percent of net sales

 

50.7

%

50.4

%

51.4

%

Selling, general & administrative expenses as a percent of net sales

 

38.2

%

38.4

%

39.6

%

 

Our consolidated gross profit margin (defined as gross profit divided by net sales) for 2006 increased from 2005, primarily driven by pricing and cost savings initiatives which more than offset higher delivered product costs during the year.

 

Selling, general and administrative expenses as a percentage of sales continued to improve in 2006. The improvement in the 2006 expense ratio is primarily due to increased sales leverage and cost saving programs which more than offset investments in the business.

 

 

 

2006

 

2005

 

2004

 

 

 

 

 

 

 

 

 

Operating income as a percent of net sales

 

12.5

%

12.0

%

11.7

%

 

Operating income increased 13 percent in 2006 over 2005. As a percent of sales, operating income also increased from 2005. The increase in operating income in 2006 is due to pricing, sales volume and cost reduction initiatives partially offset by higher delivered product costs as well as investments in the business.

 

Our net income was $369 million in 2006, an increase of 15 percent compared to $319 million in 2005. Net income in both years included items of a non-recurring nature that are not necessarily indicative of future operating results. Net income in 2006 included the benefit of a $1.8 million tax settlement for stewardship costs which was offset by a $2.8 million charge ($1.8 million net of tax benefit) in selling, general and administrative expense to recognize minimum royalties under a licensing agreement with no future benefit. Net income in 2005 included a tax charge of $3.1 million related to the repatriation of foreign earnings under the American Jobs Creation Act (AJCA). Excluding these items, net income increased 14 percent for 2006. This increase in net income reflects improved sales, gross margin and operating income growth. Currency translation positively impacted net income in 2006 by approximately $2 million. Our 2006 net income also benefited when compared to 2005 due to a lower overall effective income tax rate which was the result of international mix, lower international statutory rates and tax planning efforts.

20




2005 COMPARED WITH 2004

 

Our consolidated net sales for 2005 increased 8 percent to $4.5 billion compared to $4.2 billion in 2004. Acquisitions and divestitures increased consolidated net sales by 1 percent. Changes in currency translation also positively impacted the sales growth rate by 1 percent. Sales benefited from pricing, new account gains, new product and service offerings and investments in the sales-and-service-force.

 

Our consolidated gross profit margin for 2005 decreased from 2004. The decrease was primarily driven by higher delivered product costs, partially offset by pricing and cost savings programs.

 

Selling, general and administrative expenses as a percentage of sales improved for 2005 compared to 2004. The improvement in the 2005 expense ratio is primarily due to pricing, sales leverage and cost savings programs partially offset by investments in the sales-and-service force, research and development and technology.

 

Operating income for 2005 increased 11 percent over 2004. As a percent of sales, operating income also increased from 2004. The increase in operating income in 2005 is due to sales volume, pricing, cost reduction initiatives and lower share-based compensation expense, partially offset by higher delivered product costs as well as investments in the sales-and-service force, research and development and technology. Operating income also benefited from significant operating improvement at GCS Service in 2005.

 

Our net income was $319 million in 2005, an increase of 13 percent as compared to $283 million in 2004. Net income in both years included items of a non-recurring nature that are not necessarily indicative of future operating results. Net income in 2005 included a tax charge of $3.1 million related to the repatriation of foreign earnings under the AJCA. Net income in 2004 included benefits from a reduction in previously recorded restructuring expenses of $0.6 million (after tax) and a gain on the sale of a small international business of $0.2 million (after tax). Income tax expense and net income in 2004 also included a tax benefit of $1.9 million related to prior years. These benefits were more than offset by a charge of $1.6 million for in-process research and development as part of the acquisition of Alcide Corporation and a charge of $2.4 million (after tax) related to the disposal of a grease management product line. Excluding these items from both years, net income increased 14 percent for 2005. This increase in net income reflects improved operating income growth by most of our business units in the face of a challenging raw material cost environment. Currency translation positively impacted net income growth in 2005 by approximately $5 million. Our 2005 net income also benefited when compared to 2004 due to a lower overall effective income tax rate which was the result of a lower international rate, international mix and tax planning efforts. Excluding the items of a non-recurring nature previously mentioned, net income was 7 percent of net sales for both 2005 and 2004.

 

SEGMENT PERFORMANCE

 

Our operating segments have been aggregated into three reportable segments: United States Cleaning & Sanitizing, United States Other Services and International. We evaluate the performance of our International operations based on fixed management rates of currency exchange. Therefore, International sales and operating income totals, as well as the International financial information included in this financial discussion, are based on translation into U.S. dollars at the fixed currency exchange rates used by management for 2006. The difference between actual currency exchange rates and the fixed currency exchange rates used by management is included in “Effect of Foreign Currency Translation” within our operating segment results. All other accounting policies of the reportable segments are consistent with U.S. GAAP and the accounting policies of the company described in Note 2 of the notes to consolidated financial statements. Additional information about our reportable segments is included in Note 16 of the notes to consolidated financial statements.

 

SALES BY REPORTABLE SEGMENT

 

millions

 

2006

 

2005

 

2004

 

Net sales

 

 

 

 

 

 

 

United States

 

 

 

 

 

 

 

Cleaning & Sanitizing

 

$

2,152

 

$

1,952

 

$

1,797

 

Other Services

 

411

 

375

 

339

 

Total United States

 

2,563

 

2,327

 

2,136

 

International

 

2,261

 

2,137

 

2,038

 

Total

 

4,824

 

4,464

 

4,174

 

Effect of foreign currency translation

 

72

 

71

 

11

 

Consolidated

 

$

4,896

 

$

4,535

 

$

4,185

 

 

Percent Change From Prior Year

 

2006

 

2005

 

Net sales

 

 

 

 

 

United States

 

 

 

 

 

Cleaning & Sanitizing

 

10

%

9

%

Other Services

 

9

 

11

 

Total United States

 

10

 

9

 

International (management rates)

 

6

 

5

 

Consolidated (management rates)

 

8

 

8

 

Consolidated (public rates)

 

8

%

7

%

 

 

Sales of our United States Cleaning & Sanitizing operations increased 10 percent to $2.2 billion in 2006. Sales were driven by double-digit sales growth in our Institutional and Kay divisions, along with good growth from our Food & Beverage division. Institutional sales increased 11 percent in 2006, benefiting from significant new account gains during the year. Institutional results reflect sales growth into all end market segments, including double-digit growth in travel, casual dining and health care markets. Food & Beverage division sales increased 8 percent for 2006. The acquisition of DuChem added 1 percent and the remaining increase was due to double-digit gains in the meat & poultry market as well as good gains in the dairy, food

21




and soft drink markets. Kay recorded an 11 percent sales increase in 2006 led by gains in its core quickservice and food retail markets. Kay benefited from good ongoing demand from existing customers as well as new account gains.

 

 

Sales of our United States Other Services operations increased 9 percent in 2006. Pest Elimination continued its double-digit sales growth as sales rose 13 percent. Sales were driven by growth in both core pest elimination contract and non-contract services. Sales also benefited from new accounts and strong customer retention. GCS Service sales grew modestly as service and installed parts sales increased over last year. GCS Service continued to focus on infrastructure and process development that will improve competitive advantage and business scalability in the future.

 

 

Management rate sales of our International operations were $2.3 billion in 2006, an increase of 6 percent over 2005. Acquisitions and divestitures added 1 percent to the year over year sales growth in 2006. Sales in Europe increased 4 percent from 2005. Good sales growth in the United Kingdom was partially offset by slower sales growth in Germany, France and Italy. Europe also achieved geographic growth in 2006 through further expansion in eastern Europe. Asia Pacific sales grew 6 percent primarily driven by growth in China, Australia, Thailand and Hong Kong partially offset by weakness in Japan. Asia Pacific sales benefited from new corporate accounts and good results in the beverage and brewery segment. Latin America recorded strong 14 percent sales growth in 2006. The growth over last year was driven by results in Mexico, the Caribbean and Venezuela. Results were due to new account gains, growth of existing accounts and success with new programs. Sales in Canada increased 8 percent in 2006, reflecting good results from all divisions. Sales benefited from pricing, account retention and new business.

 

OPERATING INCOME BY REPORTABLE SEGMENT

 

millions

 

2006

 

2005

 

2004

 

Operating income

 

 

 

 

 

 

 

United States

 

 

 

 

 

 

 

Cleaning & Sanitizing

 

$

329

 

$

280

 

$

266

 

Other Services

 

39

 

36

 

21

 

Total United States

 

368

 

316

 

287

 

International

 

234

 

219

 

209

 

Total

 

602

 

535

 

496

 

Corporate

 

 

 

(4

)

Effect of foreign currency translation

 

10

 

7

 

(2

)

Consolidated

 

$

612

 

$

542

 

$

490

 

Operating income as a percent of net sales

 

 

 

 

 

 

 

United States

 

 

 

 

 

 

 

Cleaning & Sanitizing

 

15.3

%

14.3

%

14.8

%

Other Services

 

9.5

 

9.6

 

6.0

 

Total United States

 

14.4

 

13.6

 

13.4

 

International

 

10.3

 

10.3

 

10.2

 

Consolidated

 

12.5

%

12.0

%

11.7

%

 

Operating income of our United States Cleaning & Sanitizing operations increased 18 percent to $329 million in 2006. As a percentage of net sales, operating income increased to 15.3 percent in 2006 from 14.3 percent in 2005. Acquisitions and divestitures had no effect on the overall percentage increase in operating income. Operating income increased due to pricing, higher sales volume and improved cost efficiencies, which more than offset higher delivered product costs and investments in the business.

Operating income of our United States Other Services operations increased 8 percent to $39 million in 2006. As a percentage of net sales, operating income decreased slightly to 9.5 percent in 2006 from 9.6 percent in 2005. Double-digit operating income growth at Pest Elimination was offset by slow sales growth as well as investments in the GCS business. Operating income growth and operating income margin comparisons were also impacted by a $0.5 million regulatory expense in the second quarter of 2006 and a $0.5 million patent settlement benefit in the first quarter of 2005.

 

Management-rate based operating income of International operations rose 7 percent to $234 million in 2006. The International operating income margin was 10.3 percent in both 2006 and 2005. Acquisitions and divestitures occurring in 2006 and 2005 increased operating income growth by 1 percent over 2005. Operating income growth benefited from pricing, sales volume growth and cost efficiencies which more than offset higher delivered product costs and investments in the business.

 

Operating income margins of our International operations are generally less than those realized for our U.S. operations. The lower International margins are due to (i) the additional costs caused by the difference in scale of International operations where many operating locations are smaller in size, (ii) the additional cost of operating in numerous and diverse foreign jurisdictions and (iii) higher costs of importing raw materials and finished goods. Proportionately larger investments in sales, technical support and administrative personnel are also necessary in order to facilitate the growth of our International operations.

 

22




2005 COMPARED WITH 2004

 

Sales of our United States Cleaning & Sanitizing operations reached nearly $2.0 billion in 2005 and increased 9 percent over net sales of $1.8 billion in 2004. Acquisitions and divestitures increased sales by 1 percent for 2005. Sales benefited from double-digit organic growth in our Kay division, along with good growth in our Institutional and Food & Beverage divisions. This sales performance reflects increased account retention and penetration through enhanced service, new product and program initiatives and aggressive new account sales efforts. Institutional sales grew 7 percent in 2005 reflecting sales growth in all end market segments, including travel, casual dining, healthcare, and government markets. Food & Beverage sales increased 9 percent compared to 2004. Excluding the benefits of the 2004 Alcide acquisition, Food & Beverage sales increased 5 percent for 2005 primarily due to gains in the dairy, food and soft drink markets reflecting increasing penetration of existing corporate accounts as well as new business. Kay’s sales increased 11 percent, led by strong gains in sales to its core quickservice customers and in its food retail services business.

 

Sales of our United States Other Services operations increased 11 percent to $375 million in 2005. Pest Elimination had 12 percent sales growth including double-digit sales growth in both core pest elimination contract and non-contract services, such as bird and termite work, fumigation, one-shot services and its food safety audit business. GCS Service sales grew 8 percent in 2005 as service and installed parts sales increased over 2004. GCS continued to increase technician productivity and improve customer service satisfaction.

               

Management rate sales of our International operations were $2.1 billion in 2005, an increase of 5 percent over sales of $2.0 billion in 2004. Acquisitions and divestitures increased sales 1 percent in 2005. Sales in Europe, excluding acquisitions and divestitures, were up 2 percent from 2004. Sales were affected by an overall weak European economy, particularly in the major central countries. Sales in Asia Pacific, excluding acquisitions and divestitures, increased 7 percent. The growth was primarily driven by East Asia, including continued growth in China. Asia Pacific growth was driven by new corporate accounts and good results in the beverage and brewery segment. Latin America continued its double-digit sales growth as sales grew 15 percent over 2004, reflecting growth in all countries with Mexico, Chile and Argentina showing the strongest growth. Results were due to new account gains, growth of existing accounts and strong equipment sales. Sales in Canada increased 8 percent in 2005, reflecting good results from all divisions.

 

Operating income of our United States Cleaning & Sanitizing operations was $280 million in 2005, an increase of 5 percent from operating income of $266 million in 2004. As a percentage of net sales, operating income decreased from 14.8 percent in 2004 to 14.3 percent in 2005. Acquisitions and divestitures had no effect on the overall percentage increase in operating income. The increase in operating income in 2005 reflects the benefits of higher sales, pricing and lower share-based compensation expense being partially offset by higher delivered product costs. Operating income margins declined because the negative impact of higher delivered product costs more than offset the benefits of pricing, cost savings and sales leverage.

 

Operating income of United States Other Services operations increased 76 percent to $36 million in 2005. The operating income margin for United States Other Services increased to 9.6 percent in 2005 from 6.0 percent in 2004. Pest Elimination had double-digit operating income growth and GCS Service results reflect sharp profitability improvement in 2005. The increase in operating income for Pest Elimination was driven by strong sales and leverage of sales and administrative teams, with pricing and productivity improvements offsetting cost increases. GCS Service narrowed its operating loss substantially in 2005 due to good sales growth and operational improvements. GCS Service operating income growth also benefited from a favorable comparison to 2004 which included a sales decline, increased marketing expenses and higher than expected costs resulting from centralizing the parts and administration activities.

 

Management-rate based operating income of International operations rose 5 percent to $219 million in 2005 from operating income of $209 million in 2004. The International operating income margin was 10.3 percent in 2005 and 10.2 percent 2004. Excluding the impact of acquisitions and divestitures occurring in 2005 and 2004, operating income increased 3 percent over 2004. Sales growth, pricing, lower share-based compensation expense and cost efficiencies were partially offset by higher delivered product costs, unfavorable business mix and investments.

 

CORPORATE

 

We had no operating expenses in our corporate segment in 2006 or 2005 and $4.5 million in 2004. In 2004, corporate operating expense included a charge of $1.6 million for in-process research and development as part of the acquisition of Alcide Corporation and a charge of $4.0 million related to the disposal of a grease management product line, which were partially offset by $0.8 million of income for reductions in restructuring accruals and a $0.3 million gain on the sale of a small international business.

 

INTEREST AND INCOME TAXES

 

Net interest expense was $44 million for both 2006 and 2005. An increase in interest expense during 2006 was offset by higher interest income.

 

Net interest expense in 2005 decreased to $44 million compared to $45 million in 2004. The decrease was caused by higher interest income during the year due to increased levels of cash and cash equivalents and short-term investments offset partially by a small increase in interest expense.

 

Our effective income tax rate was 35.0 percent for 2006, compared with an effective income tax rate of 35.9 percent for 2005 and 36.4 percent in 2004. Reductions in our effective income tax rates over the last three years have primarily been due to favorable international mix, lower international statutory rates and the impact of tax planning efforts. Excluding the benefit of the $1.8 million tax settlement for stewardship costs and a $0.5 million benefit related to prior years, the estimated effective income tax rate was 35.4 percent for 2006. Excluding the effects of the $3.1 million tax charge related to the repatriation of foreign earnings under the AJCA and other onetime benefits, the estimated annual effective income tax rate for 2005 was 35.6 percent. Excluding the effects of special charges mentioned above in the corporate section and a $1.9 million tax benefit related to prior years, the estimated annual effective income tax rate was 36.7 percent for 2004.

 

23




FINANCIAL POSITION & LIQUIDITY

FINANCIAL POSITION

 

Our debt continued to be rated within the “A” categories by the major rating agencies during 2006. Significant changes in our financial position during 2006 included the following:

 

Total assets increased 16 percent to $4.4 billion as of December 31, 2006 from $3.8 billion at year-end 2005. Total assets increased primarily due to an increase in cash and cash equivalents resulting from $396 million of proceeds received from a new debt offering in December. Foreign currency translation added approximately $175 million to the value of non-U.S. assets on the balance sheet as the U.S. dollar weakened against foreign currencies, primarily the euro. Additionally, acquisitions added $83 million of assets.

 

Total liabilities increased $592 million in 2006. This included an increase in total debt discussed below and an increase of $81 million in post retirement healthcare and pension benefits due to the adoption of SFAS 158 as discussed in Note 15. Total liabilities also reflected an increase resulting from the effects of currency translation.

 

 

Total debt was $1.1 billion at December 31, 2006 and increased from total debt of $746 million at year-end 2005. This increase in total debt during 2006 was primarily due to the issuance of euro 300 million senior notes ($396 million as of December 31, 2006) to refinance our euronotes which became due in February 2007. The ratio of total debt to capitalization (total debt divided by the sum of shareholders’ equity plus total debt) was 39 percent at year-end 2006 and 31 percent at year-end 2005. The debt to capitalization ratio increased significantly in 2006, due to the new senior notes issued as well as a decrease in our equity of $168 million for a change in accounting due to the adoption of SFAS 158. Normalizing for these items, the total debt to capitalization would have been 27 percent for 2006. We view our debt to capitalization ratio as an important indicator of our creditworthiness.

 

CASH FLOWS

 

Cash provided by operating activities was $628 million for 2006, an increase over $590 million in 2005 and $571 million in 2004. The increase in operating cash flow for 2006 over 2005 reflects our higher net income offset partially by an increase in income tax payments and accounts receivable in 2006. The increase in operating cash flow for 2005 over 2004 is due to higher net income and improved collection of accounts receivable as well as better inventory management. Historically, we have had strong operating cash flows and we anticipate this will continue. We expect to continue to use this cash flow to acquire new businesses, repurchase our common stock, pay down debt and meet our ongoing obligations and commitments.

Cash used for investing activities decreased from 2005 due primarily to the timing of purchases and sales of short-term investments offset by higher acquisition activity, capital expenditures and capitalized software expenditures. Capital software expenditures increased due to investments in business systems. We expect capital software expenditures to increase significantly in 2007 as we continue to invest in our business systems.

 

Financing cash flow activity included cash proceeds from new senior note borrowings of $396 million, debt repayment and dividend payments. Share repurchases were $283 million in 2006, $213 million in 2005 and $165 million in 2004. These repurchases were funded with operating cash flows and cash from the exercise of employee stock options. In December 2004, we announced an authorization to repurchase up to 10 million shares of Ecolab common stock. In October 2006, we announced an authorization to repurchase up to 10 million additional shares of Ecolab common stock. As of December 31, 2006, approximately 12.9 million shares remained to be purchased under these authorizations. Shares are repurchased for the purpose of offsetting the dilutive effect of stock options and incentives and for general corporate purposes. During 2007, we expect to repurchase at least enough shares to offset the dilutive effect of stock options. Cash proceeds from the exercises as well as the tax benefits will provide a portion of the funding for this repurchase activity.

In 2006, we increased our indicated annual dividend rate for the fifteenth consecutive year. We have paid dividends on our common stock for 70 consecutive years. Cash dividends declared per share of common stock, by quarter, for each of the last three years were as follows:

 

 

FIRST

 

SECOND

 

THIRD

 

FOURTH

 

 

 

 

 

QUARTER

 

QUARTER

 

QUARTER

 

QUARTER

 

YEAR

 

2006

 

$

0.1000

 

$

0.1000

 

$

0.1000

 

$

0.1150

 

$

0.4150

 

2005

 

0.0875

 

0.0875

 

0.0875

 

0.1000

 

0.3625

 

2004

 

0.0800

 

0.0800

 

0.0800

 

0.0875

 

0.3275

 

 

LIQUIDITY AND CAPITAL RESOURCES

 

We currently expect to fund all of the requirements which are reasonably foreseeable for 2007, including scheduled debt repayments, new investments in the business, share repurchases, dividend payments, possible business acquisitions and pension contributions from operating cash flow, cash reserves and short-term borrowings.

 

In December 2006, we issued and sold in a private placement euro 300 million ($396 million as of December 31, 2006) aggregate principal amount of senior notes in two series: 4.355% Series A Senior Notes due 2013 in the aggregate principal amount of euro 125 million and 4.585% Series B Senior Notes due 2016 in the aggregate principal amount of euro 175 million (the “Notes),” pursuant to a Note Purchase Agreement dated July 26, 2006, between the company and the purchasers. The Notes are not subject to prepayment except where, in certain specified instances, we consolidate or merge all or substantially all of our assets with any other Person (as defined in the Note Purchase Agreement). Upon such consolidation or merger, we will offer to prepay all of the Notes at 100 percent of

 

24




the principal amount outstanding plus accrued interest. In the event of a default by the company under the Note Purchase Agreement, the Notes may become immediately due and payable for the unpaid principal amount, accrued interest and a make-whole amount determined as of the time of the default. The proceeds were used to repay our euro 300 million 5.375 percent euronotes which became due in February 2007.

 

While cash flows could be negatively affected by a decrease in revenues, we do not believe that our revenues are highly susceptible, in the short term, to rapid changes in technology within our industry. We have a $450 million U.S. commercial paper program and a $200 million European commercial paper program. Both programs are rated A-1 by Standard & Poor’s and P-1 by Moody’s. To support our commercial paper programs andother general business funding needs, we maintain a $450 million multi-year committed credit agreement which expires in June 2011 and under certain circumstances can be increased by $150 million for a total of $600 million. We can draw directly on the credit facility on a revolving credit basis. As of December 31, 2006, $30 million of this credit facility was committed to support outstanding U.S. commercial paper, leaving $420 million available for other uses. In addition, we have other committed and uncommitted credit lines of approximately $190 million with major international banks and financial institutions to support our general global funding needs. Additional details on our credit facilities are included in Note 6 of the notes to consolidated financial statements.

 

During 2006, we voluntarily contributed $45 million to our U.S. pension plan. In making this contribution, we considered the normal growth in accrued plan benefits, the impact of lower year-end discount rates on the plan liability and the tax deductibility of the contribution. We expect our combined U.S. qualified and nonqualified pension plan expense to decrease slightly to approximately $40 million in 2007 from $41 million in 2006, primarily due to expected returns on a higher level of plan assets and an increase in the discount rate from 5.57 percent to 5.79 percent for the 2007 expense calculation. The expected return on plan assets of 8.75 percent is consistent with 2006.

 

A schedule of our obligations under various notes payable, long-term debt agreements, operating leases with noncancelable terms in excess of one year, interest obligations and benefit payments are summarized in the following table:

 

 

 

PAYMENTS DUE BY PERIOD

 

THOUSANDS

 

 

 

LESS

 

 

 

 

 

MORE

 

 

 

 

 

THAN

 

1-3

 

3-5

 

THAN

 

Contractual Obligations

 

TOTAL

 

1 YEAR

 

YEARS

 

YEARS

 

5 YEARS

 

 

 

 

 

 

 

 

 

 

 

 

 

Note payable

 

$

109,100

 

$

109,100

 

$

 

$

 

$

 

Long-term debt

 

956,936

 

399,878

 

4,475

 

151,988

 

400,595

 

Operating leases

 

142,000

 

44,000

 

57,000

 

28,000

 

13,000

 

Interest*

 

223,347

 

34,172

 

64,250

 

54,290

 

70,635

 

Benefit payments**

 

760,000

 

52,000

 

123,000

 

138,000

 

447,000

 

Total contractual cash obligations

 

$

2,191,383

 

$

639,150

 

$

248,725

 

$

372,278

 

$

931,230

 

*                     Interest on variable rate debt was calculated using the interest rate at year-end 2006.

**              Benefit payments are paid out of the company’s pension and postretirement health care benefit plans.

We are not required to make any contributions to our U.S. pension and postretirement health care benefit plans in 2007, based on plan asset values as of December 31, 2006. Certain international pension benefit plans are required to be funded in accordance with local government requirements. We estimate contributions to be made to our international plans will approximate $20 million in 2007. These amounts have been excluded from the schedule of contractual obligations.

 

We lease sales and administrative office facilities, distribution center facilities, computers and other equipment under longer-term operating leases. Vehicle leases are generally shorter in duration. Vehicle leases have guaranteed residual value requirements that have historically been satisfied by the proceeds on the sale of the vehicles. No amounts have been recorded for these guarantees in the table preceding as we believe that the potential recovery of value from the vehicles when sold will be greater than the residual value guarantee.

Except for approximately $56 million of letters of credit supporting domestic and international commercial relationships and transactions, we do not have significant unconditional purchase obligations, or significant other commercial commitments, such as commitments under lines of credit, standby letters of credit, guarantees, standby repurchase obligations or other commercial commitments.

 

As of year-end 2006, we are in compliance with all covenants and other requirements of our credit agreements and indentures. Our $450 million multicurrency credit agreement, as amended and restated effective June 1, 2006, no longer includes a covenant regarding the ratio of total debt to capitalization. Our new euro 300 million senior notes include covenants regarding the amount of indebtedness secured by liens and subsidiary indebtedness allowed. Additionally, we do not have any rating triggers that would accelerate the maturity dates of our debt.

 

A downgrade in our credit rating could limit or preclude our ability to issue commercial paper under our current programs. A credit rating downgrade could also adversely affect our ability to renew existing, or negotiate new credit facilities in the future and could increase the cost of these facilities. Should this occur, we could seek additional sources of funding, including issuing term notes or bonds. In addition, we have the ability at our option to draw upon our $450 million committed credit facilities prior to their termination and, under certain conditions, can increase this amount to $600 million.

 

OFF-BALANCE SHEET ARRANGEMENTS

 

Other than operating leases, we do not have any off-balance sheet financing arrangements. See Note 12 for information on our operating leases. We do not have relationships with unconsolidated entities or financial partnerships, such as entities often referred to as “structured finance” or “special purposes entities”, which are sometimes established for the purpose of facilitating off-balance sheet financial arrangements or other contractually narrow or limited purposes. As such, we are not exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships.

 

NEW ACCOUNTING PRONOUNCEMENTS

 

We adopted the provisions of SFAS 158 effective as of our 2006 year end. The impact of adopting SFAS 158 is reflected as a reduction in net assets on our balance sheet of $168 million, with no impact to the statements of income and cash flows. See Note 15 for more information on this adoption.

FASB Interpretation No. 48 “Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement No. 109” (“FIN 48”) is effective  beginning January 1, 2007 with the cumulative effect of initially applying FIN 48 recognized as a

25




change in accounting principle recorded as an adjustment to opening retained earnings. We do not expect the impact of adoption to be material to our consolidated financial statements.

See Note 2 for additional information on these and other new accounting pronouncements.

 

MARKET RISK

 

We enter into contractual arrangements (derivatives) in the ordinary course of business to manage foreign currency exposure and interest rate risks. We do not enter into derivatives for trading purposes. Our use of derivatives is subject to internal policies that provide guidelines for control, counterparty risk and ongoing monitoring and reporting and is designed to reduce the volatility associated with movements in foreign exchange and interest rates on our income statement and cash flows.

 

We enter into forward contracts, swaps and foreign currency options to hedge certain intercompany financial arrangements, and to hedge against the effect of exchange rate fluctuations on transactions related to cash flows and net investments denominated in currencies other than U.S. dollars. At December 31, 2006, we had approximately $375 million notional amount of foreign currency forward exchange contracts with face amounts denominated primarily in euros.

 

We manage interest expense using a mix of fixed and floating rate debt. To help manage borrowing costs, we may enter into interest rate swap agreements. Under these arrangements, we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. At year-end 2006, we had an interest rate swap that converts approximately euro 78 million (approximately $103 million U.S. dollars) of our Euronote debt from a fixed interest rate to a floating or variable interest rate. This swap agreement expired in February 2007.

 

Based on a sensitivity analysis (assuming a 10 percent adverse change in market rates) of our foreign exchange and interest rate derivatives and other financial instruments, changes in exchange rates or interest rates would not materially affect our financial position and liquidity. The effect on our results of operations would be substantially offset by the impact of the hedged items.

 

FORWARD-LOOKING STATEMENTS AND RISK FACTORS

 

This financial discussion and other portions of this Annual Report to Shareholders contain various “Forward-Looking Statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include expectations concerning:

 

·   business progress and expansion,

·   business acquisitions,

·   currency translation,

·   cash flows,

·   debt repayments,

·   share repurchases,

·   global economic conditions,

·   pension expenses and potential contributions,

·   income taxes

·   and liquidity requirements.

 

Without limiting the foregoing, words or phrases such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “we believe,” “we expect,” “estimate,” “project” (including the negative or variations thereof) or similar terminology, general identify forward-looking statements. Forward-looking statements may also represent challenging goals for us. We caution that undue reliance should not be placed on such forward-looking statements, which speak only as of the date made. Some of the factors which could cause results to differ from those expressed in any forward-looking statements are set forth under Item 1A of our Form 10-K for the year ended December 31, 2006, entitled Risk Factors.

 

In addition, we note that our stock price can be affected by fluctuations in quarterly earnings. There can be no assurances that our earnings levels will meet investors’ expectations. We undertake no duty to update our Forward-Looking Statements.

26




Consolidated Statement of Income

 

Year ended December 31 (thousands, except per share)

 

2006

 

2005

 

2004

 

 

 

 

 

 

 

 

 

Net sales

 

$

4,895,814

 

$

4,534,832

 

$

4,184,933

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

Cost of sales (including special charges (income) of ($106) in 2004)

 

2,416,058

 

2,248,831

 

2,033,492

 

Selling, general and administrative expenses

 

1,868,114

 

1,743,581

 

1,657,084

 

Special charges

 

 

 

 

 

4,467

 

Operating income

 

611,642

 

542,420

 

489,890

 

Interest expense, net

 

44,418

 

44,238

 

45,344

 

Income before income taxes

 

567,224

 

498,182

 

444,546

 

Provision for income taxes

 

198,609

 

178,701

 

161,853

 

Net income

 

$

368,615

 

$

319,481

 

$

282,693

 

 

 

 

 

 

 

 

 

Net income per common share

 

 

 

 

 

 

 

Basic

 

$

1.46

 

$

1.25

 

$

1.10

 

Diluted

 

$

1.43

 

$

1.23

 

$

1.09

 

 

 

 

 

 

 

 

 

Dividends declared per common share

 

$

0.4150

 

$

0.3625

 

$

0.3275

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding

 

 

 

 

 

 

 

Basic

 

252,132

 

255,741

 

257,575

 

Diluted

 

257,144

 

260,098

 

260,407

 

 

The accompanying notes are an integral part of the consolidated financial statements.

27




Consolidated Balance Sheet

 

DECEMBER 31 (THOUSANDS, EXCEPT PER SHARE)

 

2006

 

2005

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

Current assets

 

 

 

 

 

Cash and cash equivalents

 

$

484,029

 

$

104,378

 

Short-term investments

 

 

 

125,063

 

Accounts receivable, net

 

867,541

 

743,520

 

Inventories

 

364,886

 

325,574

 

Deferred income taxes

 

86,870

 

65,880

 

Other current assets

 

50,231

 

57,251

 

Total current assets

 

1,853,557

 

1,421,666

 

Property, plant and equipment, net

 

951,569

 

868,053

 

Goodwill

 

1,035,929

 

937,019

 

Other intangible assets, net

 

223,787

 

202,936

 

Other assets, net

 

354,523

 

366,954

 

Total assets

 

$

4,419,365

 

$

3,796,628

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities

 

 

 

 

 

Short-term debt

 

$

508,978

 

$

226,927

 

Accounts payable

 

330,858

 

277,635

 

Compensation and benefits

 

252,686

 

214,131

 

Income taxes

 

17,698

 

39,583

 

Other current liabilities

 

392,510

 

361,081

 

Total current liabilities

 

1,502,730

 

1,119,357

 

Long-term debt

 

557,058

 

519,374

 

Postretirement health care and pension benefits

 

420,245

 

302,048

 

Other liabilities

 

259,102

 

206,639

 

Shareholders’ equity (a)

 

1,680,230

 

1,649,210

 

Total liabilities and shareholders’ equity

 

$

4,419,365

 

$

3,796,628

 

 

(a)              Common stock, 400,000 shares authorized, $1.00 par value, 251,337 shares issued and outstanding at December 31, 2006, 254,143 shares issued and outstanding at December 31, 2005.

 

The accompanying notes are an integral part of the consolidated financial statements.

28




Consolidated Statement of Cash Flows

 

YEAR ENDED DECEMBER 31 (THOUSANDS)

 

2006

 

2005

 

2004

 

 

 

 

 

 

 

 

 

OPERATING ACTIVITIES

 

 

 

 

 

 

 

Net income

 

$

368,615

 

$

319,481

 

$

282,693

 

Adjustments to reconcile net income to cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

268,569

 

256,935

 

246,954

 

Deferred income taxes

 

(18,806

)

(13,021

)

14,342

 

Share-based compensation expense

 

36,326

 

39,087

 

44,660

 

Excess tax benefits from share-based payment arrangements

 

(19,763

)

(11,682

)

(11,556

)

Disposal loss, net

 

387

 

 

 

3,691

 

Charge for in-process research and development

 

 

 

 

 

1,600

 

Other, net

 

1,282

 

(882

)

(2,507

)

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

Accounts receivable

 

(66,774

)

(44,839

)

(47,217

)

Inventories

 

(17,987

)

2,553

 

(5,481

)

Other assets

 

(27,138

)

(21,853

)

(31,723

)

Accounts payable

 

44,519

 

18,987

 

34,841

 

Other liabilities

 

58,334

 

45,370

 

40,611

 

Cash provided by operating activities

 

627,564

 

590,136

 

570,908

 

 

 

 

 

 

 

 

 

INVESTING ACTIVITIES

 

 

 

 

 

 

 

Capital expenditures

 

(287,885

)

(268,783

)

(275,871

)

Property disposals

 

25,622

 

21,209

 

18,373

 

Capitalized software expenditures

 

(33,054

)

(10,949

)

(9,688

)

Businesses acquired and investments in affiliates, net of cash acquired

 

(65,532

)

(26,967

)

(129,822

)

Sale of businesses and assets

 

1,802

 

1,441

 

3,417

 

Proceeds from sales and maturities of short-term investments

 

125,063

 

60,625

 

 

 

Purchases of short-term investments

 

 

 

(185,688

)

 

 

Cash used for investing activities

 

(233,984

)

(409,112

)

(393,591

)

 

 

 

 

 

 

 

 

FINANCING ACTIVITIES

 

 

 

 

 

 

 

Net borrowings (repayments) of notes payable

 

(47,712

)

96,683

 

(17,474

)

Long-term debt borrowings

 

396,150

 

4,664

 

7,325

 

Long-term debt repayments

 

(86,287

)

(5,710

)

(6,632

)

Reacquired shares

 

(282,764

)

(213,266

)

(165,414

)

Cash dividends on common stock

 

(101,174

)

(89,807

)

(82,419

)

Exercise of employee stock options

 

87,946

 

49,726

 

59,989

 

Excess tax benefits from share-based payment arrangements

 

19,763

 

11,682

 

11,556

 

Other, net

 

(2,283

)

 

 

(800

)

Cash used for financing activities

 

(16,361

)

(146,028

)

(193,869

)

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash

 

2,432

 

(1,849

)

2,157

 

 

 

 

 

 

 

 

 

Increase (decrease) in cash and cash equivalents

 

379,651

 

33,147

 

(14,395

)

Cash and cash equivalents, beginning of year

 

104,378

 

71,231

 

85,626

 

Cash and cash equivalents, end of year

 

$

484,029

 

$

104,378

 

$

71,231

 

 

The accompanying notes are an integral part of the consolidated financial statements.

29




Consolidated Statement of Comprehensive Income and Shareholders' Equity

 

 

 

 

 

 

 

 

 

ACCUMULATED

 

 

 

 

 

 

 

 

 

ADDITIONAL

 

 

 

OTHER

 

 

 

 

 

 

 

COMMON

 

PAID-IN

 

RETAINED

 

COMPREHENSIVE

 

TREASURY

 

 

 

(THOUSANDS)

 

STOCK

 

CAPITAL

 

EARNINGS

 

INCOME (LOSS)

 

STOCK

 

TOTAL

 

Balance December 31, 2003

 

$

310,284

 

$

459,974

 

$

1,294,165

 

$

4,098

 

$

(747,440

)

$

1,321,081

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

282,693

 

 

 

 

 

282,693

 

Foreign currency translation

 

 

 

 

 

 

 

71,029

 

 

 

71,029

 

Other comprehensive loss

 

 

 

 

 

 

 

(2,674

)

 

 

(2,674

)

Minimum pension liability

 

 

 

 

 

 

 

(293

)

 

 

(293

)

Comprehensive income

 

 

 

 

 

 

 

 

 

 

 

350,755

 

Cash dividends declared

 

 

 

 

 

(84,410

)

 

 

 

 

(84,410

)

Stock options and awards

 

3,624

 

115,238

 

 

 

 

 

118

 

118,980

 

Business acquisitions

 

1,835

 

55,314

 

 

 

 

 

 

 

57,149

 

Reacquired shares

 

 

 

 

 

 

 

 

 

(165,414

)

(165,414

)

Balance December 31, 2004

 

315,743

 

630,526

 

1,492,448

 

72,160

 

(912,736

)

1,598,141

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

319,481

 

 

 

 

 

319,481

 

Foreign currency translation

 

 

 

 

 

 

 

(50,516

)

 

 

(50,516

)

Other comprehensive income

 

 

 

 

 

 

 

4,365

 

 

 

4,365

 

Minimum pension liability

 

 

 

 

 

 

 

(16,245

)

 

 

(16,245

)

Comprehensive income

 

 

 

 

 

 

 

 

 

 

 

257,085

 

Cash dividends declared

 

 

 

 

 

(92,728

)

 

 

 

 

(92,728

)

Stock options and awards

 

2,860

 

96,902

 

 

 

 

 

216

 

99,978

 

Reacquired shares

 

 

 

 

 

 

 

 

 

(213,266

)

(213,266

)

Balance December 31, 2005

 

318,603

 

727,428

 

1,719,201

 

9,764

 

(1,125,786

)

1,649,210

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

368,615

 

 

 

 

 

368,615

 

Foreign currency translation

 

 

 

 

 

 

 

65,776

 

 

 

65,776

 

Other comprehensive income

 

 

 

 

 

 

 

(3,352

)

 

 

(3,352

)

Minimum pension liability

 

 

 

 

 

 

 

(617

)

 

 

(617

)

Comprehensive income

 

 

 

 

 

 

 

 

 

 

 

430,422

 

Cumulative effect adjustment for adoption of SFAS 158

 

 

 

 

 

 

 

(168,083

)

 

 

(168,083

)

Cash dividends declared

 

 

 

 

 

(104,544

)

 

 

 

 

(104,544

)

Stock options and awards

 

3,975

 

140,745

 

 

 

 

 

960

 

145,680

 

Reacquired shares

 

 

 

 

 

 

 

 

 

(272,455

)

(272,455

)

Balance December 31, 2006

 

$

322,578

 

$

868,173

 

$

1,983,272

 

$

(96,512

)

$

(1,397,281

)

$

1,680,230

 

 

COMMON STOCK ACTIVITY

 

 

2006

 

2005

 

2004

 

 

 

COMMON

 

TREASURY

 

COMMON

 

TREASURY

 

COMMON

 

TREASURY

 

YEAR ENDED DECEMBER 31 (SHARES)

 

STOCK

 

STOCK

 

STOCK

 

STOCK

 

STOCK

 

STOCK

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares, beginning of year

 

318,602,705

 

(64,459,800

)

315,742,759

 

(58,200,908

)

310,284,083

 

(52,867,561

)

Stock options

 

3,975,722

 

172,665

 

2,859,946

 

18,666

 

3,623,917

 

1,200

 

Stock awards, net issuances

 

 

 

49,519

 

 

 

34,689

 

 

 

24,460

 

Business acquisitions

 

 

 

 

 

 

 

 

 

1,834,759

 

 

 

Reacquired shares

 

 

 

(7,003,944

)

 

 

(6,312,247

)

 

 

(5,359,007

)

Shares, end of year

 

322,578,427

 

(71,241,560

)

318,602,705

 

(64,459,800

)

315,742,759

 

(58,200,908

)

 

The accompanying notes are an integral part of the consolidated financial statements.

30




Notes to Consolidated Financial Statements

 

1. NATURE OF BUSINESS

 

Ecolab Inc. (the “company”) develops and markets premium products and services for the hospitality, foodservice, healthcare and industrial markets.  The company provides cleaning and sanitizing products and programs, as well as pest elimination, maintenance and repair services primarily to hotels and restaurants, healthcare and educational facilities, quickservice (fast-food and convenience stores) units, grocery stores, commercial and institutional laundries, light industry, dairy plants and farms, food and beverage processors and the vehicle wash industry.

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

PRINCIPLES OF CONSOLIDATION

 

The consolidated financial statements include the accounts of the company and all majority-owned subsidiaries. International subsidiaries are included in the financial statements on the basis of their November 30 fiscal year-ends to facilitate the timely inclusion of such entities in the company’s consolidated financial reporting. All intercompany transactions and profits are eliminated in consolidation.

 

USE OF ESTIMATES

 

The preparation of the company’s financial statements requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from these estimates.

 

FOREIGN CURRENCY TRANSLATION

 

Financial position and results of operations of the company’s international subsidiaries generally are measured using local currencies as the functional currency. Assets and liabilities of these operations are translated at the exchange rates in effect at each fiscal year end. The translation adjustments related to assets and liabilities that arise from the use of differing exchange rates from period to period are included in accumulated other comprehensive income (loss) in shareholders’ equity. The cumulative translation gain as of year-end 2006, 2005 and 2004 was $57.0 million, $8.1 million and $87.1 million, respectively. Income statement accounts are translated at the average rates of exchange prevailing during the year. The different exchange rates from period to period impact the amount of reported income from the company’s international operations. Foreign currency translation positively impacted net income by approximately $2 million, $5 million and $11 million for the years ended December 31, 2006, 2005 and 2004, respectively.

 

RECLASSIFICATION

 

Capitalized software has been reclassified on the company’s  balance sheet from Other Assets to Property, Plant and Equipment. Prior period balance sheet amounts have also been reclassified to conform to the current year presentation. Net capitalized software was $54.7 million and $32.6 million at December 31, 2006 and 2005, respectively.

 

CASH AND CASH EQUIVALENTS

 

Cash equivalents include highly-liquid investments with a maturity of three months or less when purchased.

 

SHORT-TERM INVESTMENTS

 

Short-term investments at December 31, 2005 consist solely of auction-rate debt securities classified as available-for-sale, which are stated at estimated fair value. All of these securities held by the company as of December 31, 2005 have auction reset periods of 35 days or less and the carrying value approximates market value given the short reset periods. These investments were sold in the first quarter of 2006. No unrealized or realized gains or losses were recognized related to short-term investments during the years ended December 31, 2006 and 2005.

 

ALLOWANCE FOR DOUBTFUL ACCOUNTS

 

The company estimates the balance of allowance for doubtful accounts by analyzing accounts receivable balances by age and applying historical write-off trend rates to the most recent 12 months’ sales, less actual write-offs to date. The company estimates include separately providing for specific customer balances when it is deemed probable that the balance is uncollectible. Account balances are charged off against the allowance when it is probable the receivable will not be recovered.

 

The company’s allowance for doubtful accounts balance includes an allowance for the expected return of products shipped and credits related to pricing or quantities shipped of approximately $6 million and $5 million as of December 31, 2006 and 2005, respectively. This returns and credit activity is recorded directly to sales.

 

The following table summarizes the activity in the allowance for doubtful accounts:

 

THOUSANDS

 

2006

 

2005

 

 

 

 

 

 

 

Beginning balance

 

$

38,851

 

$

44,199

 

Bad debt expense

 

12,947

 

11,589

 

Write-offs

 

(17,483

)

(14,743

)

Other*

 

3,304

 

(2,194

)

Ending balance

 

$

37,619

 

$

38,851

 

*                     Other amounts are primarily the effects of changes in currency.

INVENTORY VALUATIONS

Inventories are valued at the lower of cost or market. Domestic chemical inventory costs are determined on a last-in, first-out (lifo) basis. Lifo inventories represented 28 percent and 32 percent of consolidated inventories at year-end 2006 and 2005, respectively. All other inventory costs are determined on a first-in, first-out (fifo) basis.

 

PROPERTY, PLANT AND EQUIPMENT

 

Property, plant and equipment are stated at cost. Merchandising equipment consists principally of various systems that dispense the company’s cleaning and sanitizing products and dishwashing machines. The dispensing systems are accounted for on a mass asset basis, whereby equipment is capitalized and depreciated as a group and written off when fully depreciated. The company capitalizes both internal and external costs of development or purchase of computer software for internal use. Costs incurred for data conversion, training and maintenance associated with capitalized software are expensed as incurred.

 

Depreciation is charged to operations using the straight-line method over the assets’ estimated useful lives ranging from 5 to 50 years for buildings and leaseholds, 3 to 11 years for machinery and equipment and 3 to 7 years for merchandising equipment and capital software.

31




Expenditures for repairs and maintenance are charged to expense as incurred. Expenditures for major renewals and betterments, which significantly extend the useful lives of existing plant and equipment, are capitalized and depreciated.

 

Upon retirement or disposition of plant and equipment, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in income.

 

GOODWILL AND OTHER INTANGIBLE ASSETS

 

Goodwill and other intangible assets arise principally from business acquisitions. Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired. Other intangible assets primarily include customer relationships, trademarks, patents and other technology. The fair value of identifiable intangible assets is estimated based upon discounted future cash flow projections. Other intangible assets are amortized on a straight-line basis over their estimated economic lives. The weighted-average useful life of other intangible assets was 14 years as of December 31, 2006 and 2005.

 

The weighted-average useful life by type of asset at December 31, 2006 is as follows:

 

 

 

Number of Years

 

Customer relationships

 

12

 

Intellectual property

 

15

 

Trademarks

 

20

 

Other

 

7

 

 

The straight-line method of amortization reflects an appropriate allocation of the cost of the intangible assets to earnings in proportion to the amount of economic benefits obtained by the company in each reporting period. Total amortization expense related to other intangible assets during the years ended December 31, 2006, 2005 and 2004 was approximately $25.0 million, $23.5 million and $21.7 million, respectively. As of December 31, 2006, future estimated amortization expense related to amortizable other identifiable intangible assets will be:

 

thousands

 

 

 

2007

 

$

28,000

 

2008

 

28,000

 

2009

 

26,000

 

2010

 

24,000

 

2011

 

23,000

 

 

The company tests goodwill for impairment on an annual basis for all reporting units. Generally, the company’s reporting units are its operating segments. An impairment charge is recognized for the amount, if any, by which the carrying amount of goodwill exceeds its implied fair value. Fair values of reporting units are established using a discounted cash flow method. Where available and as appropriate comparative market multiples are used to corroborate the results of the discounted cash flow method. Based on the company’s testing, there has been no impairment of goodwill during the three years ended December 31, 2006. The company performs its annual goodwill impairment test during the second quarter. If circumstances change significantly within a reporting unit, the company would also test a reporting unit for impairment prior to the annual test.

 

LONG-LIVED ASSETS

 

The company periodically reviews its long-lived assets for impairment and assesses whether significant events or changes in business circumstances indicate that the carrying value of the assets may not be recoverable. An impairment loss may be recognized when the carrying amount of an asset exceeds the anticipated future undiscounted cash flows expected to result from the use of the asset and its eventual disposition. The amount of the impairment loss to be recorded, if any, is calculated by the excess of the asset’s carrying value over its fair value.

 

REVENUE RECOGNITION

 

The company recognizes revenue as services are performed or on product sales at the time title to the product and risk of loss transfers to the customer. The company’s sales policies do not provide for general rights of return and do not contain customer acceptance clauses. Trade accounts receivable are recorded at the invoiced amount and generally do not bear interest. The company records estimated reductions to revenue for customer programs and incentive offerings, including pricing arrangements, promotions and other volume-based incentives at the time the sale is recorded. The company also records estimated reserves for anticipated uncollectible accounts and for product returns and credits at the time of sale.

 

INCOME PER COMMON SHARE

 

The computations of the basic and diluted net income per share amounts were as follows:

 

thousands, except per share

 

2006

 

2005

 

2004

 

 

 

 

 

 

 

 

 

Net income

 

$

368,615

 

$

319,481

 

$

282,693

 

Weighted-average common shares outstanding

 

 

 

 

 

 

 

Basic

 

252,132

 

255,741

 

257,575

 

Effect of dilutive stock options and awards

 

5,012

 

4,357

 

2,832

 

Diluted

 

257,144

 

260,098

 

260,407

 

Net income per common share

 

 

 

 

 

 

 

Basic

 

$

1.46

 

$

1.25

 

$

1.10

 

Diluted

 

$

1.43

 

$

1.23

 

$

1.09

 

 

Restricted stock awards of 24,670 shares for 2006, 22,175 shares for 2005 and 62,300 shares for 2004 were excluded from the computation of basic weighted-average shares outstanding because such shares were not yet vested at those dates.

Stock options to purchase approximately 2.6 million shares for 2006, 7.1 million shares for 2005 and 4.2 million shares for 2004 were not dilutive and, therefore, were not included in the computations of diluted common shares outstanding.

 

SHARE-BASED COMPENSATION

 

Effective October 1, 2005, the company early-adopted Statement of Financial Accounting Standard No. 123 (Revised 2004), “Share-Based Payment” (“SFAS 123R”) under the modified retrospective application method. SFAS 123R requires the company to measure compensation expense for share-based awards at fair value at the date of grant and recognize compensation expense over the service period for awards expected to vest. As part of the transition to the new standard, all prior period financial statements were restated to recognize share-based compensation expense historically reported in the notes to the consolidated financial statements.

 

Effective with the company’s adoption of SFAS 123R, new stock option grants to retirement eligible recipients are attributed to

32




expense using the non-substantive vesting method and are fully expensed by the time recipients attain age 55 with at least 5 years of service. If the company had used the non-substantive vesting method during all periods, net income for 2006, 2005 and 2004 would have increased by approximately $2.7 million, $2.5 million and $5.2 million, respectively. In addition, the company previously accounted for forfeitures when they occurred. Commencing at the date of adoption, the company includes a forfeiture estimate in the amount of compensation expense being recognized. This change from the company’s historical practice of recognizing forfeitures as they occur did not result in the recognition of any cumulative adjustments to income. The company has used the actual tax effects of stock options and the transition guidance prescribed within SFAS 123R for establishing the pool of excess tax benefits (APIC Pool).

 

COMPREHENSIVE INCOME

 

Comprehensive income includes net income, foreign currency translation adjustments, minimum pension liabilities, gains and losses on derivative instruments designated and effective as cash flow hedges and nonderivative instruments designated and effective as foreign currency net investment hedges that are charged or credited to the accumulated other comprehensive income (loss) account in shareholders’ equity.

 

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

 

The company uses foreign currency forward contracts, interest rate swaps and foreign currency debt to manage risks generally associated with foreign exchange rates, interest rates and net investments in foreign operations. The company does not hold derivative financial instruments of a speculative nature. On the date that the company enters into a derivative contract, it designates the derivative as (1) a hedge of (a) the fair value of a recognized asset or liability or (b) an unrecognized firm commitment (a “fair value” hedge), (2) a hedge of (a) a forecasted transaction or (b) the variability of cash flows that are to be received or paid in connection with a recognized asset or liability (a “cash flow” hedge); or (3) a foreign-currency fair-value or cash flow hedge (a “foreign currency” hedge). The company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objective and strategy for undertaking various hedge transactions. The company also formally assesses (both at the hedge’s inception and on an ongoing basis) whether the derivatives that are used in hedging transactions have been highly effective in offsetting changes in the fair value or cash flows of hedged items and whether those derivatives may be expected to remain highly effective in future periods. When it is determined that a derivative is not (or has ceased to be) highly effective as a hedge, the company will discontinue hedge accounting prospectively. The company believes that on an ongoing basis its portfolio of derivative instruments will generally be highly effective as hedges.

 

All of the company’s derivatives are recognized on the balance sheet at their fair value. The earnings impact resulting from the change in fair value of the derivative instruments is recorded in the same line item in the consolidated statement of income as the underlying exposure being hedged.

 

NEW ACCOUNTING PRONOUNCEMENTS

 

In September 2006, the FASB issued SFAS 158, “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans — an amendment of FASB statements 87, 88, 106 and 132(R)” (“SFAS 158”). SFAS 158 requires the company to recognize on its balance sheet the funded status of the company’s defined benefit pension and post-retirement plans. SFAS 158 also requires that all benefit plans use the company’s fiscal year-end as its measurement date. As required, the company prospectively adopted SFAS 158 beginning with its 2006 year end. The effect of initially adopting SFAS 158 is reflected as a cumulative adjustment to Accumulated Other Comprehensive Income (Loss) net of applicable taxes in the year of adoption. The impact of adopting SFAS 158 is reflected as a reduction in net assets on the company’s balance sheet of $168 million, with no impact to the statement of income and cash flows. See Note 15 for additional information.

 

In September 2006, the FASB issued SFAS 157, “Fair Value Measurement”, which defines fair value, establishes a framework for measuring fair value and expanded disclosures about fair value measurement. Companies are required to adopt the new standard for fiscal periods beginning after November 15, 2007. The company is evaluating the impact of this standard and does not expect it will have a material impact on its consolidated financial statements.

 

In July 2006, the FASB issued FIN 48, “Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement No. 109” (“FIN 48”). FIN 48 clarifies the accounting for uncertain tax positions in accordance with FASB Statement No. 109, “Accounting for Income Taxes”. For each tax position the company will be required to recognize, in its financial statements, the largest tax benefit that is “more-likely-than-not” to be sustained on audit based solely on the technical merits of the position as of the reporting date. FIN 48 also provides guidance on new disclosure requirements, reporting and accrual of interest and penalties, accounting in interim periods, and transition. FIN 48 is effective beginning January 1, 2007 with the cumulative effect of initially applying FIN 48 recognized as a change in accounting principle recorded as an adjustment to opening retained earnings. The company does not expect the impact of adoption to be material to the company’s consolidated financial statements.

 

No other new accounting pronouncement issued or effective has had or is expected to have a material impact on the company’s consolidated financial statements.

 

3. SPECIAL CHARGES

 

Special charges in 2004 included a charge of $1.6 million for inprocess research and development related to the Alcide acquisition and a charge of $4.0 million on the disposal of a grease management product line, which were partially offset by $0.8 million of income for reductions in restructuring accruals and a $0.3 million gain on the sale of a small international business. For segment reporting purposes, these items have been included in the company’s corporate segment, which is consistent with the company’s internal management reporting.

 

4. RELATED PARTY TRANSACTIONS

 

Henkel KGaA (“Henkel”) beneficially owned 72.7 million shares, or approximately 28.9 percent, of the company’s outstanding common stock on December 31, 2006. Under a  stockholders’ agreement between the company and Henkel, Henkel is permitted ownership in the company of up to 35 percent of the company’s outstanding common stock. Henkel is also entitled to proportionate representation on the company’s board of directors.

33




 

In 2006, 2005 and 2004, the company and its affiliates sold products and services in the aggregate amounts of $5.7 million, $3.6 million and $3.2 million, respectively, to Henkel or its affiliates, and purchased products and services in the amounts of $66.0 million, $65.3 million and $70.9 million, respectively, from Henkel or its affiliates. The transactions with Henkel and its affiliates were made in the ordinary course of business and were negotiated at arm’s length.

 

5. BUSINESS ACQUISITIONS AND DISPOSITIONS

 

BUSINESS ACQUISITIONS

 

Business acquisitions made by the company during 2006, 2005 and 2004 were as follows:

 

 

 

 

 

 

 

ESTIMATED

 

 

 

 

 

 

 

ANNUAL SALES

 

BUSINESS

 

DATE OF

 

 

 

PRIOR TO

 

ACQUIRED

 

ACQUISITION

 

              SEGMENT              

 

ACQUISITION

 

 

 

 

 

 

 

(MILLIONS)

 

 

 

 

 

 

 

(UNAUDITED)

 

 

 

 

 

 

 

 

 

2006

 

 

 

 

 

 

 

Shield Medicare Ltd.

 

June 2006

 

International (Europe)

 

$19

 

 

DuChem Industries, Inc.

 

Sept. 2006

 

U.S. C&S
(Food & Beverage)

 

10

 

 

Powles Hunt & Sons International Ltd.

 

Sept. 2006

 

International (Europe)

 

5

 

 

2005

 

 

 

 

 

 

 

 

Associated Chemicals & Services, Inc.
(Aka Midland Research)

 

Jan. 2005

 

U.S. C&S (Water Care)

 

16

 

 

YSC Chemical Company

 

Feb. 2005

 

International (Asia Pacific)

 

3

 

 

Kilco Chemicals Ltd.

 

Apr. 2005

 

International (Europe)

 

5

 

 

2004

 

 

 

 

 

 

 

 

Nigiko

 

Jan. 2004

 

International
(Europe)

 

55

 

 

Daydots International

 

Feb. 2004

 

U.S. C&S
(Institutional)

 

22

 

 

Elimco

 

May 2004

 

International
(Europe)

 

4

 

 

Restoration and Maintenance unit of VIC International

 

June 2004

 

U.S. C&S
(Professional Products)

 

5

 

 

Alcide Corporation

 

July 2004

 

U.S. C&S
(Food & Beverage)

 

24

 

 

 

The total cash consideration paid by the company for acquisitions and investments in affiliates was approximately $66 million, $27 million and $130 million for 2006, 2005 and 2004, respectively. In addition, 1,834,759 shares of common stock were issued with a market value of $57 million in the Alcide acquisition in 2004, plus $23,000 of cash in lieu of fractional shares. Total cash paid in 2004 also includes payments of restructuring costs related to the acquisition of the remaining 50 percent interest in the former Henkel-Ecolab joint venture that were accrued in 2002. The aggregate purchase price has been reduced for any cash or cash equivalents acquired with the acquisitions.

 

These acquisitions have been accounted for as purchases and, accordingly, the results of their operations have been included in the financial statements of the company from the dates of acquisition. Net sales and operating income of these businesses were not significant to the company’s consolidated financial statements, therefore pro forma financial information is not presented.

 

Based upon purchase price allocations, the components of the aggregate purchase prices of the acquisitions made were as follows:

 

MILLIONS

 

2006

 

2005

 

2004

 

Net tangible assets acquired (liabilities assumed)

 

$

(6

)

$

 

$

14

 

Identifiable intangible assets

 

28

 

8

 

44

 

In-process research and development

 

 

 

 

 

2

 

Goodwill

 

44

 

19

 

127

 

Purchase price

 

$

66

 

$

27

 

$

187

 

 

The allocation of purchase price includes adjustments to preliminary allocations from prior periods, if any. During 2004, the company recorded a charge of $1.6 million for in-process research and development (“IPR&D”) as part of the allocation of purchase price in the Alcide acquisition. The value assigned to IPR&D is based on an independent appraiser’s valuation and was determined by identifying research projects in areas for which technological feasibility had not been established and no alternative uses for the technology existed. The values were determined by estimating the discounted amount of after-tax cash flows attributable to these projects. The future cash flows were discounted to present value utilizing a risk-adjusted rate of return that considered the uncertainty surrounding the successful development of the IPR&D.

34




The changes in the carrying amount of goodwill for each of the company’s reportable segments for the years ended December 31, 2006, 2005 and 2004 are as follows:

 

THOUSANDS

 

U.S.
CLEANING &
SANITIZING

 

U.S.
OTHER
SERVICES

 

TOTAL
U.S.

 

INTERNATIONAL

 

CONSOLIDATED

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance December 31, 2003

 

$

122,346

 

$

48,929

 

$

171,275

 

$

625,936

 

$

797,211

 

Goodwill acquired during year*

 

54,936

 

 

 

54,936

 

72,270

 

127,206

 

Goodwill allocated to business dispositions

 

(69

)

 

 

(69

)

(25

)

(94

)

Foreign currency translation

 

 

 

 

 

 

 

67,488

 

67,488

 

Balance December 31, 2004

 

177,213

 

48,929

 

226,142

 

765,669

 

991,811

 

Goodwill acquired during year*

 

12,639

 

595

 

13,234

 

6,162

 

19,396

 

Goodwill allocated to business dispositions

 

(130

)

 

 

(130

)

(376

)

(506

)

Foreign currency translation

 

 

 

 

 

 

 

(73,682

)

(73,682

)

Balance December 31, 2005

 

189,722

 

49,524

 

239,246

 

697,773

 

937,019

 

Goodwill acquired during year*

 

7,346

 

990

 

8,336

 

35,713

 

44,049

 

Goodwill allocated to business dispositions

 

 

 

 

 

 

 

(423

)

(423

)

Foreign currency translation

 

 

 

 

 

 

 

55,284

 

55,284

 

Balance December 31, 2006

 

$

197,068

 

$

50,514

 

$

247,582

 

$

788,347

 

$

1,035,929

 


*                     For 2006, 2005 and 2004, goodwill related to businesses acquired of $7.7 million, $3.5 million and $92.8 million, respectively, is expected to be tax deductible. Goodwill acquired in 2006, 2005 and 2004 also includes adjustments to prior year acquisitions.

BUSINESS DISPOSITIONS

 

The company had no significant business dispositions in 2006 or 2005. In April 2004, the company sold its grease management product line. This sale resulted in a loss of approximately $4.0 million ($2.4 million after tax). Sales of the grease management product line totaled approximately $20 million in 2003 and were included in the company’s U.S. Cleaning & Sanitizing operations. In 2004, the company also recognized a gain of $0.3 million ($0.2 million after tax) on the sale of a small Hygiene Services business in its International operations.

 

6. BALANCE SHEET INFORMATION

 

December 31 (thousands)

 

2006

 

2005

 

Accounts Receivable, Net

 

 

 

 

 

Accounts receivable

 

$

905,160

 

$

782,371

 

Allowance for doubtful accounts

 

(37,619

)

(38,851

)

Total

 

$

867,541

 

$

743,520

 

Inventories

 

 

 

 

 

Finished goods

 

$

199,516

 

$

177,574

 

Raw materials and parts

 

180,619

 

161,488

 

Excess of fifo cost over lifo cost

 

(15,249

)

(13,488

)

Total

 

$

364,886

 

$

325,574

 

Property, Plant and Equipment, Net

 

 

 

 

 

Land

 

$

30,851

 

$

32,164

 

Buildings and leaseholds

 

306,775

 

283,487

 

Machinery and equipment

 

630,821

 

617,408

 

Merchandising equipment

 

1,204,716

 

1,072,853

 

Capitalized software

 

72,904

 

68,062

 

Construction in progress

 

72,139

 

42,244

 

 

 

2,318,206

 

2,116,218

 

Accumulated depreciation

 

(1,366,637

)

(1,248,165

)

Total

 

$

951,569

 

$

868,053

 

Other Intangible Assets, Net

 

 

 

 

 

Cost

 

 

 

 

 

Customer relationships

 

$

217,423

 

$

176,778

 

Intellectual property

 

45,569

 

41,887

 

Trademarks

 

73,216

 

63,933

 

Other intangibles

 

11,624

 

7,459

 

 

 

347,832

 

290,057

 

Accumulated amortization

 

 

 

 

 

Customer relationships

 

(80,153

)

(55,328

)

Intellectual property

 

(17,254

)

(9,901

)

Trademarks

 

(23,542

)

(16,523

)

Other intangibles

 

(3,096

)

(5,369

)

Total

 

$

223,787

 

$

202,936

 

Other Assets, Net

 

 

 

 

 

Deferred income taxes

 

$

176,184

 

$

42,618

 

Pension

 

37,591

 

201,078

 

Sole supply fees

 

67,423

 

61,632

 

Other

 

73,325

 

61,626

 

Total

 

$

354,523

 

$

366,954

 

Short-Term Debt

 

 

 

 

 

Notes payable

 

$

109,100

 

$

146,725

 

Long-term debt, current maturities

 

399,878

 

80,202

 

Total

 

$

508,978

 

$

226,927

 

Other Current Liabilities

 

 

 

 

 

Discounts and rebates

 

$

190,434

 

$

152,774

 

Dividends payable

 

28,930

 

25,526

 

Other

 

173,146

 

182,781

 

Total

 

$

392,510

 

$

361,081

 

Long-Term Debt

 

 

 

 

 

4.355% series A senior notes, due 2013

 

$

165,062

 

$

 

4.585% series B senior notes, due 2016

 

231,088

 

 

6.875% notes, due 2011

 

149,356

 

149,356

 

5.375% euronotes, due 2007

 

397,415

 

355,246

 

7.19% senior notes, due 2006

 

 

74,673

 

Other

 

14,015

 

20,301

 

 

 

956,936

 

599,576

 

Long-term debt, current maturities

 

(399,878

)

(80,202

)

Total

 

$

557,058

 

$

519,374

 

Other Liabilities

 

 

 

 

 

Deferred income taxes

 

$

92,478

 

$

80,760

 

Income taxes payable — noncurrent

 

66,202

 

43,695

 

Other

 

100,422

 

82,184

 

Total

 

$

259,102

 

$

206,639

 

 

35




The company has a $450 million multicurrency credit agreement with a consortium of banks that has a term through June 1, 2011. Under certain circumstances, this credit agreement can be increased by $150 million for a total of $600 million. The company may borrow varying amounts in different currencies from time to time on a revolving credit basis. The company has the option of borrowing based on various short-term interest rates. Effective June 1, 2006, the credit agreement was amended and restated by, among other things, deleting the financial covenant regarding total debt to capitalization, increasing the lien basket from $75 million to $100 million and extending the term of the agreement from August 2009 to June 2011. No amounts were outstanding under this agreement at year-end 2006 and 2005.

 

The multicurrency credit agreement supports the company’s $450 million U.S. commercial paper program and its $200 million European commercial paper program. The company had $30.3 million in outstanding U.S. commercial paper at December 31, 2006, with an average annual interest rate of 5.3 percent. There was no U.S. commercial paper outstanding at December 31, 2005. The company had $88.2 million in outstanding European commercial paper at December 31, 2005, with an average annual interest rate of 2.4 percent. The company had no commercial paper outstanding under its European commercial paper program at December 31, 2006. Both programs were rated A-1 by Standard & Poor’s and P-1 by Moody’s as of December 31, 2006.

 

In December 2006, the company issued and sold in a private placement 300 million euro ($396 million as of December 31, 2006) aggregate principal amount of the company’s senior notes in two series: 4.355% Series A Senior Notes due 2013 in the aggregate principal amount of 125 million euro and 4.585% Series B Senior Notes due 2016 in the aggregate principal amount of 175 million euro, pursuant to a Note Purchase Agreement dated July 26, 2006, between the company and the purchasers. The company used the proceeds to repay its euro 300 million ($396 million as of December 31, 2006) 5.375 percent euronotes which became due in February 2007.

 

In January 2006, the company repaid the $75 million 7.19% senior notes which were due January 2006.

As of December 31, the weighted-average interest rate on notes payable was 6.0 percent in 2006, 3.9 percent in 2005 and 5.7 percent in 2004.

 

As of December 31, 2006, the aggregate annual maturities of long-term debt for the next five years were:

 

thousands

 

 

2007

 

$399,878

 

2008

 

2,830

 

2009

 

1,645

 

2010

 

1,277

 

2011

 

150,711

 

 

7. INTEREST

 

Interest expense was $51.3 million in 2006, $49.8 million in 2005 and $48.5 million in 2004. Interest income was $6.9 million in 2006, $5.6 million in 2005 and $3.2 million in 2004. Total interest paid was $50.6 million in 2006, $49.4 million in 2005 and $47.0 million in 2004.

 

8. FINANCIAL INSTRUMENTS

 

FOREIGN CURRENCY FORWARD CONTRACTS

 

The company has entered into foreign currency forward contracts to hedge transactions related to intercompany debt, subsidiary royalties, product purchases, firm commitments and other intercompany transactions. The company uses these contracts to hedge against the effect of foreign currency exchange rate fluctuations on forecasted cash flows. These contracts generally relate to the company’s European operations and are denominated in euros. The company had foreign currency forward exchange contracts that totaled approximately $375 million at December 31, 2006, $395 million at December 31, 2005 and $239 million at December 31, 2004. These contracts generally expire within one year. The gains and losses related to these contracts were included as a component of other comprehensive income until the hedged item is reflected in earnings. As of December 31, 2006, other comprehensive income includes a cumulative loss of $1.3 million related to these contracts.

 

INTEREST RATE SWAP AGREEMENTS

 

The company enters into interest rate swap agreements to manage interest rate exposures and to achieve a desired proportion of variable and fixed rate debt.

 

In May 2006, the company entered into two forward starting interest rate swap agreements in connection with the senior note private placement offering that convert euro 250 million (euro 125 million due December 2013 and euro 125 million due December 2016) of the private placement funding from a variable interest rate to a fixed interest rate. The interest rate swap agreements were designated as, and effective as a cash flow hedge of the private placement offering. In June 2006 the company closed the swap agreements. The decline in fair value of $2.1 million, net of tax, was recorded in other comprehensive income and will be recognized in earnings as part of interest expense as the forecasted transactions occur.

 

During 2002, the company entered into an interest rate swap agreement in connection with the issuance of its euronotes. This agreement converts approximately euro 78 million (approximately $103 million at year-end 2006) of the euronote debt from a fixed interest rate to a floating or variable interest rate and is effective until February 2007. This interest rate swap was designated as a fair value hedge and had a value of $1.7 million, $4.0 million and $7.0 million as of December 31, 2006, 2005 and 2004, respectively. The mark to market gain on this agreement has been recorded as part of interest expense and has been offset by the loss recorded in interest expense on the mark to market on this portion of the euronotes. There is no hedge ineffectiveness on this interest rate swap.

 

NET INVESTMENT HEDGES

 

The company designated all euro 300 million euronote debt as a hedge of existing foreign currency exposures related to net investments the company has in certain European subsidiaries. Accordingly, the transaction gains and losses that are designated and effective as hedges of the company’s net investments have been included as a component of the cumulative translation account within accumulated other comprehensive income (loss). Total transaction gains and losses related to the euronotes and charged to this shareholders’ equity account were a loss of $44.8 million in 2006, a gain of $45.7 million for 2005 and a loss of $39.6 million for 2004.

36




CREDIT RISK

 

The company is exposed to credit loss in the event of nonperformance of counterparties for foreign currency forward exchange contracts and interest rate swap agreements. The company monitors its exposure to credit risk by using credit approvals and credit limits and selecting major international banks and financial institutions as counterparties. The company does not anticipate nonperformance by any of these counterparties.

 

FAIR VALUE OF OTHER FINANCIAL INSTRUMENTS

 

The carrying amount and the estimated fair value of other financial instruments held by the company were:

 

December 31 (thousands)

 

2006

 

2005

 

 

 

 

 

 

 

Carrying amount

 

 

 

 

 

Cash and cash equivalents

 

$

484,029

 

$

104,378

 

Short-term investments

 

 

 

125,063

 

Accounts receivable

 

867,541

 

743,520

 

Notes payable

 

78,850

 

58,525

 

Commercial paper

 

30,250

 

88,200

 

Long-term debt (including current maturities)

 

956,936

 

599,576

 

Fair value

 

 

 

 

 

Long-term debt (including current maturities)

 

$

967,020

 

$

623,040

 

 

The carrying amounts of cash equivalents, short-term investments, accounts receivable, notes payable and commercial paper approximate fair value because of their short maturities.

 

The fair value of long-term debt is based on quoted market prices for the same or similar debt instruments.

 

9. SHAREHOLDERS’ EQUITY

 

Authorized common stock, par value $1.00 per share, was 400 million shares in 2006, 2005 and 2004. Treasury stock is stated at cost. Dividends declared per share of common stock were $0.4150 for 2006, $0.3625 for 2005 and $0.3275 for 2004.

 

The company has 15 million shares, without par value, of authorized but unissued preferred stock. Of these 15 million shares, 0.4 million shares were designated as Series A Junior Participating Preferred Stock and 14.6 million shares were undesignated.

 

In February 2006, the company’s Board of Directors authorized the renewal of the company’s shareholder rights plan. Under the company’s renewed shareholder rights plan, one preferred stock purchase right is issued for each outstanding share of the company’s common stock. A right entitles the holder, upon occurrence of certain events, to buy one one-thousandth of a share of Series A Junior Participating Preferred Stock at a purchase price of $135, subject to adjustment. The rights, however, do not become exercisable unless and until, among other things, any person or group acquires 15 percent or more of the outstanding common stock of the company, or the company’s board of directors declares a holder of 10 percent or more of the outstanding common stock to be an “adverse person” as defined in the rights plan. Upon the occurrence of either of these events, the rights will become exercisable for common stock of the company (or in certain cases common stock of an acquiring company) having a market value of twice the exercise price of a right. The rights provide that the holdings by Henkel KGaA or its affiliates at the time of the renewal of the rights plan, subject to compliance by Henkel with certain conditions, will not cause the rights to become exercisable nor cause Henkel to be an “adverse person.” The rights are redeemable under certain circumstances at one cent per right and, unless redeemed earlier, will expire on March 10, 2016.

 

The company reacquired 6,875,400 shares of its common stock in 2006, 5,974,300 shares in 2005 and 4,581,400 shares in 2004 through open and private market purchases. The company also reacquired 128,544 shares, 337,947 shares and 777,607 shares of its common stock in 2006, 2005 and 2004, respectively, related to the exercise of stock options and the vesting of stock awards. In December 2004, the company’s Board of Directors authorized the repurchase of up to 10 million shares of the company’s common stock, including shares to be repurchased under Rule 10b5-1. In October 2006, the company’s Board of Directors authorized the repurchase of up to 10 million additional shares of common stock, including shares to be repurchased under Rule 10b5-1. Shares are repurchased to offset the dilutive effect of stock options and incentives and for general corporate purposes. As of December 31, 2006, 12,926,000 shares remained to be purchased under the company’s repurchase authority. The company intends to repurchase all shares under this authorization, for which no expiration date has been established, in open market or privately negotiated transactions, subject to market conditions. The company expects to repurchase at least enough shares during 2007 to offset the dilutive effect of stock options, based on estimates of stock option exercises for 2007. Cash proceeds from the exercises as well as the tax benefits will provide a portion of the funding for this repurchase activity.

 

10. STOCK INCENTIVE AND OPTION PLANS

 

The company’s stock incentive and option plans provide for grants of stock options, stock awards and other incentives. Common shares available for grant as of December 31 were 11,689,435 for 2006, 12,748,989 for 2005 and 4,216,012 for 2004. Common shares available for grant reflect 12 million shares approved by shareholders in 2005 for issuance under the plans.

 

Almost all of the awards granted are non-qualified stock options granted to employees that vest annually in equal amounts over a three year service period. Options are granted to purchase shares of the company’s stock at the average daily share price on the date of grant. These options generally expire within ten years from the grant date. The company recognizes compensation expense for these awards on a straight-line basis over the three year vesting period, in accordance with SFAS 123R. Upon adoption of SFAS 123R, new stock option grants to retirement eligible recipients are attributed to expense using the non-substantive vesting method.

 

37




A summary of stock option activity and average exercise prices is as follows:

 

SHARES

 

2006

 

2005

 

2004

 

Granted

 

2,669,223

 

3,862,966

 

4,876,408

 

Exercised

 

(4,215,387

)

(2,878,612

)

(3,625,117

)

Canceled

 

(368,984

)

(148,568

)

(386,512

)

December 31:

 

 

 

 

 

 

 

Outstanding

 

21,653,143

 

23,568,291

 

22,732,505

 

Exercisable

 

15,804,403

 

16,461,958

 

15,332,623

 

 

AVERAGE 
PRICE PER SHARE

 

2006

 

2005

 

2004

 

Granted

 

$

44.93

 

$

33.93

 

$

33.49

 

Exercised

 

21.57

 

17.27

 

16.55

 

Canceled

 

33.36

 

29.03

 

24.81

 

December 31:

 

 

 

 

 

 

 

Outstanding

 

29.74

 

26.61

 

24.20

 

Exercisable

 

26.36

 

23.87

 

21.31

 

 

The total intrinsic value of options (the amount by which the stock price exceeded the exercise price of the option on the date of exercise) that were exercised during 2006, 2005 and 2004 was $80.2 million, $45.3 million and $53.8 million, respectively.

 

Information related to stock options outstanding and stock options exercisable as of December 31, 2006, is as follows:

 

OPTIONS OUTSTANDING

 

RANGE OF

 

 

 

WEIGHTED-
AVERAGE

 

WEIGHTED-
AVERAGE

 

EXERCISE

 

OPTIONS

 

REMAINING

 

EXERCISE

 

PRICES

 

OUTSTANDING

 

CONTRACTURAL LIFE

 

PRICE

 

$10.95-19.27

 

3,542,308

 

4.0 years

 

$

18.62

 

$19.72-24.90

 

3,880,787

 

5.4 years

 

23.67

 

$25.21-30.58

 

4,119,915

 

7.0 years

 

27.52

 

$31.29-34.08

 

4,374,642

 

8.7 years

 

33.86

 

$34.26-34.50

 

3,049,590

 

7.9 years

 

34.50

 

$35.26-46.05

 

2,685,633

 

9.9 years

 

44.92

 

$93.42*

 

268

 

0.8 years

 

93.42

 

 

 

21,653,143

 

 

 

 

 

*                     Includes 268 shares of Ecolab’s common stock subject to stock options which Ecolab assumed in connection with the acquisition of Alcide Corporation in June 2004.

 

 

 

OPTIONS EXERCISABLE

 

RANGE OF

 

 

 

WEIGHTED-
AVERAGE

 

WEIGHTED-
AVERAGE

 

EXERCISE

 

OPTIONS

 

REMAINING

 

EXERCISE

 

PRICES

 

EXERCISABLE

 

CONTRACTURAL LIFE

 

PRICE

 

$10.95-19.27

 

3,542,308

 

4.0 years

 

$

18.62

 

$19.72-24.90

 

3,880,787

 

5.4 years

 

23.67

 

$25.21-30.58

 

4,054,239

 

7.0 years

 

27.49

 

$31.29-34.08

 

2,145,597

 

8.5 years

 

33.68

 

$34.26-34.50

 

2,031,021

 

7.9 years

 

34.50

 

$35.26-46.05

 

150,183

 

9.4 years

 

41.08

 

$93.42*

 

268

 

0.8 years

 

93.42

 

 

 

15,804,403

 

 

 

 

 

*                     Includes 268 shares of Ecolab’s common stock subject to stock options which Ecolab assumed in connection with the acquisition of Alcide Corporation in June 2004.

The total aggregate intrinsic value of options outstanding and options exercisable as of December 31, 2006 was $336.7 million and $299.1 million, respectively.

 

The lattice (binomial) option-pricing model was used to estimate the fair value of options at grant date beginning in the fourth quarter of 2005. The company’s primary employee option grant occurs during the fourth quarter. Prior to adoption of SFAS 123R, the Black-Scholes option-pricing model was used. The weighted-average grant-date fair value of options granted in 2006, 2005 and 2004, and the significant assumptions used in determining the underlying fair value of each option grant, on the date of grant were as follows:

 

 

 

2006

 

2005

 

2004

 

 

 

 

 

 

 

 

 

Weighted-average grant-date fair value of options granted at market prices

 

$12.92

 

$9.35

 

$9.45

 

 

 

 

 

 

 

 

 

Assumptions

 

 

 

 

 

 

 

Risk-free rate of return

 

4.5

%

4.4

%

3.8

%

Expected life

 

6 years

 

6 years

 

6 years*

 

Expected volatility

 

24.4

%

24.3

%

25.5

%

Expected dividend yield

 

1.0

%

1.2

%

1.0

%

 

*                     During 2004 significant reload options were also granted with a weighted-average expected life of 3.5 years.

 

The risk-free rate of return is determined based on a yield curve of U.S. treasury rates from one month to ten years and a period commensurate with the expected life of the options granted. Expected volatility is established based on historical volatility of the company’s stock price. The expected dividend yield is determined based on the company’s annual dividend amount as a percentage of the average stock price at the time of the grant.

 

The expense associated with shares of restricted stock issued under the company’s stock incentive plans is based on the market price of the company’s stock at the date of grant and is amortized on a straight-line basis over the periods during which the restrictions lapse. The company currently has restricted stock outstanding that vests over periods between 12 and 36 months. Stock awards are not performance based and vest with continued employment. Stock awards are subject to forfeiture in the event of termination of employment. The company granted 14,845 shares in 2006, 11,479 shares in 2005 and 13,550 shares in 2004 under its restricted stock award program.

38




A summary of non-vested stock option and stock award activity is as follows:

 

NON-VESTED STOCK OPTIONS AND STOCK AWARDS

 

 

 

 

 

WEIGHTED-

 

 

 

WEIGHTED-

 

 

 

 

 

AVERAGE

 

 

 

AVERAGE

 

 

 

 

 

FAIR VALUE

 

 

 

FAIR VALUE

 

 

 

STOCK

 

AT GRANT

 

STOCK

 

AT GRANT

 

 

 

OPTIONS

 

DATE

 

AWARDS

 

DATE

 

December 31, 2005

 

7,106,333

 

$

9.37

 

22,175

 

$

32.53

 

Granted

 

2,669,223

 

12.92

 

14,845

 

44.46

 

Vested/Earned

 

(3,537,235

)

9.16

 

(10,350

)

32.85

 

Cancelled

 

(389,581

)

9.27

 

(2,000

)

36.57

 

December 31, 2006

 

5,848,740

 

$

11.13

 

24,670

 

$

39.25

 

 

Total compensation expense related to share-based compensation plans was $36.3 million, ($23.1 million net of tax benefit), $39.1 million, ($24.7 million net of tax benefit) and $44.7 million, ($28.1 million net of tax benefit) during 2006, 2005 and 2004, respectively.

 

As of December 31, 2006, there was $54.0 million of total measured but unrecognized compensation expense related to non-vested share-based compensation arrangements granted under our plans. That cost is expected to be recognized over a weighted-average period of 1.9 years.

 

Total cash received from the exercise of share-based instruments in 2006 was $87.9 million.

 

The company generally issues authorized but previously unissued shares to satisfy stock option exercises. The company has a policy of repurchasing shares on the open market to offset the dilutive effect of stock options, as discussed in Note 9.

 

11. INCOME TAXES

 

Income before income taxes consisted of:

 

THOUSANDS

 

2006

 

2005

 

2004

 

Domestic

 

$

321,117

 

$

278,795

 

$

238,307

 

Foreign

 

246,107

 

219,387

 

206,239

 

Total

 

$

567,224

 

$

498,182

 

$

444,546

 

 

The provision for income taxes consisted of:

 

THOUSANDS

 

2006

 

2005

 

2004

 

Federal and state

 

$

143,647

 

$

121,409

 

$

79,830

 

Foreign

 

73,768

 

70,313

 

67,681

 

Currently payable

 

217,415

 

191,722

 

147,511

 

 

 

 

 

 

 

 

 

Federal and state

 

(15,847

)

(8,901

)

13,470

 

Foreign

 

(2,959

)

(4,120

)

872

 

Deferred

 

(18,806

)

(13,021

)

14,342

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

$

198,609

 

$

178,701

 

$

161,853

 

 

The company’s overall net deferred tax assets and deferred tax liabilities were comprised of the following:

 

DECEMBER 31 (THOUSANDS)

 

2006

 

2005

 

Deferred tax assets

 

 

 

 

 

Other accrued liabilities

 

$

56,979

 

$

49,257

 

Loss carryforwards

 

6,256

 

6,538

 

Share-based compensation

 

47,253

 

45,718

 

Other comprehensive income

 

163,092

 

42,028

 

Other, net

 

36,457

 

24,739

 

Valuation allowance

 

(376

)

(2,711

)

Total

 

309,661

 

165,569

 

Deferred tax liabilities

 

 

 

 

 

Postretirement health care and pension benefits

 

7,787

 

3,217

 

Property, plant and equipment basis differences

 

37,785

 

61,489

 

Intangible assets

 

95,516

 

73,853

 

Other, net

 

3,484

 

2,631

 

Total

 

144,572

 

141,190

 

Net deferred tax assets

 

$

165,089

 

$

24,379

 

 

A reconciliation of the statutory U.S. federal income tax rate to the company’s effective income tax rate was:

 

 

 

2006

 

2005

 

2004

 

Statutory U.S. rate

 

35.0

%

35.0

%

35.0

%

State income taxes, net of federal benefit

 

2.3

 

2.3

 

2.4

 

Foreign operations

 

(1.8

)

(2.0

)

(0.9

)

Reinvested earnings in U.S. under the American Jobs Creation Act

 

 

 

0.6

 

 

 

Other, net

 

(0.5

)

 

 

(0.1

)

Effective income tax rate

 

35.0

%

35.9

%

36.4

%

 

Cash paid for income taxes was approximately $182 million in 2006, $165 million in 2005 and $163 million in 2004.

 

As of December 31, 2006, the company had undistributed earnings of international affiliates of approximately $607 million. These earnings are considered to be reinvested indefinitely or available for distribution with foreign tax credits available to offset the amount of applicable income tax and foreign withholding taxes that might be payable on earnings. It is impractical to determine the amount of incremental taxes that might arise if all undistributed earnings were distributed.

 

On October 22, 2004, the President signed the American Jobs Creation Act of 2004 (the “Act”). The Act provides a deduction for income from qualified domestic production activities, which will be phased in from 2005 through 2010. In return, the Act also provides for a two-year phase-out of the existing extra-territorial income exclusion (ETI) for foreign sales that was viewed to be inconsistent with international trade protocols by the European Union.

 

Under the guidance in FASB Staff Position No. 109-1, “Application of FASB Statement No. 109, Accounting for Income Taxes, to the Tax Deduction on Qualified Production Activities Provided by the American Jobs Creation Act of 2004”, the deduction will be treated as a “special deduction” as described in SFAS No. 109. As such, the special deduction has no effect on deferred tax assets

39




and liabilities existing at the enactment date. Rather, the impact of this deduction is reported in the period in which the deduction is claimed on the company’s tax return. The company recorded a modest benefit in both 2006 and 2005 from this deduction.

 

The Act also creates a temporary incentive for U.S. corporations to repatriate accumulated income earned abroad by providing an 85 percent dividends received deduction for certain dividends from controlled foreign corporations. In the fourth quarter of 2005 the company approved a plan for the reinvestment of foreign earnings in the U.S. pursuant to the provisions of the Act. The company repatriated $223 million of foreign earnings into the U.S. As a result of completing the repatriation, the company recorded tax expense of approximately $3.1 million, net of available foreign tax credits, in the fourth quarter of 2005.

 

12. RENTALS AND LEASES

 

The company leases sales and administrative office facilities, distribution center facilities, automobiles, computers and other equipment under operating leases. Rental expense under all operating leases was $104.3 million in 2006, $97.3 million in 2005 and $86.6 million in 2004. As of December 31, 2006, future minimum payments under operating leases with noncancelable terms in excess of one year were:

 

thousands

 

 

2007

 

$44,000

 

2008

 

33,000

 

2009

 

24,000

 

2010

 

17,000

 

2011

 

11,000

 

Thereafter

 

13,000

 

Total

 

$142,000

 

 

The company enters into operating leases for vehicles whose noncancelable terms are one year or less in duration with month-to-month renewal options. These leases have been excluded from the table above. The company estimates payments under such leases will approximate $51 million in 2007. These automobile leases have guaranteed residual values that have historically been satisfied primarily by the proceeds on the sale of the vehicles. No estimated losses have been recorded for these guarantees as the company believes, based upon the results of previous leasing arrangements, that the potential recovery of value from the vehicles when sold will be greater than the residual value guarantee.

 

13. RESEARCH EXPENDITURES

 

Research expenditures that related to the development of new products and processes, including significant improvements and refinements to existing products are expensed as incurred. Such costs were $73.3 million in 2006, $68.4 million in 2005 and $61.5 million in 2004.

 

14. COMMITMENTS AND CONTINGENCIES

 

The company and certain subsidiaries are party to various lawsuits, claims and environmental actions that have arisen in the ordinary course of business. These include possible obligations to investigate and mitigate the effects on the environment of the disposal or release of certain chemical substances at various sites, such as Superfund sites and other operating or closed facilities. The effect of all actions on the company’s financial position, results of operations and cash flows to date has not been material. The company is currently participating in environmental assessments and remediation at a number of locations and environmental liabilities have been accrued reflecting management’s best estimate of future costs. The accrual for environmental remediation costs was $4.9 million and $4.3 million at December 31, 2006 and 2005, respectively. Potential insurance reimbursements are not anticipated in the company’s accruals for environmental liabilities.

 

The company is self-insured in North America for most workers compensation, general liability and automotive liability losses subject to per occurrence and aggregate annual liability limitations. The company is insured for losses in excess of these limitations. The company has recorded both a liability and an offsetting receivable for amounts in excess of these limitations. The company is self-insured for health care claims for eligible participating employees subject to certain deductibles and limitations. The company determines its liability for claims incurred but not reported on an actuarial basis. While the final resolution of these contingencies could result in expenses different than current accruals, and therefore have an impact on the company’s consolidated financial results in a future reporting period, management believes the ultimate outcome will not have a significant effect on the company’s consolidated results of operations, financial position or cash flows.

 

15. RETIREMENT PLANS

 

PENSION AND POSTRETIREMENT HEALTH CARE BENEFITS PLANS

 

The company has a noncontributory defined benefit pension plan covering most of its U.S. employees. Effective January 1, 2003, the U.S. pension plan was amended to provide a cash balance type pension benefit to employees hired on or after the effective date. For employees hired prior to January 1, 2003, plan benefits are based on years of service and highest average compensation for five consecutive years of employment. For employees hired after December 31, 2002, plan benefits are based on contribution credits equal to a fixed percentage of their current salary and interest credits. The company also has U.S. noncontributory non-qualified defined benefit plans, which provide for benefits to employees in excess of limits permitted under its U.S. pension plan. The measurement date used for determining the U.S. pension plan assets and obligations is December 31. Various international subsidiaries also have defined benefit pension plans. The measurement date used for determining the international pension plan assets and obligations is November 30, the fiscal year-end of the company’s international affiliates. The information following includes all of the company’s international defined benefit pension plans.

 

The company provides postretirement health care benefits to certain U.S. employees. The plan is contributory based on years of service and family status, with retiree contributions adjusted annually. The measurement date used to determine the U.S. postretirement healthcare plan assets and obligations is December 31. Certain employees outside the U.S. are covered under government-sponsored programs, which are not required to be fully funded. The expense and obligation for providing international postretirement healthcare benefits is not significant.

40




Effective December 31, 2006, the company prospectively adopted Statement of Financial Accounting Standards No. 158, “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans — An Amendment of FASB Statements No. 87, 88, 106 and 132(R) (“SFAS 158”). As a result of the adoption of SFAS 158, the company has recorded a cumulative effect adjustment as a component of other comprehensive income within shareholders’ equity. The company’s disclosures for the fiscal year ended 2006 also reflect the revised accounting and disclosure requirements of SFAS 158. Reported items for fiscal years 2005 and 2004 were not affected.

 

The adoption of SFAS 158 on December 31, 2006 resulted in incremental adjustments to the following individual line items in the consolidated balance sheet:

 

 

 

Before

 

 

 

After

 

 

 

Application of

 

 

 

Application of

 

thousands

 

SFAS 158

 

Adjustments

 

SFAS 158

 

Deferred income taxes

 

$

86,084

 

$

786

 

$

86,870

 

Other assets, net*

 

456,833

 

(102,310

)

354,523

 

Total assets

 

4,520,889

 

(101,524

)

4,419,365

 

Compensation and benefits

 

244,172

 

8,514

 

252,686

 

Postretirement health care and pension benefit liabilities

 

338,990

 

81,255

 

420,245

 

Other liabilities**

 

282,312

 

(23,210

)

259,102

 

Shareholders’ equity

 

1,848,313

 

(168,083

)

1,680,230

 

Total liabilities and shareholders’ equity

 

4,520,889

 

(101,524

)

4,419,365

 

 

*          The adjustment to “Other assets, net” represents the net effect of an adjustment of $(179,046) to the company’s net pension assets, an adjustment of $99,946 for the recognition of deferred taxes and the reclassification of deferred tax liabilities of $(23,210) from the application of SFAS 158.

**   The adjustment to the “Other liabilities” represents the recognition and reclassification of deferred taxes from the application of SFAS 158.

 

A reconciliation of changes in the benefit obligations and fair value of assets of the company’s plan as follows:

 

 

 

U.S. Pension Benefits
(Qualified and
Non Qualified Plans)

 

International
Pension Benefits

 

U.S. Postretirement
Health Care Benefits

 

thousands

 

2006

 

2005

 

2006

 

2005

 

2006

 

2005

 

Benefit obligation, beginning of year

 

$

785,664

 

$

709,676

 

$

402,317

 

$

372,045

 

$

165,358

 

$

158,030

 

Service cost

 

40,635

 

40,646

 

18,899

 

14,970

 

3,113

 

3,085

 

Interest cost

 

43,611

 

40,174

 

18,995

 

18,307

 

8,992

 

8,860

 

Participant contributions

 

 

 

 

 

2,336

 

2,539

 

2,675

 

2,467

 

Divestitures

 

 

 

 

 

 

 

(58

)

 

 

 

 

Plan amendments, settlements and curtailments

 

1,175

 

 

 

(2,159

)

18

 

127

 

(3,566

)

Actuarial loss (gain)

 

(15,076

)

17,482

 

8,375

 

48,342

 

1,276

 

7,535

 

Benefits paid

 

(22,199

)

(22,314

)

(19,629

)

(14,622

)

(12,183

)

(11,053

)

Foreign currency translation

 

 

 

 

 

48,806

 

(39,224

)

 

 

 

 

Benefit obligation, end of year

 

$

833,810

 

$

785,664

 

$

477,940

 

$

402,317

 

$

169,358

 

$

165,358

 

 

 

 

 

U.S. PENSION BENEFITS
(QUALIFIED AND
NON QUALIFIED PLANS)

 

INTERNATIONAL
PENSION BENEFITS

 

U.S. POSTRETIREMENT
HEALTH CARE BENEFITS

 

THOUSANDS

 

2006

 

2005

 

2006

 

2005

 

2006

 

2005

 

Fair value of plan assets, beginning of year

 

$

679,209

 

$

618,133

 

$

220,143

 

$

201,482

 

$

25,224

 

$

21,740

 

Actual gains on plan assets

 

89,974

 

42,171

 

22,245

 

23,126

 

3,610

 

1,499

 

Company contributions

 

46,416

 

41,219

 

18,873

 

27,273

 

12,176

 

10,571

 

Participant contributions

 

 

 

 

 

2,336

 

2,539

 

1,388

 

2,467

 

Settlements

 

 

 

 

 

(315

)

 

 

 

 

 

 

Benefits paid

 

(22,199

)

(22,314

)

(19,629

)

(14,622

)

(12,183

)

(11,053

)

Foreign currency translation

 

 

 

 

 

25,987

 

(19,655

)

 

 

 

 

Fair value of plan assets, end of year

 

$

793,400

 

$

679,209

 

$

269,640

 

$

220,143

 

$

30,215

 

$

25,224

 

 

41




A reconciliation of the funded status for the pension and postretirement plans to the net amount recognized is as follows:

 

 

 

U.S. PENSION BENEFITS
(QUALIFIED AND
NON QUALIFIED PLANS)

 

INTERNATIONAL
PENSION BENEFITS

 

U.S. POSTRETIREMENT
HEALTH CARE BENEFITS

 

THOUSANDS

 

2006

 

2005

 

2006

 

2005

 

2006

 

2005

 

Funded status

 

$

(40,410

)

$

(106,455

)

$

(208,300

)

$

(182,174

)

$

(139,143

)

$

(140,134

)

Unrecognized actuarial loss

 

 

 

248,451

 

 

 

82,672

 

 

 

58,539

 

Unrecognized prior service cost (benefit)

 

 

 

6,978

 

 

 

1,425

 

 

 

(25,981

)

Unrecognized net transition (asset) obligation

 

 

 

 

 

 

 

(21

)

 

 

 

 

Net amount recognized

 

$

(40,410

)

$

148,974

 

$

(208,300

)

$

(98,098

)

$

(139,143

)

$

(107,576

)

 

The total amounts recognized in the balance sheet, including accumulated other comprehensive income, and the accumulated benefit obligation are as follows:

 

 

 

U.S. PENSION BENEFITS
(QUALIFIED AND
NON QUALIFIED PLANS)

 

INTERNATIONAL
PENSION BENEFITS

 

U.S. POSTRETIREMENT
HEALTH CARE BENEFITS

 

THOUSANDS

 

2006

 

2005

 

2006

 

2005

 

2006

 

2005

 

Noncurrent benefit asset

 

$

13,591

 

$

174,063

 

$

24,000

 

$

27,015

 

 

 

 

 

Current benefit liability

 

(3,400

)

 

 

(6,484

)

 

 

$

(1,130

)

 

 

Noncurrent benefit liability

 

(50,601

)

(25,089

)

(225,816

)

(169,143

)

(138,013

)

$

(107,576

)

Intangible asset

 

 

 

 

 

 

 

1,211

 

 

 

 

 

Accumulated other comprehensive loss (pre-tax)

 

195,080

 

 

 

86,955

 

42,819

 

30,965

 

 

 

Total amount recognized

 

$

154,670

 

$

148,974

 

$

(121,345

)

$

(98,098

)

$

(108,178

)

$

(107,576

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated benefit obligation

 

$

687,708

 

$

627,917

 

$

330,751

 

$

358,837

 

$

169,358

 

$

165,358

 

 

Accumulated other comprehensive loss for pension and other postretirement benefit plan activity is as follows:

 

 

 

U.S. PENSION BENEFITS
(QUALIFIED AND NON
QUALIFIED PLANS)

 

INTERNATIONAL
PENSION BENEFITS

 

U.S. POSTRETIREMENT
HEALTH CARE BENEFITS

 

THOUSANDS

 

2006

 

2006

 

2006

 

Accumulated other comprehensive loss, beginning of year

 

$

 

$

27,117

 

$

 

Recognition of additional minimum pension liability

 

 

 

979

 

 

 

Cumulative effect adjustment of change in accounting — adoption of SFAS 158 to recognize funded status

 

195,080

 

43,157

 

30,965

 

Tax benefit

 

(75,569

)

(13,917

)

(11,995

)

Accumulated other comprehensive loss (income), end of year

 

$

119,511

 

$

57,336

 

$

18,970

 

 

The components of accumulated other comprehensive loss related to pension and postretirement benefit plans are as follows:

 

 

U.S. PENSION BENEFITS
(QUALIFIED AND NON
QUALIFIED PLANS)

 

INTERNATIONAL
PENSION BENEFITS

 

U.S. POSTRETIREMENT
HEALTH CARE BENEFITS

 

THOUSANDS

 

2006

 

2006

 

2006

 

Unrecognized net actuarial losses

 

$

188,924

 

$

87,248

 

$

50,384

 

Unrecognized net prior service costs (benefits)

 

6,156

 

(325

)

(19,419

)

Unrecognized net transition costs

 

 

 

32

 

 

 

Tax benefit

 

(75,569

)

(29,619

)

(11,995

)

Accumulated other comprehensive loss, end of year

 

119,511

 

57,336

 

18,970

 

 

 

42




Estimated amounts in accumulated other comprehensive income expected to be reclassified to net period cost during 2007 are as follows:

THOUSANDS

 

U.S. PENSION BENEFITS
(QUALIFIED AND NON
QUALIFIED PLANS)

 

INTERNATIONAL
PENSION BENEFITS

 

U.S. POSTRETIREMENT
HEALTH CARE BENEFITS

 

Net actuarial losses

 

$

13,021

 

$

3,048

 

$

7,354

 

Net prior service costs/(benefits)

 

2,008

 

21

 

(6,419

)

Net transition costs

 

 

4

 

 

Total

 

$

15,029

 

$

3,073

 

$

935

 

 

For certain international pension plans, the accumulated benefit obligations exceeded the fair value of plan assets. The company recognized an addition to the minimum pension liability in other comprehensive income of $1.0 million pre-tax ($0.6 million net of deferred tax asset) in 2006, $24.4 million pre-tax ($16.2 million net of deferred tax asset) during 2005 and $0.4 million pre-tax ($0.3 million net of deferred tax asset) during 2004. The additional minimum pension liability recognized prior to adoption of SFAS 158 was considered in determining the cumulative effect adjustment of adopting SFAS 158 as of December 31, 2006.

 

The aggregate projected benefit obligation, accumulated benefit obligation and fair value of plan assets for those U.S. nonqualified plans and international plans with accumulated benefit obligations in excess of plan assets were as follows:

 

 

DECEMBER 31

 

THOUSANDS

 

2006

 

2005

 

Aggregate projected benefit obligation

 

$

414,731

 

$

385,141

 

Accumulated benefit obligation

 

364,034

 

331,640

 

Fair value of plan assets

 

138,479

 

136,937

 

 

These plans relate to various international subsidiaries and the U.S. nonqualified plans and are funded consistent with local practices and requirements. As of December 31, 2006, there were approximately $17 million of future postretirement benefits covered by insurance contracts.

 

PLAN ASSETS
UNITED STATES

 

The company’s pension and postretirement health care benefits plans at December 31, 2006 and 2005 and target allocation for 2007 are as follows:

ASSET

 

2007
TARGET
ASSET
ALLOCATION

 

PERCENTAGE OF PLAN ASSETS

 

CATEGORY

 

PERCENTAGE

 

2006

 

2005

 

Large cap equity

 

43

%

 

43

%

 

43

%

 

Small cap equity

 

12

 

 

12

 

 

12

 

 

International equity

 

15

 

 

16

 

 

16

 

 

Fixed income

 

25

 

 

24

 

 

24

 

 

Real estate

 

  5

 

 

  5

 

 

  5

 

 

Total

 

100

%

 

100

%

 

100

%

 

 

The company’s U.S. investment strategy and policies are designed to maximize the possibility of having sufficient funds to meet the long-term liabilities of the pension fund, while achieving a balance between the goals of asset growth of the plan and keeping risk at a reasonable level. Current income is not a key goal of the plan. The pension and health care plans’ demographic characteristics generally reflect a younger plan population relative to an average pension plan. Therefore, the asset allocation position reflects the ability and willingness to accept relatively more short-term variability in the performance of the pension plan portfolio in exchange for the expectation of better long-term returns, lower pension costs and better funded status in the long run.

 

Since diversification is widely recognized as important to reduce unnecessary risk, the pension fund is diversified across a number of asset classes and securities. Selected individual portfolios within the asset classes may be undiversified while maintaining the diversified nature of total plan assets.

 

The company’s U.S. investment policies prohibit investing in letter stock, warrants and options, and engaging in short sales, margin transactions, private placements, or other specialized investment activities. The use of derivatives is also prohibited for the purpose of speculation or introducing leverage in the portfolio, circumventing the investment guidelines or taking risks that are inconsistent with the fund’s guidelines. Selected derivatives may only be used for hedging and transactional efficiency.

 

INTERNATIONAL

 

The company’s plan asset allocations for its international defined benefit pension plans at December 31, 2006 and 2005 are as follows:

ASSET

 

PERCENTAGE OF PLAN ASSETS

 

CATEGORY

 

2006

 

2005

 

Equity securities

 

40%

 

44%

 

Fixed income

 

46

 

45

 

Real estate

 

  5

 

  2

 

Other

 

  9

 

  9

 

Total

 

  100%

 

  100%

 

 

Assets of funded retirement plans outside the U.S. are managed in each local jurisdiction and asset allocation strategy is set in accordance with local rules, regulations and practice. Therefore, no target asset allocation for 2007 is presented. The funds are invested in a variety of stocks, fixed income and real estate investments and in some cases, the assets are managed by insurance companies which may offer a guaranteed rate of return. Total international pension plan assets represent 24 percent of total Ecolab pension plan assets worldwide.

43




AMENDMENTS

 

During 2004, the American Jobs Creation Act of 2004 (the “Act”) added a new Section 409A to the Internal Revenue Code (the “Code”) which significantly changed the federal tax law applicable to amounts deferred after December 31, 2004 under nonqualified deferred compensation plans. In response to this, the company amended the “Non-Employee Director Stock Option and Deferred Compensation Plan (“Director Plan”) and the Mirror Savings Plan in December 2004. The amendments (1) allow compensation that was “deferred” (as defined by the Act) prior to January 1, 2005 to qualify for “grandfathered” status and to continue to be governed by the law applicable to nonqualified deferred compensation prior to the addition of Internal Revenue Code Section 409A by the Act, and (2) cause deferred compensation that is deferred after December 31, 2004 to be in compliance with the requirements of Code Section 409A. For amounts deferred after December 31, 2004, the amendments generally (1) require that such amounts be distributed as a single lump sum payment as soon as practicable after the participant has had a separation of service, with the exception of payments to “key employees” (as defined by the Act) which lump sum payments are required to be held for 6 months after their separation from service, and (2) prohibit the acceleration of distribution of such amounts except for an unforeseeable emergency (as defined by the Act).

 

Additionally, in December 2004 the company amended the Supplemental Executive Retirement Plan (“SERP”) and the Mirror Pension Plan to (1) allow amounts deferred prior to January 1, 2005 to qualify for “grandfathered” status and to continue to be governed by the law applicable to nonqualified deferred compensation prior to the Act, and (2) temporarily freeze the accrual of benefits as of December 31, 2004 due to the uncertainty regarding the effect of the Act on such benefits. The Secretary of Treasury and the Internal Revenue Service are expected to issue regulations and/or other guidance with respect to the provisions of the new Act throughout 2007 and final amendments to comply with the Act are required by the end of 2007. The company currently intends to rescind the freeze, following issuance of regulations to ensure compliance for post-2004 benefit accruals.

 

CASH FLOWS

 

As of year-end 2006, the company’s estimate of benefits expected to be paid in each of the next five fiscal years, and in the aggregate for the five fiscal years thereafter for the company’s pension and postretirement health care benefit plans are as follows:

 

 

 

 

 

MEDICARE
SUBSIDY

 

THOUSANDS

 

ALL PLANS

 

RECEIPTS

 

2007

 

$

52,000

 

$

1,000

 

2008

 

59,000

 

1,000

 

2009

 

64,000

 

1,000

 

2010

 

66,000

 

1,000

 

2011

 

72,000

 

1,000

 

2012-2016

 

447,000

 

11,000

 

 

The company’s funding policy for the U.S. pension plan is to achieve and maintain a return on assets that meets the long-term funding requirements identified by the projections of the pension plan’s fiduciary responsibilities prescribed in ERISA. The company also takes into consideration the tax deductibility of contributions to the benefit plans. The company is not required to make any contributions to the U.S. pension and postretirement health care benefit plans in 2007. The company estimates contributions to be made to the international plans will approximate $20 million in 2007.

 

The company is not aware of any expected refunds of plan assets within the next 12 months from any of its existing U.S. or international pension or postretirement benefit plans.

 

NET PERIODIC BENEFIT COSTS

Pension and postretirement health care benefits expense for the company’s operations was:

 

 

 

U.S. PENSION BENEFITS
(QUALIFIED AND NON
QUALIFIED PLANS)

 

INTERNATIONAL
PENSION BENEFITS

 

U.S. POSTRETIREMENT
HEALTH CARE BENEFITS

 

THOUSANDS

 

2006

 

2005

 

2004

 

2006

 

2005

 

2004

 

2006

 

2005

 

2004

 

Service cost — employee benefits earned during the year

 

$

40,635

 

$

40,646

 

$

32,806

 

$

18,899

 

$

14,970

 

$

13,409

 

$

3,113

 

$

3,085

 

$

3,188

 

Interest cost on benefit obligation

 

43,611

 

40,174

 

36,401

 

18,995

 

18,307

 

17,830

 

8,992

 

8,860

 

9,041

 

Expected return on plan assets

 

(62,109

)

(53,114

)

(50,161

)

(13,192

)

(11,751

)

(11,403

)

(2,457

)

(1,770

)

(1,843

)

Recognition of net actuarial loss

 

16,586

 

11,183

 

6,547

 

3,059

 

1,597

 

1,458

 

8,278

 

5,734

 

5,706

 

Amortization of prior service cost (benefit)

 

1,997

 

1,906

 

2,026

 

45

 

162

 

426

 

(6,435

)

(5,660

)

(5,696

)

Amortization of net transition (asset) obligation

 

 

 

(702

)

(1,403

)

24

 

329

 

333

 

 

 

 

 

 

 

Curtailment (gain) loss

 

 

 

 

 

 

 

(170

)

(40

)

(51

)

 

 

 

 

 

 

Total expense

 

$

40,720

 

$

40,093

 

$

26,216

 

$

27,660

 

$

23,574

 

$

22,002

 

$

11,491

 

$

10,249

 

$

10,396

 

 

44




PLAN ASSUMPTIONS

 

 

U.S. PENSION BENEFITS

 

INTERNATIONAL
PENSION BENEFITS

 

U.S. POSTRETIREMENT
HEALTH CARE BENEFITS

 

 

 

2006

 

2005

 

2004

 

2006

 

2005

 

2004

 

2006

 

2005

 

2004

 

Weighted-average actuarial assumptions used to determine benefit obligations as of December 31:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Discount rate

 

5.79

%

5.57

%

5.75

%

4.65

%

4.54

%

5.22

%

5.79

%

5.57

%

5.75

%

Projected salary increase

 

4.32

 

4.30

 

4.30

 

3.27

 

3.15

 

3.13

 

 

 

 

 

 

 

Weighted-average actuarial assumptions used to determine net cost:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Discount rate

 

5.57

 

5.75

 

6.25

 

4.56

 

5.18

 

5.37

 

5.57

 

5.75

 

6.25

 

Expected return on plan assets

 

8.75

 

8.75

 

9.00

 

5.80

 

5.68

 

5.75

 

8.75

%

8.75

%

9.00

%

Projected salary increase

 

4.30

%

4.30

%

4.30

%

3.21

%

3.12

%

3.07

%

 

 

 

 

 

 

 

The expected long-term rate of return is generally based on the pension plan’s asset mix, assumptions of equity returns based on historical long-term returns on asset categories, expectations for inflation, and estimates of the impact of active management of the assets.

 

For postretirement benefit measurement purposes as of December 31, 2006, 10 percent (for pre-age 65 retirees) and 11 percent (for post-age 65 retirees) annual rates of increase in the per capita cost of covered health care were assumed. The rates were assumed to decrease by 1 percent each year until they reach 5 percent in 2012 for pre-age 65 retirees and 5 percent in 2013 for post-age 65 retirees and remain at those levels thereafter. Health care costs which are eligible for subsidy by the company are limited to a maximum 4 percent annual increase beginning in 1996 for certain employees.

 

Assumed health care cost trend rates have a significant effect on the amounts reported for the company’s U.S. postretirement health care benefits plan. A one-percentage point change in the assumed health care cost trend rates would have the following effects:

 

 

 

1-PERCENTAGE POINT

 

THOUSANDS

 

INCREASE

 

DECREASE

 

Effect on total of service and interest cost components

 

$

509

 

$

(453

)

Effect on postretirement benefit obligation

 

9,597

 

(8,531

)

 

The Medicare Prescription Drug, Improvement and Modernization Act of 2003 (the Act) introduces a prescription drug benefit under Medicare as well as a federal subsidy to sponsors of retiree health care benefit plans. The company’s U.S. postretirement health care benefits plan offers prescription drug benefits. The company amended its plan effective January 1, 2005 in order to obtain the benefits provided under the Act. In accordance with FSP No. 106-2 “Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003”, the company began recording favorable benefits of the Act in the third quarter of 2004, using the prospective transition method consistent with this guidance. The after-tax benefit for 2004 was approximately $1.0 million. The company recognized an actuarial gain and a reduction in its postretirement benefit obligation of $15.5 million at July 1, 2004 related to the Act.

 

SAVINGS PLAN AND ESOP

 

The company provides a 401(k) savings plan for substantially all U.S. employees. Employee before-tax contributions of up to 3 percent of eligible compensation are matched 100 percent by the company and employee before-tax contributions between 3 percent and 5 percent of eligible compensation are matched 50 percent by the company. The match is 100 percent vested immediately. Effective January 2003, the plan was amended to provide that all employee contributions which are invested in Ecolab stock will be part of the employee’s ESOP account while so invested. The company’s contributions are invested in Ecolab common stock and amounted to $18.9 million in 2006, $17.4 million in 2005 and $15.8 million in 2004. Effective January 1, 2006, the plan was amended to allow employees to immediately re-allocate company matching contributions in Ecolab common stock to other investment funds within the plan.

 

16. OPERATING SEGMENTS

 

The company’s thirteen operating segments have been aggregated into three reportable segments.

 

The “United States Cleaning & Sanitizing” reportable segment provides cleaning and sanitizing products to United States markets through its Institutional, Food & Beverage, Kay, Textile Care, Healthcare, Vehicle Care and Water Care Services operating segments. The company’s Professional Products operating segment has been combined with Institutional to leverage Institutional’s sales force, delivering the professional products line to customers in the hospitality, healthcare and commercial markets. These operating segments exhibit similar products, manufacturing processes, customers, distribution methods and economic characteristics.

 

The “United States Other Services” reportable segment includes all other U.S. operations of the company. This segment provides pest elimination and kitchen equipment repair and maintenance through its Pest Elimination and GCS Service operating segments. These two operating segments are primarily fee for service businesses. Since the primary focus of these segments is service, they have not been combined with the company’s “United States Cleaning & Sanitizing” reportable segment. These operating segments are combined and disclosed as an “all other” category in accordance with SFAS 131. Total service revenue for this segment was $334 million, $300 million and $269 million for 2006, 2005 and 2004, respectively.

 

45




The company’s “International” reportable segment includes four operating segments; Europe/Middle East/Africa (EMEA), Asia Pacific, Latin America and Canada. These segments provide cleaning and sanitizing products as well as pest elimination service. International operations are managed by geographic region and exhibit similar products, manufacturing processes, customers, distribution methods and economic characteristics. Total service revenue for international pest elimination was $169 million, $161 million and $146 million for 2006, 2005 and 2004, respectively.

 

Information on the types of products and services of each of the company’s operating segments is included on the inside front cover under “Services/Products Provided” of the Ecolab Overview section of this Annual Report.

 

The company evaluates the performance of its International operations based on fixed management currency exchange rates. All other accounting policies of the reportable segments are consistent with accounting principles generally accepted in the United States of America and the accounting policies of the company described in Note 2 of these notes to consolidated financial statements. The profitability of the company’s operating segments is evaluated by management based on operating income.

 

Financial information for each of the company’s reportable segments is as follows:

 

THOUSANDS

 

U.S.
CLEANING &
SANITIZING

 

U.S.
OTHER
SERVICES

 

TOTAL
U.S.

 

INTERNATIONAL

 

FOREIGN
CURRENCY
TRANSLATION

 

CORPORATE

 

CONSOLIDATED

 

NET SALES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2006

 

$

2,152,330

 

$

410,480

 

$

2,562,810

 

$

2,261,414

 

$

71,590

 

 

 

$

4,895,814

 

2005

 

1,952,220

 

375,234

 

2,327,454

 

2,136,664

 

70,714

 

 

 

4,534,832

 

2004

 

1,796,355

 

339,305

 

2,135,660

 

2,037,907

 

11,366

 

 

 

4,184,933

 

OPERATING INCOME (LOSS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2006

 

329,155

 

38,943

 

368,098

 

233,587

 

9,957

 

 

 

611,642

 

2005

 

279,960

 

36,012

 

315,972

 

219,104

 

7,344

 

 

 

542,420

 

2004

 

266,072

 

20,447

 

286,519

 

209,490

 

(1,758

)

$

(4,361

)

489,890

 

DEPRECIATION & AMORTIZATION

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2006

 

132,030

 

6,416

 

138,446

 

117,911

 

4,522

 

7,690

 

268,569

 

2005

 

123,644

 

5,460

 

129,104

 

113,564

 

7,595

 

6,672

 

256,935

 

2004

 

119,831

 

5,254

 

125,085

 

112,726

 

3,644

 

5,499

 

246,954

 

TOTAL ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2006

 

1,301,916

 

174,970

 

1,476,886

 

2,237,915

 

171,091

 

533,473

 

4,419,365

 

2005

 

1,348,706

 

154,870

 

1,503,576

 

2,100,205

 

(30,983

)

223,830

 

3,796,628

 

CAPITAL EXPENDITURES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2006

 

165,324

 

5,855

 

171,179

 

113,050

 

3,656

 

 

 

287,885

 

2005

 

149,100

 

7,246

 

156,346

 

108,245

 

4,192

 

 

 

268,783

 

2004

 

153,503

 

4,993

 

158,496

 

117,698

 

(323

)

 

 

275,871

 

 

Consistent with the company’s internal management reporting, corporate operating income includes special charges included on the consolidated statement of income for 2004. Corporate assets are principally cash and cash equivalents and short-term investments.

 

The company has two classes of products within its United States Cleaning & Sanitizing and International operations which comprise 10 percent or more of consolidated net sales. Sales of warewashing products were approximately 21 percent, 21 percent and 22 percent of consolidated net sales in 2006, 2005 and 2004, respectively. Sales of laundry products were approximately 10 percent, 11 percent and 10 percent of consolidated net sales in 2006, 2005 and 2004, respectively.

 

Property, plant and equipment of the company’s United States and International

 

DECEMBER 31 (THOUSANDS)

 

2006

 

2005

 

United States

 

$

599,153

 

$

532,430

 

International

 

332,200

 

338,117

 

Effect of foreign currency translation

 

20,216

 

(2,494

)

Consolidated

 

$

951,569

 

$

868,053

 

 

46




17. QUARTERLY FINANCIAL DATA (UNAUDITED)

 

THOUSANDS, EXCEPT PER SHARE

 

FIRST
QUARTER

 

SECOND
QUARTER

 

THIRD
QUARTER

 

FOURTH
QUARTER

 

YEAR

 

2006

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

 

 

 

 

 

 

 

 

 

 

United States Cleaning & Sanitizing

 

$

513,447

 

$

544,477

 

$

561,707

 

$

532,699

 

$

2,152,330

 

United States Other Services

 

93,233

 

104,902

 

108,297

 

104,048

 

410,480

 

International

 

510,088

 

561,800

 

584,273

 

605,253

 

2,261,414

 

Effect of foreign currency translation

 

3,307

 

14,705

 

24,578

 

29,000

 

71,590

 

Total

 

1,120,075

 

1,225,884

 

1,278,855

 

1,271,000

 

4,895,814

 

Cost of sales

 

552,491

 

608,003

 

625,554

 

630,010

 

2,416,058

 

Selling, general and administrative expenses

 

436,127

 

464,754

 

471,937

 

495,296

 

1,868,114

 

Operating income

 

 

 

 

 

 

 

 

 

 

 

United States Cleaning & Sanitizing

 

79,525

 

86,118

 

98,976

 

64,536

 

329,155

 

United States Other Services

 

8,009

 

10,625

 

12,466

 

7,843

 

38,943

 

International

 

43,238

 

55,145

 

66,221

 

68,983

 

233,587

 

Effect of foreign currency translation

 

685

 

1,239

 

3,701

 

4,332

 

9,957

 

Total

 

131,457

 

153,127

 

181,364

 

145,694

 

611,642

 

Interest expense, net

 

10,328

 

11,014

 

11,219

 

11,857

 

44,418

 

Income before income taxes

 

121,129

 

142,113

 

170,145

 

133,837

 

567,224

 

Provision for income taxes

 

43,243

 

48,934

 

59,786

 

46,646

 

198,609

 

Net income

 

$

77,886

 

$

93,179

 

$

110,359

 

$

87,191

 

$

368,615

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per common share

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.31

 

$

0.37

 

$

0.44

 

$

0.35

 

$

1.46

 

Diluted

 

$

0.30

 

$

0.36

 

$

0.43

 

$

0.34

 

$

1.43

 

Weighted-average common shares outstanding

 

 

 

 

 

 

 

 

 

 

 

Basic

 

253,540

 

252,152

 

251,573

 

251,263

 

252,132

 

Diluted

 

258,055

 

256,692

 

256,657

 

256,639

 

257,144

 

 

 

 

 

 

 

 

 

 

 

 

 

2005

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

 

 

 

 

 

 

 

 

 

 

United States Cleaning & Sanitizing

 

$

467,179

 

$

496,808

 

$

510,476

 

$

477,757

 

$

1,952,220

 

United States Other Services

 

85,810

 

96,328

 

98,315

 

94,781

 

375,234

 

International

 

483,997

 

536,454

 

550,197

 

566,016

 

2,136,664

 

Effect of foreign currency translation

 

32,894

 

29,074

 

5,785

 

2,961

 

70,714

 

Total

 

1,069,880

 

1,158,664

 

1,164,773

 

1,141,515

 

4,534,832

 

Cost of sales

 

526,975

 

571,066

 

572,862

 

577,928

 

2,248,831

 

Selling, general and administrative expenses

 

424,918

 

449,346

 

429,464

 

439,853

 

1,743,581

 

Operating income

 

 

 

 

 

 

 

 

 

 

 

United States Cleaning & Sanitizing

 

71,605

 

72,660

 

85,933

 

49,762

 

279,960

 

United States Other Services

 

7,534

 

10,287

 

11,124

 

7,067

 

36,012

 

International

 

36,503

 

52,431

 

64,212

 

65,958

 

219,104

 

Effect of foreign currency translation

 

2,345

 

2,874

 

1,178

 

947

 

7,344

 

Total

 

117,987

 

138,252

 

162,447

 

123,734

 

542,420

 

Interest expense, net

 

11,190

 

12,184

 

11,529

 

9,335

 

44,238

 

Income before income taxes

 

106,797

 

126,068

 

150,918

 

114,399

 

498,182

 

Provision for income taxes

 

37,371

 

44,667

 

52,960

 

43,703

 

178,701

 

Net income

 

$

69,426

 

$

81,401

 

$

97,958

 

$

70,696

 

$

319,481

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per common share

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.27

 

$

0.32

 

$

0.38

 

$

0.28

 

$

1.25

 

Diluted

 

$

0.27

 

$

0.31

 

$

0.38

 

$

0.27

 

$

1.23

 

Weighted-average common shares outstanding

 

 

 

 

 

 

 

 

 

 

 

Basic

 

256,272

 

255,474

 

255,817

 

255,402

 

255,741

 

Diluted

 

260,626

 

259,594

 

259,911

 

259,723

 

260,098

 

 

Per share amounts do not necessarily sum due to changes in the calculation of shares outstanding for each discrete period and rounding.

 

47




REPORTS OF MANAGEMENT

 

To our Shareholders:

 

MANAGEMENT’S RESPONSIBILITY FOR FINANCIAL STATEMENTS

 

Management is responsible for the integrity and objectivity of the consolidated financial statements. The statements have been prepared in accordance with accounting principles generally accepted in the United States of America and, accordingly, include certain amounts based on management’s best estimates and judgments.

 

The Board of Directors, acting through its Audit Committee composed solely of independent directors, is responsible for determining that management fulfills its responsibilities in the preparation of financial statements and maintains financial control of operations. The Audit Committee recommends to the Board of Directors the appointment of the company’s independent registered public accounting firm, subject to ratification by the shareholders. It meets regularly with management, the internal auditors and the independent auditors.

 

The independent registered public accounting firm has audited the consolidated financial statements included in this annual report and have expressed their opinion regarding whether these consolidated financial statements present fairly in all material respects our financial position and results of operation and cash flows as stated in their report presented separately herein.

 

MANAGEMENT’S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). Under the supervision and with the participation of management, including the principal executive officer and principal financial officer, an evaluation of the design and operating effectiveness of internal control over financial reporting was conducted based on the framework in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on the evaluation under the framework in Internal Control — Integrated Framework, management concluded that internal control over financial reporting was effective as of December 31, 2006.

 

Management’s assessment of the effectiveness of the company’s internal control over financial reporting as of December 31, 2006 has been audited by PricwaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report which is included herein.

 

/s/ Douglas M. Baker, Jr.

 

Douglas M. Baker, Jr.

Chairman of the Board, President and Chief Executive Officer

 

/s/ Steven L. Fritze

 

Steven L. Fritze

Executive Vice President and Chief Financial Officer

 

48




REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Shareholders and Directors of Ecolab Inc.:

 

We have completed integrated audits of Ecolab Inc.’s consolidated financial statements and of its internal control over financial reporting as of December 31, 2006, in accordance with the standards of the Public Company Accounting Oversight Board (United States). Our opinions, based on our audits, are presented below.

 

CONSOLIDATED FINANCIAL STATEMENTS

In our opinion, the accompanying consolidated balance sheet and the related consolidated statements of income, of cash flows, of comprehensive income and shareholders’ equity present fairly, in all material respects, the financial position of Ecolab Inc. and its subsidiaries at December 31, 2006 and 2005, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2006 in conformity with accounting principles generally accepted in the United States of America. These financial statements are the responsibility of Ecolab Inc.’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits of these statements in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit of financial statements includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation.

 

As discussed in Note 2 to the consolidated financial statements, Ecolab Inc. changed the manner in which it accounts for defined benefit pension and other postretirement plans effective December 31, 2006.

 

INTERNAL CONTROL OVER FINANCIAL REPORTING

Also, in our opinion, management’s assessment, included in the accompanying Management’s Report on Internal Control Over Financial Reporting, that Ecolab Inc. maintained effective internal control over financial reporting as of December 31, 2006 based on criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), is fairly stated, in all material respects, based on those criteria. Furthermore, in our opinion, Ecolab Inc. maintained, in all material respects, effective internal control over financial   reporting as of December 31, 2006, based on criteria established in Internal Control - Integrated Framework issued by the COSO. Ecolab Inc.’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting. Our responsibility is to express opinions on management’s assessment and on the effectiveness of Ecolab Inc.’s internal control over financial reporting based on our audit. We conducted our audit of internal control over financial reporting in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. An audit of internal control over financial reporting includes obtaining an understanding of internal control over financial reporting, evaluating management’s assessment, testing and evaluating the design and operating effectiveness of internal control, and performing such other procedures as we consider necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinions.

 

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

/s/ PricewaterhouseCoopers LLP

PricewaterhouseCoopers LLP

Minneapolis, Minnesota

February 23, 2007

 

49




SUMMARY OPERATING AND FINANCIAL DATA

 

DECEMBER 31 (THOUSANDS, EXCEPT PER SHARE)

 

2006

 

2005

 

2004

 

2003

 

OPERATIONS

 

 

 

 

 

 

 

 

 

Net sales

 

 

 

 

 

 

 

 

 

United States

 

$

2,562,810

 

$

2,327,454

 

$

2,135,660

 

$

2,014,767

 

International (at average rates of currency exchange during the year)

 

2,333,004

 

2,207,378

 

2,049,273

 

1,747,052

 

Total

 

4,895,814

 

4,534,832

 

4,184,933

 

3,761,819

 

Cost of sales (including special charges (income) of $(106) in 2004, $(76) in 2003 and $8,977 in 2002, $(566) in 2001 and $1,948 in 2000)

 

2,416,058

 

2,248,831

 

2,033,492

 

1,846,584

 

Selling, general and administrative expenses

 

1,868,114

 

1,743,581

 

1,657,084

 

1,459,818

 

Special charges, sale of business and merger expenses

 

 

 

 

 

4,467

 

408

 

Operating income

 

611,642

 

542,420

 

489,890

 

455,009

 

Gain on sale of equity investment

 

 

 

 

 

 

 

11,105

 

Interest expense, net

 

44,418

 

44,238

 

45,344

 

45,345

 

Income from continuing operations before income taxes, equity earnings and changes in accounting principle

 

567,224

 

498,182

 

444,546

 

420,769

 

Provision for income taxes

 

198,609

 

178,701

 

161,853

 

160,179

 

Equity in earnings of Henkel-Ecolab

 

 

 

 

 

 

 

 

 

Income from continuing operations

 

368,615

 

319,481

 

282,693

 

260,590

 

Gain from discontinued operations

 

 

 

 

 

 

 

 

 

Changes in accounting principle

 

 

 

 

 

 

 

 

 

Net income, as reported

 

368,615

 

319,481

 

282,693

 

260,590

 

Adjustments

 

 

 

 

 

 

 

 

 

Adjusted net income

 

$

368,615

 

$

319,481

 

$

282,693

 

$

260,590

 

Income per common share, as reported

 

 

 

 

 

 

 

 

 

Basic - continuing operations

 

$

1.46

 

$

1.25

 

$

1.10

 

$

1.00

 

Basic - net income

 

1.46

 

1.25

 

1.10

 

1.00

 

Diluted - continuing operations

 

1.43

 

1.23

 

1.09

 

0.99

 

Diluted - net income

 

1.43

 

1.23

 

1.09

 

0.99

 

Adjusted income per common share

 

 

 

 

 

 

 

 

 

Basic - continuing operations

 

1.46

 

1.25

 

1.10

 

1.00

 

Basic - net income

 

1.46

 

1.25

 

1.10

 

1.00

 

Diluted - continuing operations

 

1.43

 

1.23

 

1.09

 

0.99

 

Diluted - net income

 

$

1.43

 

$

1.23

 

$

1.09

 

$

0.99

 

Weighted-average common shares outstanding — basic

 

252,132

 

255,741

 

257,575

 

259,454

 

Weighted-average common shares outstanding — diluted

 

257,144

 

260,098

 

260,407

 

262,737

 

 

 

 

 

 

 

 

 

 

 

SELECTED INCOME STATEMENT RATIOS

 

 

 

 

 

 

 

 

 

Gross profit

 

50.7

%

50.4

%

51.4

%

50.9

%

Selling, general and administrative expenses

 

38.2

 

38.4

 

39.6

 

38.8

 

Operating income

 

12.5

 

12.0

 

11.7

 

12.1

 

Income from continuing operations before income taxes

 

11.6

 

11.0

 

10.6

 

11.2

 

Income from continuing operations

 

7.5

 

7.0

 

6.8

 

6.9

 

Effective income tax rate

 

35.0

%

35.9

%

36.4

%

38.1

%

 

 

 

 

 

 

 

 

 

 

FINANCIAL POSITION

 

 

 

 

 

 

 

 

 

Current assets

 

$

1,853,557

 

$

1,421,666

 

$

1,279,066

 

$

1,150,340

 

Property, plant and equipment, net

 

951,569

 

868,053

 

866,982

 

769,112

 

Investment in Henkel-Ecolab

 

 

 

 

 

 

 

 

 

Goodwill, intangible and other assets

 

1,614,239

 

1,506,909

 

1,570,126

 

1,309,466

 

Total assets

 

$

4,419,365

 

$

3,796,628

 

$

3,716,174

 

$

3,228,918

 

Current liabilities

 

$

1,502,730

 

$

1,119,357

 

$

939,547

 

$

851,942

 

Long-term debt

 

557,058

 

519,374

 

645,445

 

604,441

 

Postretirement health care and pension benefits

 

420,245

 

302,048

 

270,930

 

249,906

 

Other liabilities

 

259,102

 

206,639

 

262,111

 

201,548

 

Shareholders’ equity

 

1,680,230

 

1,649,210

 

1,598,141

 

1,321,081

 

Total liabilities and shareholders’ equity

 

$

4,419,365

 

$

3,796,628

 

$

3,716,174

 

$

3,228,918

 

 

 

 

 

 

 

 

 

 

 

SELECTED CASH FLOW INFORMATION

 

 

 

 

 

 

 

 

 

Cash provided by operating activities

 

$

627,564

 

$

590,136

 

$

570,908

 

$

523,932

 

Depreciation and amortization

 

268,569

 

256,935

 

246,954

 

228,103

 

Capital expenditures

 

287,885

 

268,783

 

275,871

 

212,035

 

Cash dividends declared per common share

 

$

0.4150

 

$

0.3625

 

$

0.3275

 

$

0.2975

 

 

 

 

 

 

 

 

 

 

 

SELECTED FINANCIAL MEASURES/OTHER

 

 

 

 

 

 

 

 

 

Total debt

 

$

1,066,036

 

$

746,301

 

$

701,577

 

$

674,644

 

Total debt to capitalization

 

38.8

%

31.2

%

30.5

%

33.8

%

Book value per common share

 

$

6.69

 

$

6.49

 

$

6.21

 

$

5.13

 

Return on beginning equity

 

22.4

%

20.0

%

21.4

%

23.3

%

Dividends per share/diluted net income per common share

 

29.0

%

29.5

%

30.0

%

30.1

%

Net interest coverage

 

13.8

 

12.3

 

10.8

 

10.0

 

Year end market capitalization

 

$

11,360,426

 

$

9,217,763

 

$

9,047,445

 

$

7,045,490

 

Annual common stock price range

 

$

46.40-33.64

 

$

37.15-30.68

 

$

35.59-26.12

 

$

27.92-23.08

 

Number of employees

 

23,130

 

22,404

 

21,338

 

20,826

 

 

Property, plant and equipment amounts have been restated to include capital software which was previously classified in other assets.  Results for 2004 through 1996 have been restated to reflect the effect of retroactive application of SFAS No. 123R, “Share-Based Payment”. The former Henkel-Ecolab joint venture is included as a consolidated subsidiary effective November 30, 2001.  Adjusted results for 1996 through 2001 reflect the pro forma effect of the discontinuance of the amortization of goodwill as if SFAS No. 142 had been in effect since January 1, 1996. All per share, shares outstanding and market price data reflect the two-for-one stock splits declared in 2003 and 1997.  Return on beginning equity is net income divided by beginning shareholders’ equity.

50




 

2002

 

2001

 

2000

 

1999

 

1998

 

1997

 

1996

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$       1,923,500

 

$

1,821,902

 

$

1,746,698

 

$

1,605,385

 

$

1,429,711

 

$

1,251,517

 

$

1,127,281

 

1,480,085

 

498,808

 

483,963

 

444,413

 

431,366

 

364,524

 

341,231

 

3,403,585

 

2,320,710

 

2,230,661

 

2,049,798

 

1,861,077

 

1,616,041

 

1,468,512

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,688,710

 

1,121,133

 

1,056,899

 

963,900

 

875,102

 

745,437

 

694,909

 

1,304,239

 

898,159

 

864,072

 

804,436

 

730,170

 

655,726

 

590,641

 

37,031

 

824

 

(20,736

)

 

 

 

 

 

 

 

 

373,605

 

300,594

 

330,426

 

281,462

 

255,805

 

214,878

 

182,962

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

43,895

 

28,434

 

24,605

 

22,713

 

21,742

 

12,637

 

14,372

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

329,710

 

272,160

 

305,821

 

258,749

 

234,063

 

202,241

 

168,590

 

131,277

 

110,453

 

124,467

 

106,412

 

99,340

 

83,911

 

69,840

 

 

 

15,833

 

19,516

 

18,317

 

16,050

 

13,433

 

13,011

 

198,433

 

177,540

 

200,870

 

170,654

 

150,773

 

131,763

 

111,761

 

1,882

 

 

 

 

 

 

 

38,000

 

 

 

 

 

(4,002

)

 

 

(2,428

)

 

 

 

 

 

 

 

 

196,313

 

177,540

 

198,442

 

170,654

 

188,773

 

131,763

 

111,761

 

 

 

18,471

 

17,762

 

16,631

 

14,934

 

11,195

 

10,683

 

$          196,313

 

$

196,011

 

$

216,204

 

$

187,285

 

$

203,707

 

$

142,958

 

$

122,444

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$                0.77

 

$

0.70

 

$

0.79

 

$

0.66

 

$

0.58

 

$

0.51

 

$

0.43

 

0.76

 

0.70

 

0.78

 

0.66

 

0.73

 

0.51

 

0.43

 

0.76

 

0.68

 

0.76

 

0.63

 

0.56

 

0.49

 

0.42

 

0.75

 

0.68

 

0.75

 

0.63

 

0.70

 

0.49

 

0.42

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.77

 

0.77

 

0.86

 

0.72

 

0.64

 

0.55

 

0.47

 

0.76

 

0.77

 

0.85

 

0.72

 

0.79

 

0.55

 

0.47

 

0.76

 

0.75

 

0.83

 

0.70

 

0.62

 

0.53

 

0.46

 

$                0.75

 

$

0.75

 

$

0.82

 

$

0.70

 

$

0.76

 

$

0.53

 

$

0.46

 

258,147

 

254,832

 

255,505

 

259,099

 

258,314

 

258,891

 

257,983

 

261,574

 

259,855

 

263,892

 

268,837

 

268,095

 

267,643

 

265,634

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

50.4%

 

51.7

%

52.6

%

53.0

%

53.0

%

53.9

%

52.7

%

38.3

 

38.7

 

38.7

 

39.2

 

39.2

 

40.6

 

40.2

 

11.0

 

13.0

 

14.8

 

13.7

 

13.7

 

13.3

 

12.5

 

9.7

 

11.7

 

13.7

 

12.6

 

12.6

 

12.5

 

11.5

 

5.8

 

7.7

 

9.0

 

8.3

 

8.1

 

8.2

 

7.6

 

39.8%

 

40.6

%

40.7

%

41.1

%

42.4

%

41.5

%

41.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$       1,015,937

 

$

929,583

 

$

600,568

 

$

577,321

 

$

503,514

 

$

509,501

 

$

435,507

 

716,095

 

668,413

 

512,581

 

454,376

 

423,941

 

400,537

 

336,314

 

 

 

 

 

199,642

 

219,003

 

253,646

 

239,879

 

285,237

 

1,133,875

 

943,400

 

411,871

 

341,966

 

293,528

 

267,731

 

151,403

 

$       2,865,907

 

$

2,541,396

 

$

1,724,662

 

$

1,592,666

 

$

1,474,629

 

$

1,417,648

 

$

1,208,461

 

$          853,828

 

$

827,952

 

$

532,034

 

$

470,674

 

$

399,791

 

$

404,464

 

$

327,771

 

539,743

 

512,280

 

234,377

 

169,014

 

227,041

 

259,384

 

148,683

 

207,596

 

183,281

 

117,790

 

97,527

 

85,793

 

76,109

 

73,577

 

144,993

 

121,135

 

72,803

 

86,715

 

67,829

 

124,641

 

138,415

 

1,119,747

 

896,748

 

767,658

 

768,736

 

694,175

 

553,050

 

520,015

 

$       2,865,907

 

$

2,541,396

 

$

1,724,662

 

$

1,592,666

 

$

1,474,629

 

$

1,417,648

 

$

1,208,461

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$          412,697

 

$

358,508

 

$

309,813

 

$

290,098

 

$

233,727

 

$

234,126

 

$

253,819

 

220,635

 

158,785

 

143,212

 

129,240

 

117,646

 

97,449

 

86,791

 

212,757

 

157,937

 

150,009

 

145,622

 

147,631

 

121,667

 

111,518

 

$            0.2750

 

$

0.2625

 

$

0.2450

 

$

0.2175

 

$

0.1950

 

$

0.1675

 

$

0.1450

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$          699,842

 

$

745,673

 

$

370,969

 

$

281,074

 

$

295,032

 

$

308,268

 

$

176,292

 

38.5%

 

45.4

%

32.6

%

26.8

%

29.8

%

35.8

%

25.3

%

$                4.31

 

$

3.51

 

$

3.02

 

$

2.97

 

$

2.68

 

$

2.14

 

$

2.01

 

21.9%

 

23.1

%

25.8

%

24.6

%

34.1

%

25.3

%

24.5

%

36.7%

 

38.6

%

32.7

%

34.5

%

27.9

%

34.2

%

34.5

%

8.5

 

10.6

 

13.4

 

12.4

 

11.8

 

17.0

 

12.7

 

$       6,432,035

 

$

5,147,980

 

$

5,492,072

 

$

5,063,409

 

$

4,685,512

 

$

3,579,240

 

$

2,450,258

 

$    25.20-18.27

 

$

22.10-14.25

 

$

22.85-14.00

 

$

22.22-15.85

 

$

19.00-13.07

 

$

14.00-9.07

 

$

9.88-7.28

 

20,417

 

19,326

 

14,250

 

12,870

 

12,007

 

10,210

 

9,573

 

 

51



EXHIBIT (21)

Registrant

ECOLAB INC.

Name of Affiliate

 

State or Other
 Jurisdiction of
 Incorporation

 

Percentage
 of
Ownership

 

 

 

 

 

Ecolab (Antigua) Ltd.

 

Antigua

 

100

 

 

 

 

 

Ecolab S.A.

 

Argentina

 

100

 

 

 

 

 

Ecolab Australia Pty Ltd.

 

Australia

 

100

 

 

 

 

 

Ecolab Pty Ltd.

 

Australia

 

100

 

 

 

 

 

Ecolab Water Care Services Pty Limited

 

Australia

 

100

 

 

 

 

 

Gibson Chemical Industries Pty Ltd.

 

Australia

 

100

 

 

 

 

 

Gibson Chemicals (NSW) Pty Limited

 

Australia

 

100

 

 

 

 

 

Gibson Chemicals Fiji Pty Limited

 

Australia

 

100

 

 

 

 

 

Gibson Chemicals Pty Limited

 

Australia

 

100

 

 

 

 

 

Robust Chemicals Pty Limited

 

Australia

 

100

 

 

 

 

 

Vessey Chemicals (Holdings) Pty Limited

 

Australia

 

95

 

 

 

 

 

Vessey Chemicals Pty Limited

 

Australia

 

95

 

 

 

 

 

Vessey Chemicals (Vic.) Pty Limited

 

Australia

 

95

 

 

 

 

 

Vessey Chemicals (WA) Pty Limited

 

Australia

 

95

 

 

 

 

 

Ecolab Ges.m.b.H

 

Austria

 

100

 

 

 

 

 

Ecolab Holding Europe GmbH

 

Austria

 

100

 

 

 

 

 

Ecolab Limited

 

Bahamas

 

100

 

 

 

 

 

Ecolab (Barbados) Limited

 

Barbados

 

100

 

 

 

 

 

Ecolab B.V.B.A./S.P.R.L.

 

Belgium

 

100

 

 

 

 

 

Kay N.V.

 

Belgium

 

100

 

 

 

 

 

Ecolab Emprecendimentos E Participacoes Ltda.

 

Brazil

 

100

 

 

 

 

 

Ecolab Quimica Ltda.

 

Brazil

 

100

 




 

 

 

 

 

 

Ecolab EOOD

 

Bulgaria

 

100

 

 

 

 

 

Ecolab Co.

 

Canada

 

100

 

 

 

 

 

Ecolab S.A.

 

Chile

 

100

 

 

 

 

 

Ecolab Colombia S.A.

 

Colombia

 

100

 

 

 

 

 

Ecolab, Sociedad Anonima

 

Costa Rica

 

100

 

 

 

 

 

Ecolab d.o.o.

 

Croatia

 

100

 

 

 

 

 

Ecolab Holding (Cyprus) Limited

 

Cyprus

 

100

 

 

 

 

 

Ecolab Hygiene s.r.o.

 

Czech Republic

 

100

 

 

 

 

 

Ecolab ApS

 

Denmark

 

100

 

 

 

 

 

Ecolab Holding Denmark ApS

 

Denmark

 

100

 

 

 

 

 

Ecolab, S.A. de C.V.

 

El Salvador

 

100

 

 

 

 

 

Oy Ecolab AB

 

Finland

 

100

 

 

 

 

 

Ecolab Pest IDF SAS

 

France

 

100

 

 

 

 

 

Artois Chimie SAS

 

France

 

100

 

 

 

 

 

Alpha Holding SAS

 

France

 

100

 

 

 

 

 

Amboile Services SAS

 

France

 

100

 

 

 

 

 

Amperia SARL

 

France

 

100

 

 

 

 

 

Biophyte SARL

 

France

 

100

 

 

 

 

 

Centre Régional de Désinfectisation et de Dératisation SAS

 

France

 

100

 

 

 

 

 

Ecolab SAS

 

France

 

100

 

 

 

 

 

Ecolab SNC

 

France

 

100

 

 

 

 

 

Hygiene Champenoise SAS

 

France

 

100

 

 

 

 

 

Hygiene de L’Est SAS

 

France

 

100

 

 

 

 

 

Lorillou Hygiene SAS

 

France

 

100

 




 

Multiser SA

 

France

 

100

 

 

 

 

 

Nigiko SAS

 

France

 

100

 

 

 

 

 

Omniser SARL

 

France

 

100

 

 

 

 

 

SCI Aphomia

 

France

 

100

 

 

 

 

 

SCI Dugard

 

France

 

100

 

 

 

 

 

SCI Dumoulin

 

France

 

100

 

 

 

 

 

SCI Eliomys

 

France

 

100

 

 

 

 

 

SCI Erebia

 

France

 

100

 

 

 

 

 

SCI Louvette

 

France

 

100

 

 

 

 

 

SCI Marco

 

France

 

100

 

 

 

 

 

SCI Orly

 

France

 

100

 

 

 

 

 

Shield Medicare sarl

 

France

 

100

 

 

 

 

 

Bionagro Natureprodukte GmbH

 

Germany

 

100

 

 

 

 

 

Ecolab Beteiligungs GmbH

 

Germany

 

100

 

 

 

 

 

Ecolab Deutschland GmbH

 

Germany

 

100

 

 

 

 

 

Ecolab Export GmbH

 

Germany

 

100

 

 

 

 

 

Ecolab Holding GmbH

 

Germany

 

100

 

 

 

 

 

Ecolab GmbH & Co. OHG

 

Germany

 

100

 

 

 

 

 

Ecolab Management GmbH

 

Germany

 

100

 

 

 

 

 

Ecolab NFK Beteilgungen Management GmbH

 

Germany

 

100

 

 

 

 

 

Ecolab NFK R&D GmbH & Co. OHG

 

Germany

 

100

 

 

 

 

 

Ecolab NFK R&D Verwaltungs GmbH

 

Germany

 

100

 

 

 

 

 

Ecolab Technologies GmbH

 

Germany

 

100

 

 

 

 

 

Lang Apparatebau GmbH

 

Germany

 

100

 




 

Lang Engineering GmbH

 

Germany

 

100

 

 

 

 

 

Lang Hygiene Systeme GmbH

 

Germany

 

100

 

 

 

 

 

Shield Medicare GmbH

 

Germany

 

100

 

 

 

 

 

Ecolab A.E.B.E.

 

Greece

 

100

 

 

 

 

 

Ecolab (Guam) LLC

 

Guam

 

100

 

 

 

 

 

Ecolab, Sociedad Anonima

 

Guatemala

 

100

 

 

 

 

 

Peter Cox Insurance Co. Limited

 

Guernsey

 

100

 

 

 

 

 

Quimicas Ecolab, S.A.

 

Honduras

 

100

 

 

 

 

 

Ecolab Limited

 

Hong Kong

 

100

 

 

 

 

 

Ecolab Holding Hungary Ltd.

 

Hungary

 

100

 

 

 

 

 

Ecolab Hygiene Kft.

 

Hungary

 

100

 

 

 

 

 

P.T. Ecolab Indonesia

 

Indonesia

 

100

 

 

 

 

 

Eclab Export Limited

 

Ireland

 

100

 

 

 

 

 

Ecolab Co.

 

Ireland

 

100

 

 

 

 

 

Ecolab Finance Company Limited

 

Ireland

 

100

 

 

 

 

 

Ecolab (Holdings) Limited

 

Ireland

 

100

 

 

 

 

 

Ecolab Limited

 

Ireland

 

100

 

 

 

 

 

Ecolab JVZ Limited

 

Israel

 

100

 

 

 

 

 

Ecolab-Zohar Dalia L.P.

 

Israel

 

51

 

 

 

 

 

Ecolab-Zohar Dalia Management Company Ltd.

 

Israel

 

51

 

 

 

 

 

Ecolab Holding Italy Srl

 

Italy

 

100

 

 

 

 

 

Ecolab Srl

 

Italy

 

100

 

 

 

 

 

Elton Chemical Srl

 

Italy

 

100

 

 

 

 

 

Findesadue Srl

 

Italy

 

100

 

 

 

 

 

Ecolab Limited

 

Jamaica

 

100

 

 

 

 

 

Ecolab K.K.

 

Japan

 

100

 




 

Ecolab East Africa (Kenya) Limited

 

Kenya

 

100

 

 

 

 

 

Ecolab Korea Ltd.

 

Korea

 

100

 

 

 

 

 

Ecolab SIA

 

Latvia

 

100

 

 

 

 

 

Ecolab-Importacao E Exportacao Limitada

 

Macau

 

100

 

 

 

 

 

Ecolab Sdn Bhd

 

Malaysia

 

100

 

 

 

 

 

Ecolab, S. de R.L. de C.V.

 

Mexico

 

100

 

 

 

 

 

Ecolab Holdings Mexico, S.A. de C.V.

 

Mexico

 

100

 

 

 

 

 

Ecolab Maroc S. A.

 

Morocco

 

100

 

 

 

 

 

Ecolab (Proprietary) Limited

 

Namibia

 

100

 

 

 

 

 

Ecolab Finance N.V.

 

Netherlands Antilles (Curacao)

 

100

 

 

 

 

 

Ecolabone B.V.

 

Netherlands

 

100

 

 

 

 

 

Ecolabtwo B.V.

 

Netherlands

 

100

 

 

 

 

 

Ecolab Holdings B.V.

 

Netherlands

 

100

 

 

 

 

 

Ecolab B.V.

 

Netherlands

 

100

 

 

 

 

 

Ecolab Limited

 

New Zealand

 

100

 

 

 

 

 

Ecolab Nicaragua, S.A.

 

Nicaragua

 

100

 

 

 

 

 

Ecolab A/S

 

Norway

 

100

 

 

 

 

 

Ecolab S.A.

 

Panama

 

100

 

 

 

 

 

Ecolab Chemicals Ltd.

 

People’s Republic of China

 

100

 

 

 

 

 

Ecolab China Ltd.

 

People’s Republic of China

 

100

 

 

 

 

 

Ecolab (GZ) Chemicals Limited

 

People’s Republic of China

 

100

 

 

 

 

 

Ecolab Perú Holdings S.R.L.

 

Peru

 

100

 

 

 

 

 

Ecolab Philippines Inc.

 

Philippines

 

100

 

 

 

 

 

Ecolab Sp.z o.o.

 

Poland

 

100

 




 

Ecolab S.R.L.

 

Romania

 

100

 

 

 

 

 

ZAO Ecolab

 

Russia

 

100

 

 

 

 

 

Ecolab Hygiene d.o.o.

 

Serbia

 

100

 

 

 

 

 

Ecolab Pte. Ltd.

 

Singapore

 

100

 

 

 

 

 

Ecolab s.r.o.

 

Slovakia

 

100

 

 

 

 

 

Ecolab d.o.o.

 

Slovenia

 

100

 

 

 

 

 

Ecolab (Proprietary) Ltd.

 

South Africa

 

100

 

 

 

 

 

Ecolab Hispano-Portuguesa, S.A.

 

Spain

 

100

 

 

 

 

 

Ecolab (St. Lucia) Limited

 

St. Lucia

 

100

 

 

 

 

 

Ecolab AB

 

Sweden

 

100

 

 

 

 

 

Ecolab GmbH

 

Switzerland

 

100

 

 

 

 

 

Ecolab Ltd.

 

Taiwan

 

100

 

 

 

 

 

Ecolab East Africa (Tanzania) Limited

 

Tanzania

 

100

 

 

 

 

 

Ecolab Ltd.

 

Thailand

 

100

 

 

 

 

 

Ecolab Temizleme Sistemleri Limited Sirketi

 

Turkey

 

100

 

 

 

 

 

Ecolab East Africa (Uganda) Limited

 

Uganda

 

100

 

 

 

 

 

Ecolab LLC

 

Ukraine

 

100

 

 

 

 

 

Ecolab Gulf FZE

 

UAE

 

100

 

 

 

 

 

Ecolab Limited

 

United Kingdom

 

100

 

 

 

 

 

Ecolab (U.K.) Holdings Limited

 

United Kingdom

 

100

 

 

 

 

 

Peter Cox Limited

 

United Kingdom

 

100

 

 

 

 

 

Shield Holdings Limited

 

United Kingdom

 

100

 

 

 

 

 

Shield Medicare Limited

 

United Kingdom

 

100

 

 

 

 

 

Shield Salvage Associates Limited

 

United Kingdom

 

100

 




 

Sterishield Systems Limited

 

United Kingdom

 

100

 

 

 

 

 

Ecolab S. A.

 

Uruguay

 

100

 

 

 

 

 

Ecolab Foreign Sales Corp.

 

U.S. Virgin Islands

 

100

 

 

 

 

 

Ecolab S.A.

 

Venezuela

 

74

 

 

 

 

 

United States

 

 

 

 

 

 

 

 

 

Daydots Inc.

 

Delaware

 

100

 

 

 

 

 

Ecolabone LLC

 

Delaware

 

100

 

 

 

 

 

Ecolabtwo LLC

 

Delaware

 

100

 

 

 

 

 

Ecolabthree LLC

 

Delaware

 

100

 

 

 

 

 

Ecolabfour LLC

 

Delaware

 

100

 

 

 

 

 

Ecolabfive LLC

 

Delaware

 

100

 

 

 

 

 

Ecolabsix LLC

 

Delaware

 

100

 

 

 

 

 

Ecolabseven LLC

 

Delaware

 

100

 

 

 

 

 

Ecolab AP Holdings LLC

 

Delaware

 

100

 

 

 

 

 

Ecolab Finance Inc.

 

Delaware

 

100

 

 

 

 

 

Ecolab Holdings Inc.

 

Delaware

 

100

 

 

 

 

 

Ecolab Holdings (Europe) Inc.

 

Delaware

 

100

 

 

 

 

 

Ecolab Investment Inc.

 

Delaware

 

100

 

 

 

 

 

Ecolab Israel Holdings LLC

 

Delaware

 

100

 

 

 

 

 

Ecolab Manufacturing Inc.

 

Delaware

 

100

 

 

 

 

 

Ecolab Marketing LLC

 

Delaware

 

100

 

 

 

 

 

GCS Service, Inc.

 

Delaware

 

100

 

 

 

 

 

ETAC Inc.

 

Minnesota

 

100

 

 

 

 

 

Kay Chemical Company

 

North Carolina

 

100

 




 

Kay Chemical International, Inc.

 

North Carolina

 

100

 

 

 

 

 

Wabasha Leasing LLC

 

Delaware

 

100


Certain additional subsidiaries, which are not significant in the aggregate, are not shown.



Exhibit (24)

POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENTS , That the undersigned, a director of Ecolab Inc., a Delaware corporation, does hereby make, nominate and appoint LAWRENCE T. BELL and SARAH Z. ERICKSON, and each of them, to be my attorney-in-fact, with full power and authority to sign his or her name to the Annual Report on Form 10-K of Ecolab Inc. for the fiscal year ended December 31, 2006, and all amendments thereto, provided that the Annual Report and any amendments thereto, in final form, be approved by said attorney-in-fact; and his or her name, when thus signed, shall have the same force and effect as though I had manually signed said document.

IN WITNESS WHEREOF , I have hereunto affixed my signature this 23 rd  day of February, 2007.

 

/s/Les S. Biller

 

 

 

 

 Les S. Biller

 

 

 

 

/s/Richard U. De Schutter

 

 

 

 

Richard U. De Schutter

 

 

 

 

/s/Jerry A. Grundhofer

 

 

 

 

Jerry A. Grundhofer

 

 

 

 

/s/Stefan Hamelmann

 

 

 

 

Stefan Hamelmann

 

 

 

 

/s/Joel W. Johnson

 

 

 

 

Joel W. Johnson

 

 

 

 

/s/Jerry W. Levin

 

 

 

 

Jerry W. Levin

 

 

 

 

/s/Robert L. Lumpkins

 

 

 

 

Robert L. Lumpkins

 

 

 

 

/s/Beth M. Pritchard

 

 

 

 

Beth M. Pritchard

 

 

 

 

/s/Kasper Rorsted

 

 

 

 

Kasper Rorsted

 

 

 

 

/s/John J. Zillmer

 

 

 

 

John J. Zillmer

 

 

 



EXHIBIT (31)

CERTIFICATIONS

I, Douglas M. Baker, Jr., certify that:

1.                                        I have reviewed this annual report on Form 10-K of Ecolab Inc.;

2.                                        Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.                                        Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.                                        The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)                                   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)                                  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)                                   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and




(d)                                  Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.                                        The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)                                   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)                                  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 28, 2007

/s/Douglas M. Baker, Jr.

 

Douglas M. Baker, Jr.

 

Chairman of the Board,

 

President and Chief Executive Officer

 

 




I, Steven L. Fritze, certify that:

1.                                        I have reviewed this annual report on Form 10-K of Ecolab Inc.;

2.                                        Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.                                        Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.                                        The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)                                   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)                                  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)                                   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and




(d)                                  Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.                                        The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)                                   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)                                  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 28, 2007

/s/Steven L. Fritze

 

Steven L. Fritze

 

Executive Vice President and

 

Chief Financial Officer

 

 



EXHIBIT (32)

SECTION 1350 CERTIFICATIONS

Pursuant to 18 U.S.C. Section 1350, each of the undersigned officers of Ecolab Inc. does hereby certify that:

(a)                                   the Annual Report on Form 10-K of Ecolab Inc. for the year ended December 31, 2006 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(b)                                  information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Ecolab Inc.

 

Dated: February 28, 2007

 

/s/Douglas M. Baker, Jr.

 

 

Douglas M. Baker, Jr.

 

 

Chairman of the Board, President and

 

 

Chief Executive Officer

 

 

 

 

 

 

 

 

 

 Dated: February 28, 2007

 

/s/Steven L. Fritze

 

 

Steven L. Fritze

 

 

Executive Vice President and

 

 

Chief Financial Officer